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Abstract 
Introduction: Prions of yeast present a novel analytical challenge in terms of both initial 
characterization and in vitro manipulation as models for human disease research. Presently, 
few robust analysis strategies have been successfully implemented which enable the 
efficient study of prion behavior in vivo. This study sought to evaluate the utilization of 
conventional dual-channel cDNA microarrays for the surveillance of transcriptomic 
regulation patterns by the [PSI+] yeast prion relative to an identical prion deficient yeast 
variant, [psi-].  
Methods: A data analysis and normalization workflow strategy was developed and 
applied to cDNA array images, yielded quality-regulated expression ratios for a subset of 
genes exhibiting statistical congruence across multiple experimental repetitions and 
nested hybridization events. The significant gene list was analyzed using classical 
analytical approaches including several clustering-based methods and singular value 
decomposition. To add biological meaning to the differential expression data in hand, 
functional annotation using the Gene Ontology as well as several pathway-mapping 
approaches was conducted. Finally, the expression patterns observed were queried 
against all publically curated microarray data performed using S. cerevisiae in order to 
discover similar expression behavior across a vast array of experimental conditions.  
Results: These data collectively implicate a low-level of overall genomic regulation 
as a result of the [PSI+] state, where the maximum statistically significant degree of 
differential expression was less than ±1 Log2(FC) in all cases. Notwithstanding, the [PSI+] 
differential expression was localized to several specific classes of structural elements and 
iv 
 
cellular functions, implying under homeostatic conditions, significant up or down 
regulation is likely unnecessary, but possible in those specific systems if environmental 
conditions warranted. As a result of these findings additional work pertaining to this 
system should include controlled insult to both yeast variants of differing environmental 
properties to promote a potential [PSI+] regulatory response coupled with co-surveillance 
of these conditions using transcriptomic and proteomic analysis methodologies.  
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Introduction 
 
Prions and the characterization of the [PSI+] state in Saccharomyces cerevisiae 
 
 Perhaps one of the most elusive artifacts of proteomic evolution to characterize is the de 
novo appearance of infectious protein residues, known as prions. These particles, first described 
by Stanley Prusiner at the University of California, are a modified form of a normal protein that 
has undergone secondary and tertiary structural re-organization whereby the alpha helices and 
coiled-coil structures of the protein re-fold and align as beta-pleated sheets (Prusiner, Molecular 
biology of prion diseases, 1991). This structural modification serves to alter the physiochemical 
properties of the protein acting not only as a framework which facilitates the conversion of a 
normal protein structure to the prion variant, but also instigating the aggregation of the 
predominately beta pleated sheet structures into amyloid fibrils (Prusiner, Prions, 1998).  It is this 
aggregation of amyloid fibers that has been established as the causal element in a number of 
neurodegenerative conditions broadly classified as transmissible spongiform encephalopathies. 
Characterized pathologies in this disease class include Creutzfeldt-Jakob (CJ), kuru, Gerstmann-
Sträussler-Scheinker syndrome (GSS) and Fatal Familial Insomnia (FLL) (Wisnieweksi & Sigurdsson, 
2007).  Due to the difficulty in the diagnosis of these diseases and further complications associated 
with their study due to practical limitations, a model organism (in this study Saccharomyces 
cerevisiae containing a prion protein determinant) provides a practical mechanism to characterize 
prion behavior and propagation in-vivo.  
 While several prion proteins have been identified in S. cerevisiae, perhaps one of the best 
characterized is Sup35p (the Sup35 gene product). Originally described in parallel with an 
unrelated yeast prion, Ure2p in 1994 by Reed Wickner at the NIDDK, (Wickner R. , 1994) the 
Sup35p prion variant has been extensively investigated by a robust research community as a 
cytoplasmic heritable element responsible for a constellation of phenotypic consequences. 
Saccharomyces lineages known to harbor the Sup35p prion variant are denoted by the capitalized 
dominant phenotype indicated in brackets (indicating a non-mendelian inheritance modality); 
[PSI+], with wild-type strains referred to as [psi-]. (Tuite M. F., Appendix IV: Nomenclature for 
Yeast Genes and Proteins, 1998) Under normal circumstances in [psi-] wild type Sup35 
(YDR172W) produces Eukaryotic Release Factor 3 (eRF3), which, in complex with the SUP45 gene 
product, eRF1, terminates ribosomal translation of mRNA into a polypeptide (Liebman & 
Derkatch, 1999), summarized in the schematic shown below (Figure 1). 
 
Figure 11: Translational release in Eukaryotes. Proper translational release from the ribosomal subunit complex in 
eukaryotes is dependent on the functionality of a complex comprised of Eukaryotic Release Factors 1 and 3. Essentially 
the process begins upon entry of a stop codon into the A-site of the ribosomal complex, and is recognized by eRF1, 
already complexed to eRF3 (which has further recruited and bound a Guanosine Triphosphate (GTP) molecule). The 
ribosome bound release complex then stimulates cleavage of the peptide-tRNA bond and is then released itself via GTP 
hydrolysis. Thus, in this manner, the peptide chain and translational release complex are disengaged from the ribosomal 
complex, which later dissociates into the individual components of the ribosomal complex. (Valouev, Kushnirov, & Ter-
Avanesyan, 2002) 
 
However, in its [PSI+] prion state Sup35pPSI+ prohibits efficient translational release via the 
formation of eRF3 aggregates due to altered conformation of the n-terminus, prion-inducible, 
1 (Image credit: http://www.ewa.cz/pages1/813_soubory/termination.gif) 
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region of the mature protein (True & Lindquist, 2000). Transition of eRF3 to this prion form causes 
the de novo formation of insoluble amyloid fibrils, resultant of participation of the N-terminus 
region in a rigid, cross-β spine of amyloid fibrils, illustrated graphically in Figure 2. (Nelson, et al., 
2005) 
 
Figure 2:  Soluble and amyloid ERF3. A) Native soluble eRF3 crystal structure (PDB ID: 1R5N) complexed with 
Guanosine-5-diphosphate, illustrating the native α helices predominate at the N-terminal region. B) The 7 residue 
peptide of the eRF3 N-Terminus region (PDB ID: 1YJP) which participates in amyloid fibril formation via strong 
association in β-sheet conformation with architecture of the amyloid-type, cross-β spine shown (C) (Nelson, et al., 2005) 
 
Presence of the eRF3 prion variant in yeast causes several phenotypic deviations from yeast 
containing native eRF3, most notably a significant loss in translational release fidelity, causing 
intermittent read-through of stop codons during normal translation of mRNAs by ribosomes.  
In particular, this phenomenon is readily observed by the difference in colony color of a 
particular strain of yeast, which is ADE1 deficient.  The [psi-] strain appears red due to the 
inhibition of adenine synthesis caused by a missense mutation, specifically the insertion of a 
premature stop-codon in the ADE1 gene, an N-succinyl-5-aminoimidazole-4-carboxamide ribotide 
(SAICAR) synthetase, which is required for de novo purine nucleotide biosynthesis. This pathway 
inhibition causes a by-product to collect in the cell that must ultimately be excreted as waste, 
yielding a distinctive red colony color in [psi-] yeast with the mutant ADE1. Subsequently [PSI+], 
which exhibits poor translational release, ignores the premature stop codon during ADE1 
translation and as a result, ADE1 is translated properly. Since the immature ADE1 product is not 
excreted, [PSI+] yeast exhibits a white or pinkish color and adenine synthesis proceeds normally 
A 
B C 
3 
(Cox, Tuite, & McLauglin, 1988). While such phenotypic differences as colony color and 
morphology assist in differentiating between [PSI+] and [psi-], there are little consensus on the 
physiologically beneficial aspects of the prion form manifesting itself in the cell itself. This fact 
seems to be paradoxical in nature since it is known that this particular prion form is well conserved 
in the evolution of S. cerevisiae, being persistent for well over 100 million years. This indicates not 
only the possibility of a specific desirable function yielded from its conservation, but also a model 
for epigenetic inheritance via cytosolic transmittance of the prion from parent to progeny. 
(Uptain, Sawicki, Caughey, & Lindquist, 2001) It is this seemingly persistent evasion of the strong 
evolutionary force of natural selection which promotes curing of deleterious characteristics 
associated with many prion strains, [PSI+] in particular, that begs further investigation (Saupe & 
Supattapone, 2006) 
 One possible explanation of conserved prion SUP35 inheritance is its marked effect on 
the translation release complex with respect to translational fidelity. Normal translational 
termination is regarded in eukaryotes as a highly efficient process, with suppression of this event 
occurring at very low rates (0.001% -0.1%). (Keeling, et al., 2004) However with the [PSI+] state, 
yeast demonstrate a significantly higher rate of termination suppression, with estimates of the 
actual rate of read through ranging from 10% - 30% (Wilson, Meaux, Parker, & van Hoof, 2005). 
Thus, by this mechanism, large regions of the 3’ Untranslated Region (UTR), are incorporated into 
the growing polypeptide chain, in some cases with sufficient extension to allow for the addition 
of secondary and tertiary structures, altering the physiochemical properties of the protein 
translated. In this manner, it is plausible that the prion may in fact convey additional directed 
patterns of proteome expression for the potential benefit of the organism as a whole. 
Furthermore, this partial read-through event is likely heavily regulated at multiple levels of 
genomic data processing and dependent on a number of factors, which may act in harmony with 
4 
other characteristics of the prion state, accessing yet undiscovered control over the yeast 
phenotype. 
Indeed, it is the observable phenotypic deviations caused by the [PSI+] state, which has 
allowed most of the information available regarding prion maintenance to be collected. Most 
notable is the curious relationship between [PSI+] and members of the Heat Shock Family of 
proteins, reviewed in recent literature ( (Cashikar, Duennwald, & Lindquist, 2005) and (Jones & 
Masison, 2002).   Typifying this relationship is Hsp104, which acts as a molecular chaperone 
performing housekeeping functions in S. cerevisiae that are essential to cellular homeostasis (Bosl, 
Grimminger, & Walter, 2006). Specifically, Hsp104 as a hexamer acts to mediate the cellular 
response to environmental stress, particularly increasing the thermotolerance of the cell via its 
ability to salvage heat-denatured proteins. It has been previously established that Hsp104, in 
conjunction with other protein re-folding factors, works to re-solubilize damaged or inactivated 
proteins including Sup35pPSI+ aggregates in-vivo (Inoue, Taguchi, Kishimoto, & Yoshida, 2004), a 
process depicted by the diagram given in Figure 3 below. 
 
Figure 3: Prion maintenance via heat shock proteins. A proposed model of cellular maintenance of PSI+ aggregates, 
which indicates the integral relationship of chaperone proteins and activated hexameric Hsp104 in the maintenance of 
polymeric Sup35 (eRF3). Here chaperones Ydj1, Ssa1, Ssa2,Ssb, Sla2, Sse1, and Sis1 are described as performing various 
roles in assisting prion aggregate self-assembly and maintenance, via coordinated shielding of the polymer from Hsp104 
cleavage activity. (Bagriantsev, Gracheva, Richmond, & Liebman, 2008) 
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The relationship between Sup35pPSI+ and Hsp104 relationship is further characterized as being 
necessary for the formation of the prion variant itself, with inactivation or removal of Hsp104 
from [PSI+] inducing complete curing of [PSI+] (Park, Hahn, Fan, Thiele, & Li, 2006).  Thus, Hsp104 
is clearly critical not only for proper disaggregation of prion fibers, but for maintenance of the 
[PSI+] state itself, orchestrating a balance of Sup35pPSI+ aggregates in conjunction with other Heat 
Shock Family (HSF) regulating elements when required by the cell in response to environmental 
stimuli (Shorter & Lindquist, 2004) (Winkler, Tyedmers, Bukau, & Moqk, 2012) (Winler, Tyedmers, 
Bakau, & Moqk, 2012).  A schematic of prion fibril assembly beginning with oligomeric 
intermediate generation and proceeding through fibril assembly as chaperoned by HSF regulators 
is provided below in Figure 4. 
 
Figure 4:  Prion regulation by the heat shock protein family. An overview of the Heat Shock Family of proteins and 
their modulation of prion Sup35 as described in a 2003 review article by Tuite and Cox. Here the integral role of Hsp104 
is illustrated as both the regulatory element, which catalyzes small oligomeric eRF3 (believed to be the active 
propagating element in prion pathogenesis), as well as its role on prion disaggregation. Note: as a visual aid, wild type 
erf3 is indicated as a blue circle, the prion variant of erf3 is shown in orange, and prion fibrils are shown as purple 
rectangular complexes. (Tuite & Cox, Propagation of yeast prions, 2003) 
 
While intriguing, this particular characteristic of Sup35pPSI+ is but one of many distinct features 
which excerpt regulation of de novo prion formation and alone does not fully elucidate the 
mechanism by which the prion acts in yeast.   
6 
Importantly, as research on the topic of prion inheritance and function in yeast has 
substantially progressed since Wickner’s original characterization, prion variants have been 
identified at relatively high frequencies in wild strains (up to 30% of wild strains surveyed 
harbored some form of prion variant for just two determinants, [PSI+] and [MOT3+] according to 
a recent survey). (Halfmann R. , et al., 2012). Moreover, while three yeast prions have undergone 
extensive survey with respect to their structure, function and regulation ([URE3], [PSI+], and 
[PIN+]), at least seven additional prion protein isoforms ([SWI+], [OCT+], [MCA], [GAR+], [MOT3+], 
[ISP+], and [NSI+]) have recently been identified and reported in the literature. (Crow & Li, 2011) 
Curiously, the overwhelming majority of all prions identified are implicated as transcriptional 
regulators or serve translational machinery apparatus and assembly functions, which serve in 
specific, highly regulated capacities, and often exhibit ordered co-localization and assembly 
between two different prion species, indicating some underlying modality of cooperation 
between different prion conformers. (Halfmann & Lindquist, Epigenetics in the Extreme: Prions 
and the Inheritance of Environmentally Acquired Traits, 2010) (Liebman & Chernoff, 2012). Of 
particular interest the particular yeast prion studied in this work, [PSI+], was very recently 
implicated as existing in a ‘dynamic cloud of variants’ (Bateman & Wickner, 2013) , implying that 
new prion conformer generation is an unordered process which generates essentially random 
variants. (Wickner R. B., 2012) Logically it would hold that beneficial variants of the [PSI+] prion 
would tend to be conserved across that particular line of progeny. Concordantly, deleterious 
variants would either be cured by degredation pathways introduced earlier or prove fatal to that 
particular yeast line. Thus, in these manner prions of budding yeast are likely active facilitators of 
l the classical model of Darwinian evolution but using a fully epigenetic mechanism of heritability.  
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These indirect observations of the prion effect in yeast serve principally to determine 
what the prion is doing, but not why and by definition, how these mechanisms are regulated. 
While to date, the vast majority of research has focused on specific protein-only investigations to 
answer this question, little emphasis has been placed on the examination of potential genetic 
pressures exerted on the cell by the prion. Furthermore, while some work has suggested that 
other yeast prions, specifically the URE3 prion, fail to elicit a translational response under limited 
stimuli, this effect has not been examined with respect to [PSI+] (Ross & Wickner, 2004).  Thus, 
analysis of the complete transcriptomes of [psi-] and [PSI+] strains of Saccharomyces cerevisiae  
by cDNA microarray analysis may be employed to explore this theme. It is important to note that 
by utilizing cDNA microarray analysis, only those genes, which are actively expressed at a specific 
time point, may be observed and not the genome proper that contains substantially more stored 
genetic information. Likewise, this technique is also substantively limiting in that the data 
generated in this work utilizes a single-variable, endpoint type sampling approach. Despite these 
limitations, it is expected that, by examining the transcriptomic monitoring coupled with 
subsequent computational analysis, a functional relationship between differentially regulated 
elements in the transcriptome may elucidate a conservational mechanism for prion inheritance 
in yeast as well as a clearer understanding of the evolutionarily desirable effects of the [PSI+] prion 
in S. cerevisiae. Since the literature lacks, to date, a comprehensive analysis of the genomic 
expression activity of [PSI+] yeast, this study proposes a novel approach to characterize the global 
effect of the prion on the genome at large. While the usage of microarrays to elucidate both the 
effect and possible mechanism of persistence seems paradoxical given the epigenetic nature of 
the problem, a comprehensive overview of both transcriptomes may uncover yet unknown 
mechanisms of prion regulation and de novo appearance in yeast.  
8 
This rationale is justified given the wealth of previously reviewed literature, which delves 
into very specific process involvements of the prion via protein-protein interactions, with little 
emphasis on the possible deliberate effect on genomic expression. Further still, the true purpose 
of prion perseverance in the evolutionary history of S. cerevisiae may indefinitely elude 
researchers because of the lack of tools for accurate quantification of the model given that these 
control mechanisms may exist as transient molecular complexes, promulgated under very specific 
conditions in vivo. However theory holds that utilizing global survey techniques examining the 
genome, proteome, metabolome, and protein interaction networks, patterns may be realized 
which assist in formulating such a model, and as such is the focus of the current work.  
 
Dual Channel Microarray Theory and Practice 
 
 
Figure 5: Dual channel microarray. A dual channel microarray, demonstrating significant information density. In 
addition, two sub-grids, or print blocks, are highlighted, showing multiple levels of probe geometric arrangement typical 
of DNA microarrays.  
 
Nucleic acid interaction analysis finds its roots as a membrane-bound blotting technique 
with markedly lower information density (10’s of probe regions) originally proposed by Southern 
9 
et. al. in 1975 at the University of Edinburgh (Southern E. M., 1975). As the technique became 
more widely accepted as a research tool, significant technological advances were made, 
culminating with the survey of entire genomes using a single glass slide (Figure 5). These 
innovations enabled the evolution of the technique as a staple in the modern approach to 
analyzing the genetic expression of an organism’s genome which has been proven as an 
invaluable, high-throughput tool in typifying activity in genomic transcription (Southern E. M., 
2001). In order to qualitatively identify comparative genotypic expression between two different 
sources, cDNA must be derived from messenger RNA (mRNA), labeled, and hybridized to the 
microarray substrate for each sample, a process illustrated in Figure 6.  
 
Figure 6: Dual channel microarray workflow. A schematic representation of a typical cDNA microarray process as 
applied to this particular study and abstracted to essential process steps. Briefly, messenger RNA is isolated from 
cultures of [psi-] and [PSI+] yeast, followed by amplification, labeling and hybridization of the transcribed cDNA cocktail 
onto an array of complimentary-sequence probes. 
 
The microarray itself contains unique oligonucleotide probes representative of specific 
genes arranged in a high-density grid immobilized to a chemically derivatized glass substrate. 
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Once an mRNA from an experimental sample (the experimental genome) is prepared and isolated, 
the RNA is reverse transcribed to cDNA and labeled with a cyanine dye, which appears red in color 
(Cy5, absorption 649 nm / emission 670 nm). Likewise, the control mRNA sample (i.e. the control 
genome) is prepared in a similar manner and labeled with another cyanine dye which appears 
green in color (Cy3, absorption 550 nm / emission 570 nm) (Ernst, Gupta, Mujumdar, & Waggoner, 
1989). During hybridization labeled cDNA will bind and adhere specifically to its complimentary 
sequence immobilized to a specific spot on the array. After hybridization the array is imaged at 
both dye excitation wavelengths, producing a composite image of the microarray with the color 
of each spot determining the expression characteristics of each open reading frame (ORF) (see 
Figure 6 for an overview of the general schematic form). For example, if a particular spot is 
predominately red, then it is safe to conclude that the experimental genome is expressing that 
particular ORF at a level proportionately greater than the control genome. Conversely, a 
predominately green spot will indicate the control sample of the experiment is expressing that 
ORF at a proportionately elevated level. Logically specific interest is then given to probes that are 
predominately either red or green since it indicates that a particular ORF is expressed at a 
substantially different level in one genome as opposed to the other. However, most often a spot 
is a mixture of red and green, yielding various shades and intensities of yellow which indicates 
that a particular ORF is expressed by both genomes examined, though not necessarily 
proportionately. It is the ratio of the red vs. green intensity, which ultimately determines the 
differential expression and in so doing characterizes the relative activity of each gene in between 
two samples.  
This method is particularly appropriate to study the comparative differences in genomic 
expression levels of [psi-] and [PSI+] given its ability to visualize differences within the entire 
transcriptome globally. Examining the average expression characteristics from many multiple 
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biological samples from both strains of yeast will allow for a qualitative assessment of the effect 
of the prion state, which could allow for elucidation as to the nature of prion conservation in the 
species.  
Following the collection of a number of array image files, lower level analysis is conducted 
on each array in order to extract spot intensity data for both wavelengths. Several different 
applications generated in academia (such as ScanAlyze2 and Spotfinder3) or a variety of 
commercial applications frequently packaged with fluorescent microarray scanners (GeneSpring, 
Agilent Technologies, Santa Clara CA), may be employed to first analyze the raw image data files, 
determining the boundary of each spot and relative channel intensities. Dependent on the 
application, further statistical analyses may occur on the raw image file itself.  These include the 
determination of both local and global background and foreground noise caused by non-specific 
binding of DNA and un-conjugated dye, as well as descriptive statistics of each probe such as 
diameter, circularity, intra probe artifacts, and foreground and background intensity coefficient 
of variations (CVs) for each channel. During this stage of analysis, an array may be excluded due 
to an obvious morphological feature, such as a large scratch, dust particle, or deposit of dye on 
the array, which would skew the overall mean background and foreground intensities 
disproportionately in a widespread region. While several microarray image analysis utilities exist, 
an appropriate edge detection method must be selected such that automated spot boundary 
detection excludes artifacts and features that are not related to the hybridization event (i.e. not 
spot data). A brief discussion, including comparative analysis, of several semi-automated 
microarray image analysis utilities employed currently is provided in Appendix A.   
2 Eisen Lab, Michael B. Eisen, University of California at Berkeley (http://rana.lbl.gov/EisenSoftware.htm) 
3 Part of the TM4 Package for Microarray Analysis distributed by The Institute for Genome Research (TIGR) a 
subsidiary of the J. Craig Venter Institute (http://www.tm4.org/spotfinder.html) 
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Automated spot intensity extraction coupled with manual annotation for remarkable 
characteristics yields a raw data file, which is then mapped to information provided by the array 
manufacturer  which gives probe identities based on numerical index in the array geometry. At a 
minimum information regarding the spot’s shape, address information (usually grid coordinates 
in pixels, array coordinates, unique numeric identifier, and subsequent genetic identity in a 
standardized nomenclature), channel intensities (with deviations), and background 
characteristics for all spots on the array, is collected and stored for each hybridization. Given the 
high-dimensionality of the data and large number of experimental variables encapsulated in the 
final channel intensities for each ORF, the raw data is usually normalized in order to achieve 
statistical uniformity and significance for each spot on the array. In particular, this step is perhaps 
one of the most critical aspects of array data analysis since it is required to grant the same level 
of statistical “meaning”, or significance to each spot. Additionally, normalization assists in the 
removal of experimental bias and associated deviations between each array in the data set 
inherently contributed by the numerous wet-chemistry steps during the experimental pipeline.  
Furthermore, error introduced during the manipulation of the biological specimens (culturing, 
lysis, etc...) must also be accounted for when working with array datasets containing biological 
replicates. 
 
Microarray Data Normalization and Transformation Methodologies 
  
In order for microarray experimentation to be utilized as a reliable tool for determining 
levels of genomic differential expression, a plethora of statistical procedures collectively known 
as normalization are often applied to the data in order to attain statistical significance for each 
array. While some researchers maintain microarray data should be taken at face value, i.e. 
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without subsequent modification of any kind, the vast majority of microarray raw data presented 
in peer-reviewed work has been statistically modified to account for experimental bias. 
Normalization allows the comparison of arrays within the same study by removing this systematic 
bias, conferring the same level of significance to each array.  Specifically this strategy of analysis 
attempts to remove or negate bias introduced by the inherent wet-bench deviations between 
hybridizations as well as within the microarray process workflow as a whole, beginning with the 
initial culture used and progressing through array image generation (Smyth & Speed, 2003).  
The overall intent in data normalization is the minimization of bias differentiating one 
array from another, i.e. to generate a level playing field for a spot-to-spot comparison to occur 
across many arrays. Thus, it is apparent a robust normalization strategy must account for both 
local features such as the immediate background noise, as well as more global artifacts, such as 
the decay of printing quality of a particular pin, corresponding to poor signal over an entire print 
block. Normalization must also account for inconsistencies across an entire array, such as global 
intensity bias, or a very large background feature. Since data from both channels is being 
manipulated at this stage of the analysis, it is convenient to express the genomic activity of the 
spot as the log2 of intensity ratios, or more generally the degree of expression fold change 
observed between the experimental and control samples; 
𝐹𝐹𝐹𝐹 = log2 �𝐼𝐼𝐶𝐶𝐶𝐶5𝐼𝐼𝐶𝐶𝐶𝐶3� 
Equation 1: Expression Ratio. Relative mRNA expression is defined as the log2 of the MFI of each fluorescent intensity 
as a ratio. 
 
Thus, in this manner genes with positive fold changes are the result of a high proportion of the 
Cy5 labeled experimental genome DNA relative to the Cy3 labeled control genome, indicating 
subsequent overexpression of that gene in this particular assay.  Typical strategies for 
normalization begin with background correction (usually the subtraction of background 
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contribution from both channels), followed by some modification to the log ratio of intensity 
values, which satisfies a global ratio ideal distribution. Ideal normalization will return the overall 
distribution of these intensity ratio values to a Gaussian distribution, centered about a zero net 
fold change for all print groups, illustrated here via a box plot in Figure 7. This assumption is both 
biologically and statistically valid, since the expected differential expression between samples 
should only occur in a modest number of the genes in each print group with the likelihood of over 
or under expression, being equal assuming the array geometry is randomized.  
 
Figure 7: Normalization effect on FC. A Box Plot representation of pre (Red) and post (Green) normalization log2 
expression value distributions. Of note is the centering of each print group (block) about ‘0’ as well as a marked 
reduction in Standard Deviation for each print group after data normalization.  
 
While a vast number of normalization strategies have been applied to microarray analysis, 
it is ultimately a combination of researcher preference, and intrinsic qualities of the data set 
proper (such as dimensionality, duplicate arrays, relative amount of noise, etc.), which determines 
the ideal normalization method that should be utilized. Perhaps one of the most widely employed 
normalization strategies, both due to its ease of implementation and ability to resolve intensity 
dependent bias in a noise-resistant manner, is Locally Weighted Linear Regression (LOWESS or 
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LOESS).  Originally described as a locally weighted regression method for smoothing scatterplot 
data, LOESS is an optimal method for normalization given its ability to scale intensity data without 
interference from singular deviant points in a local region of the scatterplot (Cleveland, 1979). 
Since the goal of the LOESS methodology is to reduce intensity dependent artifacts within a 
distribution of discrete points of data, the dependency of noise on each channel individually must 
be understood. A convenient method for observing such a trend within the data is via construction 
of an R-I plot, which is so named as it is created by plotting the log ratio of channel intensities, 
log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
�, as a function of the log of the product of these intensities for each spot, 
log10�𝐶𝐶𝐶𝐶5𝑖𝑖 ∗ 𝐶𝐶𝐶𝐶3𝑖𝑖�. Application of the LOESS algorithm to the R-I distribution allows for 
correction of these artifacts by conducting a locally weighted linear regression as a function of the 
log10�𝐶𝐶𝐶𝐶5𝑖𝑖 ∗ 𝐶𝐶𝐶𝐶3𝑖𝑖�and subtraction of the best fit mean log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� at each point in the 
distribution, applying a weighting function to de-emphasize the influence of outliers in a 
progressive manner as the outlier extreme increases (Quackenbush, 2002).  
 
Thus, the LOESS algorithm effectively corrects the dependence of the ratio of intensity 
values on intensity, for each data point, in a noise resistant manner, given by the following: 
 
log2(𝑁𝑁𝑖𝑖) =  log2 ��𝐶𝐶𝐶𝐶5𝑖𝑖𝐶𝐶𝐶𝐶3𝑖𝑖� ∗ � 12𝐶𝐶(𝑥𝑥𝑖𝑖)�� 
Equation 2:  General form of LOESS normalization   
 
Where y(xi) is the dependence of the log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
�, ‘y’ on the  log10�𝐶𝐶𝐶𝐶5𝑖𝑖 ∗ 𝐶𝐶𝐶𝐶3𝑖𝑖�, ‘x’, for each 
data point, ‘i’.  As with most normalization algorithms, the LOESS method is often employed in 
either a global fashion (i.e. regression smoothing curve is calculated using all data points on the 
array) or in smaller, compartmentalized sub-groups, such as print tips or other sub-grouping 
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method. Further application of this algorithm to conduct local regression in a per print-tip fashion 
with subsequent modification of both channels independently yields a form of the LOESS 
algorithm as follows: 
�
𝐶𝐶𝐶𝐶5𝑖𝑖
′ =  𝐶𝐶𝐶𝐶5𝑖𝑖 ∗ 2𝐶𝐶(𝑥𝑥𝑖𝑖)𝑝𝑝
𝐶𝐶𝐶𝐶3𝑖𝑖
′ =  𝐶𝐶𝐶𝐶3𝑖𝑖 ∗ 2𝐶𝐶(𝑥𝑥𝑖𝑖)𝑝𝑝  
Equation 3:  Dual channel LOESS. Channel specific implementation of the general LOESS normalization form given in 
Eq. 2. 
 
Where  𝐶𝐶𝐶𝐶5𝑖𝑖
′  , 𝐶𝐶𝐶𝐶3𝑖𝑖
′ , are the normalized data points for both channels, and the corrective term  
2𝐶𝐶(𝑥𝑥𝑖𝑖)𝑝𝑝, calculates the print-tip LOESS, rather than the global LOESS (Quackenbush, 2002).  An 
example of the positive effect of this method as applied to a sample array data set is shown below 
in Figure 8. 
 
Figure 8:  Channel bias of expression data. R-I plot of micorarray data from one of the arrays incorporated in this study 
(Table B.1, array 3-B) showing the effect of channel dependant bias on the microarray data (indicated by the red 
distribution). Print Tip LOESS Normalization negates the effect of this bias and corrects the anomaly (blue distribution) 
while simultaneously maintaining the general shape of the data with respect to outlier distribution ( which, if proven 
to be significant, indicates a substantial difference in relative expression). This particular data set is shown rendered in 
TIGR MIDAS using the Print Tip LOESS normalization method. 
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 Examining the pre and post normalization distributions from above (Figure 8), the effect 
of both intensity bias and print tip associated artifacts (introduced in Figure 7) is mitigated without 
compromising the significance of notable outliers. Thus, print-tip LOESS is an optimal method of 
microarray data normalization when noisy arrays are anticipated in the data set.   
Following data normalization, the influence of experimental replicates must be accounted 
for. Consistent with properly designed experiments, microarray experiments embed a number of 
repetitive elements into several steps during the experiment in order to determine if differential 
expression is biologically significant. Thus, a typical data set is comprised of a number of biological 
replicates for each condition (i.e. independent sample treatment and preparation) in addition to 
technical replicates, or identical manipulations of the sample onto different arrays, of each 
biological sample preparation. Additionally, larger experiments may include technical repetitions, 
or assay of the same hybridization preparation (recall Figure 6) on a number of independent arrays 
( i.e. multiple hybridizations). The nested nature, summarized in Figure 9, of these replicate types 
obviates dependencies to the previous step, and thus raises the question of statistical treatment 
of data generated from each replicate type.  
 
Figure 9:  Assay repetition. General replicate types embedded into common microarray experiements . (Aerts, Moreau, 
De Moor, De Strooper, & Dabrowski, 2003) 
 
Given the discrete biological condition being tested in this particular study (prion 
containing or absent yeast) , it is most appropriate to simply average the subsequent replicates 
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of a given biological sample and perform a later downstream gene finding analysis on these 
unique samples (Altman, 2005). Alternatively if the normalized data is highly variable across 
arrays, a weighting algorithm may be applied to penalize lower quality arrays (Smyth, Ritche, 
Thorne, Wettenhall, & Shi, 2010), followed by averaging of the weighted spot intensities across 
replicates to yield the expression values for each ORF over every biological sample.  
After accounting for replicates in the experimental design, ORF expression may be 
quantified across all arrays for a given biological condition. This component of the analysis is 
crucial, as up to now the data set i consists of discrete probe values in units of fold change. For 
this particular study, a simple arithmetic mean is sufficient to determine the respective fold 
change of a given ORF since only one experimental condition is being analyzed in a discrete 
manner. Thus an appropriate statistic is required to indicate the significance of each ORF mean 
fold change with careful consideration for biological significance inherent to the system.  
Numerous methods exist for scrutinizing the statistical validity of a series of observations 
for consistency and several are often employed for microarray analysis such as the Student’s T-
Test (p-values), Significance Analysis of Microarrays (t-values), Wilcoxin Ranked Sum Test, Rank 
Product and ANOVA (f-statistic) to name a few.  The specific method employed is intimately 
related to the number of experimental conditions being assayed, and sample size considerations, 
in conjunction with the degree of statistical confidence desired. In particular, a number of factors 
directly affect the method employed, including the sample size (i.e. number of arrays in the data 
set), completeness of data (a function of the normalization and/or filtering method applied 
earlier) and desired level of confidence in the resulting significantly differentially expressed genes.  
The latter criterion is usually most influential in determining an appropriate statistical 
confidence test, since here the number of false positives (i.e. the discovery of a gene which is not 
truly differentially expressed, classified as a Type I error) and false negatives (i.e. the incidental 
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exclusion of a gene which actually is differentially expressed, classified as a Type II error) must be 
controlled for. Under ideal circumstances a statistical methodology should be applied such that 
the false discovery rate (FDR, or more specifically;
[𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝐹𝐹𝑖𝑖𝐹𝐹𝐹𝐹𝐹𝐹][𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝐹𝐹𝑖𝑖𝐹𝐹𝐹𝐹𝐹𝐹 + 𝑇𝑇𝑇𝑇𝑇𝑇𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝑖𝑖𝐹𝐹𝑖𝑖𝐹𝐹𝐹𝐹𝐹𝐹]) is minimized. 
Once statistical analysis of each ORF expression characteristic is completed the analysis may 
proceed with either a simple ranking of the genes of interest by expression ratio (highlighting the 
most significantly expressed genes given a particular condition) or further investigation using 
several higher-level computational methodologies aimed at pattern discovery, data 
dimensionality reduction, and further annotation of curated information.  
 
Computational Analysis of Microarray Data 
 
For this application, the identification of differentially expressed genes is an immensely powerful 
tool since it allows for the surveillance of potential genomic effects of the [PSI+] state as well as 
simultaneously directing further research using methods such as Real Time-Polymerase Chain 
Reaction (rtPCR) to confirm differential expression and proteomic analyses techniques such as 
2D-PAGE coupled with Mass Spectrometry, and subsequent protein interaction analysis. 
However, due to the immense size of data sets generated by microarray experimentation, it is 
difficult to contextualize the global physiological significance of the data’s implications. Rather 
than examine the extremely differentially expressed genes, several alternative downstream 
analysis methodologies exist, which seek to fill this contextual void using higher-level microarray 
analysis to elucidate patterns of differential expression. 
Using a method previously discussed it is quite easy to determine, via an ordered list of 
expression values, if there are indeed statistically significant differences between the 
transcriptomes of [psi-] and [PSI+] in S. cerevisiae. Once it has been determined that there are 
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differences, the remainder of the analysis questions what they mean. Ultimately, it must be 
understood what the implications of these differentially expressed genes are as they relate to the 
initial experimental goal, namely the elucidation of how and why the prion is conserved in yeast.  
Given the yet unknown nature of the prion on the yeast transcriptome, this study investigates the 
binary system explicitly (in other words, the only variable is the prion itself, with no regard for 
temporal or environmental influences). Furthermore, as there is there are currently no peer-
reviewed works on the topic indicating a relationship between prionogenesis and transcriptomic 
pressures, this study is essentially a priori in nature with regard to hypothesis selection. This 
distinction is substantive since an underlying hypothesis linking these two variables may influence 
the nature of downstream computational analysis greatly (for example, if several ORFs within a 
particular metabolic pathway are differentially expressed, it is a logical assumption that the bulk 
of the computational analysis will focus on pathway analysis and specific related physiological 
properties). 
Computational analysis of microarray data can fall within two distinct categories; 
supervised learning and unsupervised learning. (Shannon, Culverhouse, & Duncan, 2003) 
Supervised algorithms require the use of a data source external to the investigation, which is 
fundamentally related to the experiment to allow for the construction of a particular model that 
may then be applied to future experiments. The obvious advantage to this approach is the 
significantly increased predictive power of the algorithm given that it has been previously trained 
with physiologically similar expression data. Supervised learning approaches have enjoyed 
success in applications ranging from Linear Discriminate Analysis and the more broad collection 
of methods encapsulated within discrimination, to more robust machine learning approaches 
such as Support Vector Machines and Artificial Neural Networks. (Sawa & Ohno-Machado, 2003) 
Unsupervised approaches for gene expression analysis operate solely on one source of data, the 
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experimentally derived expression values.  Widely used examples of this method include 
clustering, support trees, and Singular Value Decomposition (employed by several methods such 
as Principle Component Analysis). (Raychaudhuri, Stuart, & Altman, 2000)  Thus while both 
methods have obvious merits, there is clearly a need to analyze the expression data in this work 
using strictly unsupervised techniques in order to elicit meaning from the data without imposing 
a predisposed order to the characteristics of the data set during this initial analysis, since no 
additional source of biological information has been validated for this application.  
 
Cluster Analysis 
 
 Perhaps the most widely employed  analysis of statsitically significant expression data, 
cluster analysis capitolizes on the assumption that similar expression indicates an underlying 
physiological similarity with the distinct advantage of yielding a visual representation of gene 
expression data in a form intuituve to biologists, an example of which is provided in Figure 10.  
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 Figure 10: Classical clustering. A microarray data set after cluster analysis, with blue dendogram on the left hand side 
indicating the hierarchal relationship of each gene with respect to the entire transcriptome over a series of six 
microarray experiments, arranged as columns. (DeRisi, Iyer, & Brown, 1997) 
  
As a result, classical hierarchal clustering (HCL) has enjoyed widespread application in the field of 
microarray analysis and is often the first pattern identificaiton technique employed for such 
applications. Cluster analysis can be performed using several different metrics by which to 
segregate genes into distinct groupings by relatedness in order to determine how specific 
variations in the cell, such as the [PSI+] state, affect major cellular processes and characteristics. 
This particular technique requires two critical design criteria in order to perform an analysis; the 
distance metric (i.e. the method for establishing the correlation between two individual data 
points) and the linkage method (or the method by which pairs of related observations are joined 
into further subsets). Thus by iteratively applying these two algorithms on a large data set, every 
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discrete observation is assigned to a particular subset of highly-similar data points, as well as the 
relatedness of each subset to all others. Sokal and Michener first achieved the novel application 
of this technique to large, complex sets of data in 1958 by generating hierarchal relationships 
between otherwise seemingly unrelated, discrete observations (Jaluria, Konstantopoulos, 
Betenbaugh, & Shiloach, 2007).   
While there are a vast array of possible distance metrics (or correlation coefficients) 
available for determining relatedness between two observations, there are three principle 
distance metrics by which the similarity of two gene expression values is usually determined; 
Euclidean, Manhattan, and Pearson’s Correlation. One particular correlation metric similar to the 
Pearson’s proposed by Eisen et. al., is given below where the log transformed expression ratio (Gi) 
for each gene (G) in a given condition (i), so that the similarity of two genes (X, Y) may be examined 
over a number of conditions (N). Note, if the mean (μ) observation for a gene is used (Goffset) then 
Φg becomes the standard deviation (σ) of each gene’s average expression value, with S(x,y) being 
equal to the anticipated Pearson’s correlation. (Eisen, Spellman, Brown, & Botstein, 1998). 
𝑆𝑆(𝑥𝑥, 𝐶𝐶) =  1
𝑁𝑁
∑ ��
𝑋𝑋𝑖𝑖−𝑋𝑋𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
𝜙𝜙𝑥𝑥
� �
𝑌𝑌𝑖𝑖−𝑌𝑌𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
𝜙𝜙𝑦𝑦
��𝑖𝑖=1,𝑁𝑁   ,    𝑎𝑎𝑎𝑎𝑎𝑎   𝜙𝜙𝐺𝐺 = �∑ �𝐺𝐺𝑖𝑖−𝐺𝐺𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜�2𝑁𝑁𝑖𝑖=1,𝑁𝑁  
Equation 4: Implementation of the Pearson’s correlation metric by Eisen et al.  
 
While the distance metric determines the method by which data are assorted into clusters 
ranked by similarity, the linkage technique is the method by which clusters are related to each 
other. For microarray applications, three primary cluster linkage techniques are employed; single-
linkage (nearest neighbor), complete-linkage (farthest neighbor), average-linkage (Unweighted 
Pair Group Method with Arithmetic mean). 
After clustering, a dendogram may be applied in order to visualize the relative similarity 
of each hierarchy of clusters, graphically represented as a colored primary data table (an example 
of which is demonstrated in Figure 10). It is these groupings, which sheds light on the specific 
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relationships of genes to major organizational roles since it has been well established that genes 
of similar function as cellular components or constituents of pathways tend to cluster together 
(Eisen, Spellman, Brown, & Botstein, 1998). Perhaps one of the most notable examples is the 
groundbreaking work published by DeRisi et al in 1997 (DeRisi, Iyer, & Brown, 1997) and later in 
1998 by Chu and colleagues (Chu, et al., 1998), examining dynamic transcriptomic control during 
yeast cell cycle progression and during specific metabolic stresses.  
In general, the process of HCL is particularly prone to some error types however, including 
bias introduced by large values of expression, which can perturb the correlation between 
neighboring genes expression profiles. (Peterson, 2002) To prevent this form of bias from 
influencing the generation of accurate clusters, a re-sampling method may be employed, so that 
the confidence of a particular gene-cluster assignment is improved. Trees generated in this 
manner are called support trees, and provide an additional degree of reinforcement to the typical 
distance metric associated with a cluster.  Support trees are typically generated via re-sampling 
of the original expression matrix with a new HCL generated after each sampling, after which the 
sample is either discarded (jackknife method) or returned for potential re-sampling (bootstrap 
method). Thus as the number of times a cluster is generated from random sampling increases, so 
too does the support score for that cluster. Furthermore, since the re-sampled matrix lacks some 
of the original data, a high support score means the cluster is not influenced by a small subset of 
data. (Saeed, et al., 2003) 
 While hierarchal clustering itself is a powerful tool for whole-genome functional 
visualization, another clustering technique, called K-Means Clustering, is capable of determining 
the relationships between individual, discrete observations which exhibit general data centrality 
about a pre-determined estimate of the number of ideal means. (MacQueen, 1967) When applied 
to microarray expression data, this technique is able to resolve relationships with particular 
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emphasis on gene assortments which are co-regulated, as well as overlapping (Shannon, 
Culverhouse, & Duncan, 2003), with the generic algorithm given as; 
 
𝐽𝐽 =  � � �𝑥𝑥𝑛𝑛 − 𝜇𝜇𝑗𝑗�2
𝑛𝑛 ∈ 𝑆𝑆𝑗𝑗
𝐾𝐾
𝑗𝑗=1
 
Equation 5: General form of multiple-sample clustering by K-Means 
 
,where the approximation of the local minimum for each iteration J  is resolved by determining 
the vector, 𝑥𝑥𝑛𝑛, which represents each nth observation, contributing to the geometric centroid, 𝜇𝜇𝑗𝑗 , 
of the collection of data in the set 𝑆𝑆𝑗𝑗, an example of which is shown graphically below in Figure 
11. 
  
Figure 11:  K-Means clustering. A representation of K-Mean clustering progression, highlighting the naïve distribution 
of the data (left) as the k-means algorithm proceeds migration of discrete data towards centroids proceeds (middle 
distribution), yielding an ordered approximation of the clustered distribution (right), pre trained  with the expectation 
of n = 4 clusters.  
 
Allowing a specific gene to associate into more than one cluster is a more biologically 
meaningful technique for gene pattern identification since it is anticipated that multiple 
associations exist between similarly expressed genes, enabling more robust cluster assortment, 
which closely mimics the relationships present in biological systems.  
However, as the stringency of assortment fidelity is relaxed, there is increased opportunity for 
assortment error, and as such this technique is more susceptible to bias contributed by Type I and 
II erroneous ORFs. 
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The susceptibility of K-means clustering to these error types was greatly diminished by 
the development of an even more robust version of this cluster algorithm, called Fuzzy K-Means 
Clustering. This advancement is significant since it allows for the classification of genes into more 
than one functional group, and further weights these associations based upon differential 
relatedness (Gasch & Eisen, 2002).  Multiple iterations of this process on the data set increases 
the discovery rate of new familial relationships, previously uncharacterized by hierarchal 
clustering and traditional K-means cluster analysis (Gasch & Eisen, 2002).  
Independent of the application, the k-means algorithm suffers from a critical flaw from 
an a priori user assumption of the number of clusters anticipated, often influenced more by the 
number of clusters desired by the user than that empirically derived based on the predicative 
power of the clustering algorithm itself. To that end, an implementation of the generic jackknife 
approach (Efron, 1982), referred to as a Figure of Merit (FOM), determines an empirical 
approximation of the number of clusters that are truly present in the dataset proper. Essentially 
the FOM approach iteratively removes potential clusters, recalculating a goodness-of-fit of 
expression data to an associated centroid. In this manner the ideal number of clusters may be 
realized, indicated by a lower FOM score, an example of which is given below in Figure 12 below.  
 
Figure 12: Figure of Merit. An example of the FOM as applied to cDNA microarray data as clustered using six different 
algorithms. From this dataset both the appropriate algorithm to employ as well as the ideal number of clusters, 
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determined by the balance struck between the FOM and number of clusters, becomes obvious. (Yeung, Haynor, & 
Ruzzo, Validating clustering for gene expression data, 2001) 
 
 
Strategies for Microarray Data Reduction 
 
In addition to cluster analysis, multiple microarray data visualizations tools exist, which 
are at the very forefront of interpreting and applying existing structured biological information, 
such as the Gene Ontology (GO). (Consortium T. G., 2000) Investigating the model organism 
Saccharomyces cerevisiae, has significant advantages on its own given the complete mapping of 
the GO to every Open Reading Frame (ORF) contained within the Saccharomyces Genome 
Database (SGC) (Dwight, et al., 2002).  Importantly, the GO provides a ubiquitous language for 
which physiological information (both computationally derived and experimentally verified) may 
be mapped to specific ORFs. Using a readily available mapping of GO terms to the yeast genome’s 
ORF names, one can readily associate a collection of manually curated GO terms to the expression 
data set. This ability lends itself to another form of analysis, using an application called the 
Expression Analysis Systematic Explorer (EASE). Essentially EASE allows for the integration of 
annotated biological data sources (such as KEGG pathway data or GO terms) and expression data, 
with the added benefit of a statistical confidence metric. The resulting analysis groups biological 
themes (GO Terms or pathway data) into clusters and prepares a statistic representative of the 
chance that a particular theme within the cluster is there by chance alone given the prevalence in 
the population. (Hosack, Dennis, Sherman, Lane, & Lempicki, 2003) 
 An extension of the EASE method of data enrichment, called Tree-EASE, performs an EASE 
analysis on the data set and then clusters the data using traditional hierarchal clustering. This 
merger yields a clustered view of the data supported by a dendogram of differentially expressed 
biological themes, an example of which is provided below in Figure 13. Importantly, by assigning 
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a statistic for significance of a node’s gene and term enrichment associations, one can infer both 
statistical and biological significance in the association of genes to specific clusters. (Gottardo, 
Raftery, Yeung, & Bumgarner, 2006) 
 
Figure 13: Tree-EASE. An example TEASE analysis. Here one node of a much larger denodogram is displayed with cluster 
constituents, corresponding mapped GO annotation and Fisher’s exact probability of GO term association is displayed 
for the strongest associations within that node. Note, colored bars on the right may be disregarded for the purposes of 
this example, also on the far right are the individual YGD gene IDs, identifying each gene within this particular cluster 
  
   
Perhaps one of the most daunting aspects of expression data analysis is the reduction in 
data dimensionality. While clustering, either by K-Means, HCL, or Support Trees work to 
compartmentalize the data into a two dimensional representation of clusters, this method of 
viewing the data as a whole is far from ideal. If the dimensionality of the display is increased, in 
particular to three dimensions, the resulting affinity of clusters becomes significantly more 
resolved. In particular, a topic introduced previously, singular value decomposition, works well 
for this particular visualization application. One such example of this approach is Correspondence 
Analysis (CA), where the relationships of genes are determined via the decomposition of a matrix 
of their χ2 values (generated from rows and columns of the expression matrix).  Inertia values are 
computed which explain the relationships of row and column elements based on the χ2 value 
dispersion. This subsequently enables filtering of the top two or three correspondences which 
best encapsulate the variation inherent in these comparisons, thus reducing the dimensionality 
of the data to those which are most significant using decomposition. (reviewed in (Greenacre, 
Theory and Application of Correspondence Analysis, 1984), (Greenacre, Correspondence Analysis 
in Practic, 1993)) 
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 Figure 14: Correspondence analysis. An example of correspondence analysis as applied to the widely published yeast 
cell-cycle expression dataset (Spellman, et al., 1998). Of critical importance is the reduction of raw data dimensionality 
into easily addressable localized regions of similarly expressed clusters of genes.  
 
Spatial placement of each element in the environment is reduced to a function of axial 
dependency, with movement towards an axis indicative of the ability of that axis to explain a more 
significant portion of the χ2 value. (Fellenburg, et al., 2001) In this manner both the genes and 
samples may be plotted in the space with the absolute distance between the sample positions 
being indicative of relatedness, an example of which is given above in Figure 14. Thus genes and 
samples which tend to cluster together are more related, i.e. have similar profiles, than those 
spread further apart, thereby enabling the identification of related patterns of expression as a 
function of sample type. A key feature of the correspondence technique is the utilization of any 
number of data types in determining associations of genes and functionally distinct categories, 
such as a wide variety of experimental conditions as well as functional annotation. (Busold, et al., 
2005)  
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 Similar to CA is Principal Component Analysis (PCA), another data reduction strategy 
utilizing an extension of the singular value decomposition technique. When applied to microarray 
data, similarly expressed genes are pooled into a low-density variable which encompasses as 
much of the variation as possible of the genes collectively, but with significantly reduced 
dimensionality, an example of which is provided in Figure 15. 
 
Figure 15: Principle Component Analysis. A typical PCA projection on two axis of microarray data comprising a probe-
set of 22,283 genes monitoring temporal changes in genomic expression during osteogenesis of human mesenchymal 
stem cells motivated by a variety of stimuli; Vitamin D3 (VIT), Bone Morphogenic Protein-2 (BMP), dexamethasone 
(DEX), and untreated (UNT). (de Haan, et al., 2006) This particular data set highlights the ability of the PCA technique 
in associating variability to a single treatment or treatments, as is evident by the directionality of the untreated data in 
an opposite direction than the various treatments. 
 
As the generation of components progresses, each new component accounts for less 
variability than the previous, thereby ranking the components in order of decreasing determinant 
weight of data variability. Following component generation the first two or three components are 
then used to map all other components in a two or three axis projection, with distance between 
each plotted component equal to the relatedness of variability explanation of the components 
already placed within the space. (Raychaudhuri, Stuart, & Altman, 2000) Though similar to CA, 
PCA lacks the sophistication to plot sample data due to sampling size deficiencies, and as a result, 
only on data type may be decomposed individually. 
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 While these methods remain somewhat objective, they do lend themselves to furthering 
the convenient visualization via data reduction of large microarray data sets in a manner intuitive 
to biologists, and should be employed as effective unsupervised approaches to microarray data 
mining. These techniques, while statistically valid, rely heavily on the SVD approach, which 
assumes near equal variances in its replacement of groups of related genes with single gene 
elements, thus exposing a potential drawback to the afore mentioned methods on data with 
known variation artifacts or small sampling size. However, the use of a three axial space for 
visualization of microarray data clusters is a powerful tool, which validates the approach despite 
the assumed potentiality of bias.  
  
a b 
Figure 16: Terrain mapping of expression data. a) Terrain mapping of high dimensionality microarray data of C. 
elegans, showing a low-dimensionality representation of the data enriched with functional annotations in three 
dimensional space, where the [x, y] axis are placed by a directed-acyclic graph and the z axis indicates  the degree of 
expression data enrichment, where a larger peak indicates greater expression correlating to a specific term. (Kim, et 
al., 2001) b) A similar low-dimensionality rendering of microarray data using MEV (TIGR) which allows for emphasis of 
specific sub-clusters within each local topographical region using the expression data projected over the terrain itself.   
 
Another extension of this three-dimensional approach to visualizing data is the use of a 
terrain map, or ‘topomap’ of the gene data of interest. (Kim, et al., 2001)  To generate the 
visualization a matrix of Pearson Correlation Coefficients (or other distance metric) is created, 
with each gene plotted on a scatter plot with [x, y] values correlating to relative position of the 
gene dictated by the 20 strongest correlations available, an iterative method collectively termed 
force-directed placement, an example of which is provided above in Figure 16a. (Rossi, 2006) Due 
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to practical limitations, plotting of an entire microarray data set is not feasible with respect to 
visibility of distinct features within the correlation data, and as such a third axis is employed where 
the [z] term becomes a function of the number of genes in a given unit space, collectively termed 
a kernel. Thus, by setting appropriate parameters for kernel generation, clusters of related data 
become evident in a much more significant manner based on the stringency of correlation. 
Perhaps one of the most unique aspects to the method is the ability to display both sample and 
gene landscapes using a number of distance metrics in order to spatially represent the data, 
elucidating intrinsic patterns which otherwise may have remained unresolved. A second example 
of such terrain mapping is provided in Figure 16b, where the Pearson’s correlation method is 
employed as the distance metric.  
 In a similar manner, Ebbels and colleagues have implemented a method for interpretation 
of complex biological networks incorporating multiple sources of experimental data (such as 
microarray, real time or protein expression analysis) using a novel data reduction strategy which 
enables the recognition of relevant systems of biological activity and their inter-relatedness. 
(Ebbels, Buxton, & Jones, 2006) Implemented in MatLab, springScape is a visualization tool which 
generates nodes via ‘spring embedding’ from a single or multiple sources of biological information 
(ontologies, pathways, etc.) then populates kernel density, placement and activity based upon 
experimental integrated by the user. A demonstration of this technique applied to a microarray 
data set and relevant biological information source is shown below in Figure 16 c.  
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Figure 16c: Sprint embedding. Cell cycle synchronized yeast time-course microarray expression data set embedded on 
a springScape comprised of the GO cellular component topography. (Ebbels T. , 2005) 
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Pathway Analysis  
 
 In seeking to understand the global effects of [PSI+]  yeast a crucial aspect of the data 
must be explored which is the application onto known biological facts. This approach is 
fundamental to the principal goal of this work, as it is assumed there is no prior knowledge of the 
prion state or its effect on the yeast as an organism. While expression data of select differentially 
expressed genes may be further analyzed empirically using alternative transcriptomic analysis  
techniques such as quantitative (qPCR) or kinetic (KPCR) Polymerase Chain Reaction (VanGuilder, 
Vrana, & Freeman, 2008), whole transcriptomic analysis via sequencing (Siezen & Wilson, 2010) 
(Tang, et al., 2009), as well as more classical wet bench techniques, in silico approaches exist which 
utilize all genes of statistical significance to populate previously characterized biological themes. 
Enabled by the harmonization of biological facts using several commonly employed 
ontologies, developed in parallel largely by the Open Biomedical Ontologies initiatives (Smith, et 
al., 2007), numerous tools have been developed to facilitate the integration of experimentally 
procured expression data and existing biological information comprising pathways from the 
metabolome, homeostasis, cell cycle, and numerous other cellular processes. One of the more 
commonly employed pathway integration application is the Gene Map Annotator and Pathway 
Profiler (GenMAPP) software utility (Dahlquist, Salomonis, Vranizan, Lawlor, & Conklin, 2002). 
GenMAPP provides both the architecture for ground up pathway generation and annotation, as 
well as the ability to load, annotate and overlay gene expression data to manually curated, peer 
reviewed pathways available from a variety of repositories (Salomonis, et al., 2007). An example 
of this particular pathway analysis technique is provided below in Figure 17, which shows a 
graphical representation of the galactose metabolism enriched with a subset of differentially 
expressed genes as well as their corresponding protein abundance.  
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 Figure 17: Pathway analyis.  GenMAPP Pathway rendering demonstrating activity of the galatctose metabolism 
pathway constuents. (Griffin, et al., 2002) This particular ernichment demonstrates the integration of two different data 
sources; classical mRNA expression ration as well as relative protein abundance,depicted as individal L/R hand color 
sets of each protein element.  
 
 One feature unique to the GenMAPP utility is an ancillary application which uses a set of 
expression data of interest and species database specified, and returns a z-score ranked hierarchy 
of available maps generated by searching all public information repositories in the MAPP format. 
The extension, called MAPPFinder, allows for further expansion of pathway analysis beyond that 
of the pathways assumed of interest to the researcher. A simple statistic (z-score) lends credibility 
to pathways which contain a number of genes of interest given the expression values provided, 
an example of which is provided below in Figure 18. (Doniger, et al., 2003) 
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 Figure 18:  Query-driven pathway discovery.  MAPPFinder hierarchal display of relevant MAPPS given an expression 
data set as input. The user need only specify the database to be searched against and the extent of terms to scrutinize 
(GO, KEGG, etc..) 
 
 A similar, web-based utility called the Pathway Tools Omics Viewer is provided by the 
YGD. This tool accepts a tab delimited expression data set of single expression values or a series 
of data under multiple conditions, and ‘paints’ the subsequent expression data onto a map 
containing the entire yeast metabolome (Christie, et al., 2004). This application draws on the 
robust collection of pathway information curated by BioCyc, commonly referred to as Pathway 
Tools, in which the biochemical network of an organism is rendered into an intuitive, biologically 
proportionate graphical representation. (Karp, et al., 2010) The application interface is fully 
navigable with expandable displays of specific pathway details enriched by expression data 
analysis in a user defined color scheme, enabling a robust analysis of pathway enrichment within 
the metabolome. (Karp, et al., 2005) A representative display of sample expression data mapped 
to the model organism E. coli is provided below in Figure 19. 
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 Figure 19: Metabolimic expression data enrichment. Metabolome of E.coli overlaid with expression data with pathway 
activity relatedness exceeding a specific threshold given by a colored bar corresponding to either up regulated (light 
lue to yellow hues) or down regulated (blue to red hues) between metabolic products. Any up differentially expressed 
pathwya may be furtehr scrutinized via selection to exhibit detailed pathway data via demonstrateion of the specific 
pathawy constituents, identifies, and expression data corelating to a full color look up table (LUT). Image Credit: 
http://biocyc.org/ov-expr.shtml 
 
 
Meta-Analysis  
 
As introduced previously, working with the novel organism S. cerevisiae has distinct 
advantages, most notably the wealth of curated data available in repositories for specific genes 
and pathways, but also in the magnitude of whole genome expression experimentation already 
performed by the research community at large. A number of web-based utilities seek to exploit 
this vast resource in order to afford the researcher a more comprehensive approach towards 
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understanding a particular data set via direct comparison to expression characteristics observed 
in other work. While this approach is strictly observational, it is beneficial in that the a priori 
assumption of this study lends itself to drawing analogs between similar patterns of expression 
observed between the data under evaluation and that which has been peer reviewed. Such 
analyses enable the development of data-driven hypotheses to guide future research in a more 
informed manner. One such utility is embedded in the YGD web interface, called Expression 
Connection, which allows for the query of a set of ORF’s of interest against a limited number of 
manually curated, publically available expression data sets stored locally on the YGD. (Gasch A. 
P., 2002) The application pools expression data collected for the query and displays a highly 
networked interface allowing for multidimensional drilling of the data set through ORF names, 
GO terms, homologous patterns of expression determined within the data set and a multitude of 
additional information. (Ball, et al., 2001)  
 
Figure 20: YGD Expression Connection. A typical query to the YGD Expression Connection of nine open reading frames 
of interest, allowing for A) navigation to the original data set (as well as a batch download of the data), GO term 
explorer, GO Mapping features, and direct navigation to the Open Reading Frame of Interest.  B) A time course 
representation of the same query plotting relative FC. 
 
A) B) 
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An added benefit to the embedded nature of Expression Connection within the YGD is the 
seamless integration to all data of relevance to the query, with examples of several features 
displays provided in Figure 20.  While fully integrated into the wealth of knowledge stored within 
the YGD for each ORF (arguably the definitive, centralized  source of yeast genomic information), 
this utility lacks the desired scope due to the limited volume of expression datasets within the 
YGD as compared to the vast quantity of public microarray data reported in the literature.  
 
Figure 21: SPELL workflow. A pictographic representation of the SPELL search engine query driven analysis pipeline. 
(Hibbs, et al., 2007) 
 
Another web based application, the Serial Patterns of Expression Levels Locator (SPELL), fulfills 
the issue of decreased experimental sample size by querying 2394 individual array hybridization 
spanning 81 peer reviewed publications, stored at the Gene Expression Omnibus, EBI’s Array 
Express Database, and the Stanford Microarray Database. Using a small subset of interest  (~100 
ORFs), a query is tested against all available data sets via a three step process; [Query Generation, 
Algorithm Processing of the Query and Summarization and Presentation of Matching Data], 
overviewed in Figure 21. (Hibbs, et al., 2007) Additionally, highly significant congruencies between 
data may be ordered or weighted by score, using the p-value of each correlation.  Thus, this 
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analysis technique yields not only an ordered graphical representation of significant data sets 
containing similar expression patterns, but also additional genes with a high degree of similarity 
with respect to expression profiles, an example of which is provided below in Figure 22. 
 
Figure 22: SPELL query results.  SPELL expression data similarity results for a query of n = 8 up-regulated genes (outlined 
in grey) with obvious concordance with expression data set of Jones et al,  2003, exploring the Ras/cAMP signal 
transduction pathway. Additional genes suggested as having similarities towards the query data are also suggested, 
given below the query ORFs. 
 
 In an effort to accurately characterize the effect of the prion on the S. cerevisiae 
transcriptome a multi-faceted approach towards data analysis with a tendency towards verbose 
spatial visualization methodologies is favored to elucidate relationships within the data. The 
application of a wide variety of clustering and visualization methods following an appropriate data 
pre-processing and normalization schema will enable a robust interpretation of the putative 
effect of the prion in the transcriptome. Once significant expression features are extracted from 
the data proper a more detailed analysis of the specific pathways will occur, merging into 
comparative analysis of the data to existing publicly available data sets. The overall intent of this 
study is to understand the utility of current approaches to microarray data analysis in discovering 
transcriptomic effects in an otherwise classically epigenetic system.  
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Materials and Methods 
 
Raw Microarray Data 
 
The raw data generated for this particular analysis stems from work previously 
accomplished by the Saccharomyces cerevisiae undergraduate research group under the direction 
of Dr. Irene Evans at the Rochester Institute of Technology. The group examined two strains of S. 
cerevisiae (L1763-  Mata ade1-14 leu2-3, 112 ura3-52 trp1-289 his 3-200 [psi-] and L1763+ Mata 
ade1-14 leu2-3, 112 ura3-52 trp1-289 hs3-200 [PSI+])4 which were cultured and subjected to RNA 
isolation via RiboPure-Yeast Kit from Ambion (Austin, TX)5. Following isolation, RNA was reverse 
transcribed generating probes using the Amino Allyl MessageAmp II aRNA Amplification Kit from 
Ambion (Austin, TX)6, and were hybridized7 to a total of 6,388, 70mer Oligos spotted on ISB8 or 
Illumina microarrays (San Diego, CA)5. Finished arrays were scanned to generate 16 bit images 
(tagged image file formatted) at the 532 nm (Cy3) and 635 nm (Cy5) emission wavelengths9. Due 
to the availability of resources to the group, the arrays themselves are sourced from two different 
manufacturers, necessitating the segregation of arrays into two discrete populations for the 
purposes of data pre-processing and normalization. A detailed discussion of this work and its 
findings are contained in Appendix B. 
4 Generously Provided by Dr. Susan Liebman from the University of Illinois at Chicago 
5 http://www.ambion.com/techlib/prot/fm_1926.pdf 
6 http://www.ambion.com/techlib/prot/fm_1753.pdf 
7 Eckdahl Method of Hybridization tailored to GCAT requirements (Eckdahl, Todd. Professor of Biology, Department of 
Biology, Missouri Western State College, 4525 Downs Drive - St. Joseph, MO 64507 
8 Provided courtesy of the Washington University in St. Louis, One Brookings Drive, St. Louis, MO 63130 
9 Microarrays scanned on an arrayWoRx® Biochip reader with scanning services generously provided by Malcom 
Campbell and Peggy Maiorano (GCAT, Davidson College, Davidson, NC) 
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 Image pre-processing was employed to crop and excise each array (printed in 
duplicate per slide) into individual top and bottom images per channel, yielding four images per 
slide. This process was performed in Image J (Abramoff, Magalhaes, & Ram, 2004) and proceeded 
with the generation of each channel file as a stack, selection and cropping of the array to a new 
image of dimensions [2019 pixels x1857 pixels], followed by splitting of the stack and saving of 
each individual channel file with the added suffix of “_t/_B), denoting top or bottom arrays. 
Following initial screening of arrays for obvious defects the final experimental populations 
considered in this study were determined as follows: 
 
 Population 1 |  n = 5 {29, 4, 23, 636, 24} 
 Population 210 |  n =6 {35, 36, 37, 39, 40, 41, 42, 43} 
 
Spot Segmentation and Intensity Extraction 
 
 Four freely available, open source spot recognition programs (MASQOT-GUI11, MAIA12, 
ScanAlyze13, and SpotFinder14) were attained and utilized for spot recognition and intensity 
extraction. Each software application was employed using ideal parameterization resultant of 
extensive screening and parameter scouting using a subset composed of  several best and worst-
case array morphologies in congruence with the literature for spot data acquisition over both data 
sets. A method of spot data acquisition for each data set was determined based on both intensity 
10 This particular sub-group is representative of work performed by S. Zimmerman, et al. at the Rochester Institute of 
Technology under the direction of I. Evans. Additional arrays of this type were available for inclusion, but were not 
included in this analysis due to under-reported experimental management of the arrays, despite the potential benefit 
of increasing the biological replicate sampling size.  
11 http://masqot-gui.sourceforge.net/ 
12 http://bioinfo-out.curie.fr/projects/maia/ 
13 http://rana.lbl.gov/EisenSoftware.htm 
14 http://www.tm4.org/spotfinder.html 
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(as log ratio) distribution and congruence with array quality scores. Overall array quality was 
assessed using an implementation of the Composite Quality Score (Qcom), described in detail by 
Wang et al. (Wang, Ghosh, & Guo, 2001) The resulting distribution of array scores was analyzed 
for significance and congruence with literature values in the Minitab Statistical Software 
Environment (Minitab Incorporated. State College Park, PA) using accepted statistical practices. A 
complete synopsis of spot recognition algorithm comparisons and subsequent qualitative and 
quantitative analysis is provided in Appendix A.  
 
Normalization and Data Transformation  
 
 Following selection of an adequate spot recognition method for both array populations 
data normalization proceeded using the Microarray Data Analysis System (MIDAS), part of the 
TM4 package15 (Saeed, et al., 2006). Multiple normalization methods available within the package 
were attempted in order to determine an optimal method for correcting bias within each array. 
Normalization methods applied included Total Intensity Normalization (Quackenbush, 2002), 
Locally Weighted Regression and Smoothing (LOESS/LOWESS) (Verducci, et al., 2006), Iterative 
Linear Regression (Finkelstein & Gollub, 2002), Iterative Log Mean Centering (Wang, Lu, Lee, Gu, 
& Clarke, 2002) and Ratio Statistics Normalization (Chen, Dougherty, & Bittner, 1997).  
 Since population 2 contains flip dye replicates, a brief study examining the consistency of 
the replicates was conducted, with Flip Dye pairs being constructed arbitrarily in MIDAS as 
follows; 
Table 1: Dye-Swap arrays. The distribution of dye-swap replicate arrays into two ‘Pairs’, or test cases. 
Pair Arrays 
1 -35, -37 
2 -35, -39 
15 http://www.tm4.org/ 
45 
                                                 
  A standard deviation cut off range of ±2σ of the mean FC was applied with a desired 
Confidence Factor > 95%. Following data normalization, log ratios were averaged across technical 
replicates to yield the biologically replicate ORF fold change expressed as log2(FC).  
 The dimensionality difference between the data set was also addressed during ratio 
averaging, where the two populations individual ORF channel intensity ratio values and 
corresponding gene IDs from their respective gene lists (Appendix B, Table B.1) were pooled into 
a master data file using a simple java program designed to perform three basic tasks; 
• Identify matching tuples (in this instance identical ORF names) from two data sources 
• Append unique columns sequentially 
• Output a sorted tab delimited text file. 
 
 Likewise, additional intra-array control probes, if presented were employed to further correct 
inter-array differences across biological replicates and arrays from different manufacturers. Thus 
having resolved the dimensionality deviations between the two data sets, the expression data 
was then added to a MEV project for the remainder of the analyses discussed except when noted 
otherwise.  
 
Cross-Slide Statistical Significance Analysis 
 
 Initially, missing or null values (resulting from either deliberate exclusion by rigorous 
quality control procedures or probes labeled bad or missing by automated spot recognition 
algorithms) were estimated using the K-Nearest Neighbor imputer with 10 nearest neighbors 
sampled. (Chu, Narasimhan, Tibshirani, & Tusher, 2002). A one class t-test (Dudoit, Yang, Callow, 
& Speed, 2000) across all slides was employed using the maximum number of random sample 
groupings to estimate the p-value with an overall critical p-value of α = 0.01. (Pan, 2002) Welch’s 
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approximation was  applied to account for unequal sample variances given the small sample size 
intrinsic to the dataset . (Welch, 1947).  Further cross slide data validation employed using the 
Statistical Analysis of Microarrays (SAM) technique, with 100 permutations and S0 selected via the 
method described by Tusher et al. (Tusher, Tibshirani, & Chu, Significance analysis of microarrays 
applied to the ionizing radiation response, 2001). A delta value was selected which minimized the 
FDR such that the Median FDR ≤ 0.05%. Rank Product determination of significance was carried 
out as described in Breitling et al. applying the method to both up and down regulated genes, 
with a global p-critical value of α=0.01 and 100 iterations of the rank product algorithm for cluster 
assortment. (Breitling, Armengaud, Amtmann, & Herzyk, 2004) 
 
Clustering and Singular Value Decomposition Analysis 
 
 All clustering and SVD analysis methods were performed using the TM4 microarray 
software suite, Multiple Experiment Viewer (MEV) interface versions 1.8 through 2.2.2 (Saeed, et 
al., 2006) Hierarchal Clustering of the significant genes proceeded as prescribed by Eisen et al, 
using Single Linkage, Euclidean distance metric (Eisen, Spellman, Brown, & Botstein, 1998). K-
Means clustering employed a 10 cluster model using the Calculated Means method with a total 
of 17 iterations until convergence. HCL trees generated from K-Means clustering used the Average 
Linkage method with Euclidean Distance. (Gasch & Eisen, 2002) The support tree method utilized 
the average linkage clustering method, with 100 bootstrap random resamples applied to both the 
genes and sample data sets. Correspondence Analysis, Principle Component Analysis and 
Terrain Building were performed as per specified in the MEV user’s guide or by the originally 
reported literature account.  Similiarly, the k-nearest neighbor method was used for the imputing 
of missing or null values using a 10-neighbor sampling baseline for PCA and CA with 20 nearest 
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neighbor sampling baseline for Terrain map generation. FOM and CAST were performed as per 
MEV suggested parameter set with final parameter specification detailed in the respective result 
section. 
  
GO Functional Annotation 
 
 Initial GO slim mapping was conducted using the SGD Gene Ontology Slim Mapper16, using 
the Super-GO Slim Term lists for Component, Function, and Process, as well as the 
Macromolecular Complex: Component term list. Resulting associations are saved as a tab 
delimited text document for term prevalence analysis in Minitab. Tree-EASE analysis was 
conducted in TIGR MEV and utilized the YGD Slim Term mapping file from YGD 17. Initially, 
hierarchal clustering was conducted employing the Manhattan distance metric with Complete 
Linkage. Subsequent EASE analysis of clustered ORFS employed Fisher’s exact probability for each 
mapped sample, with random resampling applied. GoMiner (application build 328 , database 
build 2011-01)  and VennMaster (build 328 preload)  were both employed using either default 
parameterization or optimized as discussed in relevant literature. (Zeeberg, et al., 2003), (Delneri, 
et al., 2008)  
 
Pathway Analysis 
 
 A list of the significant genes with expression values, significant at the specified 
confidence level, was generated from MEV containing ORF names and corresponding expression 
values. Using this Expression data set and S. cerevisiae gene database (retrieved current version 
16 http://www.yeastgenome.org/cgi-bin/GO/goSlimMapper.pl 
17 http://www.yeastgenome.org/DownloadContents.shtml 
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on 2-16-9 from the GenMaPP database via the built in GenMaPP Data Acquisition Tool), an 
expression data set was generated within GenMaPP using the expression data set manager and 
saved as a ‘.gex’ file for further use. Community generated content and automatically created 
metabolic and term maps from the GO and KEGG were retrieved via the GenMaPP.org data 
repository (again using the GenMaPP Data Acquisition Tool) and applied within the GenMaPP map 
viewing environment. GenMaPP18 version 2.1. Later studies utilized the latest build of the 
software, GenMAPP-CS  v 0.1 beta with pathway data sourced exclusively from the wikiPathways 
repository.  
 MAPPFinder , version 2.0 Beta was used for pathway discovery on the expression data set 
previously mentioned using the GO term prepared pathway database (curated by GenMaPP.org). 
Resulting pathway matches were stored in a .txt flat file of ANSI encoding and visualized as 
discussed previously using the MAPPFinder operating environment. A z-score (or the area under 
the hypergeometric distribution) was used to rank the maps in order of interest for manual 
analysis.  
 The YGD Expression Viewer19 was also provided with the list of significant genes, and a 
threshold of 0.5 used to generate high resolution maps of interest. The standard color scheme 
was applied with no other deviations to the operating parameters. Resulting metabolic pathway 
data of interest was saved locally for further analysis.  
 
Meta-Analysis  
18 Conklin Lab, Gladstone Institute, University of California San Francisco 
19 http://pathway.yeastgenome.org/expression.html 
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 The list of significant genes was cropped to  a susbet of the 5% tails of the Log2 FC 
expression value distributions. These select gene lists were then submitted as queries against the 
YGD Expression Connection20, and SPELL21 search engines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 http://www.yeastgenome.org/cgi-bin/expression/expressionConnection.pl 
21 http://imperio.princeton.edu:3000/yeast/ 
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Results and Discussion 
 
Image Analysis and Normalization 
 
 Using the mean qcom composite quality control score as a universal benchmark (Appendix 
A), TIGR SpotFinder and MASQOT were ultimately employed for microarray image analysis to 
extract intensities from arrays from both series (Appendix B). It is postulated these utilities 
exhibited superior performance characteristics over other algorithms scrutinized for two principle 
reasons; 1) the integration of a highly robust edge detection algorithm adaptable to the variable 
spot morphology being processed, and 2) the ability to automatically detect and correct for (or 
exclude) noise discovered during the spot segmentation process, minimizing the effect of these 
artifacts on downstream data processing. With respect to the latter, there was considerable 
emphasis during this work on the preservation of statistically significant data, while utilizing 
thresholds embedded in both methods for determining acceptable spot morphologies and local 
artifact density. Thus, quality controls within SpotFinder and MASQOT were used in order to 
preclude spots irreparably affected by local or regional artifacts. 
 Though maintaining individually unique quality control metrics, both spot recognition 
algorithms sought the same ultimate goal; to delimit good spot data from bad.  In SpotFinder this 
was achieved by applying a quality control score filter (briefly introduced in Table A.3), where the 
QC ScoreToital employed was a composite quality metric comprised of a spot size score and signal 
to noise ratio, averaged over both channels, derived as follows (Saeed, et al., 2003); 
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𝑄𝑄𝐶𝐶𝑇𝑇𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 =  ��𝑄𝑄𝐶𝐶𝑆𝑆𝑄𝑄𝑄𝑄𝑄𝑄𝑆𝑆ℎ𝑎𝑎𝑄𝑄𝑎𝑎𝐶𝐶𝐶𝐶5 ∗ 𝑄𝑄𝐶𝐶𝑆𝑆𝑁𝑁𝑄𝑄𝐶𝐶𝐶𝐶5� ∗ �𝑄𝑄𝐶𝐶𝑆𝑆𝑄𝑄𝑄𝑄𝑄𝑄𝑆𝑆ℎ𝑎𝑎𝑄𝑄𝑎𝑎𝐶𝐶𝐶𝐶3 ∗ 𝑄𝑄𝐶𝐶𝑆𝑆𝑁𝑁𝑄𝑄𝐶𝐶𝐶𝐶3��2 ,  
𝑤𝑤ℎ𝑎𝑎𝑒𝑒𝑎𝑎,    𝑄𝑄𝐶𝐶𝑆𝑆𝑄𝑄𝑄𝑄𝑄𝑄𝑆𝑆ℎ𝑎𝑎𝑄𝑄𝑎𝑎 = 𝑆𝑆𝑄𝑄𝑄𝑄𝑄𝑄𝑆𝑆𝑒𝑒𝑎𝑎𝑎𝑎𝑆𝑆𝑄𝑄𝑄𝑄𝑄𝑄𝑆𝑆𝑎𝑎𝑒𝑒𝑆𝑆𝑆𝑆𝑎𝑎𝑄𝑄𝑎𝑎𝑒𝑒 , 𝑠𝑠𝐹𝐹𝑎𝑎𝑠𝑠𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝐹𝐹ℎ 𝑄𝑄ℎ𝑎𝑎𝑄𝑄 0 ≤ 𝑄𝑄𝐶𝐶𝑆𝑆𝑄𝑄𝑄𝑄𝑄𝑄𝑆𝑆ℎ𝑎𝑎𝑄𝑄𝑎𝑎 ≤ 1
𝑄𝑄𝐶𝐶𝑆𝑆𝑁𝑁𝑄𝑄 = % 𝑆𝑆𝑆𝑆𝑥𝑥𝑎𝑎𝑠𝑠𝑠𝑠𝑤𝑤𝑆𝑆𝑄𝑄ℎ𝐼𝐼𝑎𝑎𝑄𝑄𝑎𝑎𝑎𝑎𝑠𝑠𝑆𝑆𝑄𝑄𝐶𝐶 >  2�𝑀𝑀𝑎𝑎𝑎𝑎𝑆𝑆𝑎𝑎𝑎𝑎𝐿𝐿𝐹𝐹𝐿𝐿𝐹𝐹𝐹𝐹𝐿𝐿𝐹𝐹𝐿𝐿𝐿𝐿𝐿𝐿𝑇𝑇𝐹𝐹𝑇𝑇𝑛𝑛𝐿𝐿𝐿𝐿𝐹𝐹𝐿𝐿𝑖𝑖𝐹𝐹𝑛𝑛�  
Equation 6:  Implementation of a composite QC score for probe-level data   
 
Thus, in this manner, each spot was assigned a QC Score automatically by SpotFinder which 
reflected the overall integrity of the data contained within. If the total QC score fell below a 
particular threshold the data was summarily discarded by means of flagging the spot’s address in 
the resulting data file.  As a visual aid in recognizing problem areas of a particular array, SpotFinder 
supported a graphical overlay of the edge approximation as well as resulting QC score range, 
organized by print groups, an example of which is shown below. 
 
Figure 23: Array segmentation.  A single print group of a sample microarray, exhibiting several key stages during 
microarray image analysis using SpotFinder. Image analysis begins by localization and extraction of the raw print-group 
image (left), followed by application of the segmentation algorithm (center) and subsequent exclusion of specific probes 
by application of a QC score threshold (right) 
 
Using the QC filter flag in concert with additional flags, such as the failure of a spot to be 
recognized or a spot manually set to be ignored, the raw data file of each array was subsequently 
annotated as necessary, which facilitated an increase in the quality of the downstream analysis, 
and subsequently lessening the burden of normalization.  
 Similar image analysis quality control proceeded in MASQOT using a much more 
sophisticated methodology, similar in theory to the Spotfinder approach, however accounting for 
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significantly more quality control parameters. The MASQOT quality control score sought to 
encapsulate a battery of quality indicators, encompassing the key components of microarray data 
quality, namely issues arising from low overall signal intensity, intensity distribution bias, spot 
morphology defects, and issues stemming from background noise (Bylesjö, et al., 2005). 
Appropriate statistics which represent quality indicators from these four primary characteristics 
were modified by a matrix of constants, weighting the relative importance of each quality metric, 
and then summed, yielding a quality control score generally ranging from 0 (poor quality) to 1 
(high quality) (Bylesjo, et al., 2006). Thus, in this manner MASQOTSeg applied the MASQOT quality 
control filter in a batch-wise fashion, using a QC Cutoff of 0.3, and by definition flagging spots with 
QC scores below 0.25 as bad.  This process is depicted graphically as panels in Figure 24, where 
the stepwise progression of a print-group through the MASQOT process is shown. After image 
rendering by the application (Left), MASQOTSeg isolated spot boundaries using the adaptive 
ellipse method of edge detection (center). Immediately after edge detection, a QC score was 
calculated internally for each spot, with spots having a QC score below the set threshold shaded 
in red (right). As is evident in Figure 24 (right) the large dye blob initially noted on the raw image 
is easily isolated and flagged as bad by the MASQOTSeg algorithm using the QC filtering 
implementation. Further annotation of the data proceeded with manual curation of the 
processed arrays in MASQOTView, another utility within MASQOT, which enabled the 
manipulation of the type of flag associated with a QC filtered, rejected spot indicated in red 
(bottom).  
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Figure 24: Print-group level QC in MASQOT. Excerpt of Print Tip Group 12, Array 636-B, as it progresses through the 
stages of MASQOT Processing, including; buffering of the raw image (left), spot segmentation (center), quality control 
filtering (right), and the manual annotation view (MASQOTView, bottom) 
 
 
Following conversion of .GPR files (MASQOT output only) to the ubiquitous .MEV file type, data 
normalization proceeded in TIGR MIDAS. Parallel Normalization attempts using the available 
methodologies in MIDAS were conducted (summarized above in Methods) in order to attain an 
ideal data normalization strategy for the microarray data analyzed in this study. The critical 
desirable properties of a data normalization strategy as previously discussed are centered on two 
key data characteristics; the centrality of the normally distributed log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� values about the 
condition µ = 0 (i.e. correction of channel dependant artifacts), as well as correction of print group 
associated artifacts. Thus, the overall metric for successful normalization becomes three-fold, 
relying on a goodness-of-fit test for normality of the distribution, centrality of the mean about 
zero as confirmed by a hypothesis test, and subsequent qualitative assessment of the distribution 
of log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� values in each print tip group.  
 In order to determine which normalization strategy employed yields the most normally 
distributed ratio data, the Anderson-Darling test statistic, reviewed in (Anderson & Darling, 1952), 
was employed due largely in part to its ability to discriminate the ideal distribution of a data set 
as applied to a probability distribution with a known model via a stochastic process. Using a 
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Minitab implementation of the Anderson-Darling test statistic (deriving the so-called A-Squared 
values) with an α =.05 yielded A-Squared and associated P-Values for each normalization strategy 
employed as well as the reference values for the raw log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� distribution are summarized in 
Table 2. 
Table 2: Effect of normalization method on expression data normality. The effect of Normalization Algorithm on the 
approximation of a Gaussian distribution after normalization on a single array data file. Represented here are the raw 
data (pre-normalization) and post normalization Anderson-Darling Statistics and associated P-Values for array 41-T 
(refer to Table B.1 for more array information). Here the P-Value of the A-Squared is generated from the Anderson-
Darling hypothesis test where;  
 
H0: The data follow a normal distribution 
Ha: The data do not follow a normal distribution 
 
Normalization Method A-Squared P-Value 
Ratio Statistics 7.01 <0.005 
Print-Tip LOESS 29.61 <0.005 
Iterative Log Mean Centering 41.82 <0.005 
Global LOESS 45.31 <0.005 
Total Intensity 58.61 <0.005 
Global Iterative Linear Regression 69.81 <0.005 
Print-Tip Iterative Linear Regression 69.92 <0.005 
None: Raw  Distribution 105.1 <0.005 
 
From the data presented in Table 2 clearly every normalization strategy yielded a significantly 
better approximation to a normal distribution than the unprocessed data, however with varying 
degrees of success. Indeed, the Ratio Statistics method provided the best approximation of a 
normally distributed log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� distribution, however normality is still not attained even by 
application of this method since the p-value of the Anderson-Darling Statistic is less than the 
established level of confidence for the hypothesis test (where, α>> p, and H0 is subsequently 
rejected since α = 0.05). It is important to note the susceptibility of this test to even slight 
imperfections in the data, identifying even large and highly uniform distributions, as non-normal. 
(Stephens, 1974) Thus from this data we can simply rank the various strategies applied in order 
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of normal distribution approximation, concluding the Ratio Statistics Normalization method, 
followed by the Print-Tip modified LOESS normalization algorithm, yield a more normal 
distribution of log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� values as compared to other normalization techniques with reference 
to the raw data distribution, summarized graphically in Figure 25. 
 
 
Figure 25: Distributions of normalized expression data.  Histogram representation of the log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� values as both pre-
normalized (raw data) and post-normalization using a variety of algorithms. Note: LOESS and Iterative Linear Regression 
supported both Global and Local (print-tip) implementations, and as such, both include results from the Print-Tip and 
Global methods.  
 
A cursory review of the data presented in Figure 25 indicates the raw data suffered from a 
significant negative skew in the overall distribution, caused by systemic Cy3 dye bias. After 
individual application of several normalization strategies, the data set from this array yielded 
ratios assuming a far better approximation to the Normal distribution, as expected, as well  as 
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better centrality of the distribution about the condition  log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� = 0, typified in the boxplot 
representation of the data in Figure 26, below.  
 
Figure 26: Boxplots of expression data. Distribution summaries of the raw (pre-normalized) and post-normalization 
Log2 Intensity ratio distributions as boxplots, showing the Mean (Circle), Median (Horizontal Line), Inter-Quartile Range 
(Grey Box) and Outliers (Asterisks) for each distribution. Additionally, box plots may be identified as follows {RAW_1 = 
Raw Data; TI_1 = Total Intensity; RS_1 = Ratio Statistics; PRL_1 = Print-Tip LOESS; GL_1 = Global LOESS; GILR_1 = Global 
Iterative Linear Regression; PTILR_1 = Print-Tip Iterative Linear Regression; ILMC_1 = Iterative Log Mean Centering} 
 
However, while qualitatively the assumption may be made that good congruence between the 
mean of each distribution and the condition log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� = 0 was attained, an empirical measure 
must be applied such that the mean intensity ratio is tested against the assumption that mean 
intensity ratio, µ = 0. Student’s T-Test was employed to test this hypothesis, using the following 
standard test design; 
H0 :  µ ≠ 0 
Ha :  µ = 0 
 
Application of the T-Test to the distributions given in Figure 26 yields summary statistics and 
associated p-values in Table 3. 
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Table 3: Normalization method T-Test. The result for each normalization method (and raw data as a control) in 
examining centrality of the distribution ( via comparison of mean values) about  log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� = 0, with a stringent level 
of significance (α = 0.01).     
Variable N µ σ SEM 99% CI T P 
Raw Data 6682 -0.52057 0.39306 0.00481 (-0.53296, -0.50818) -108.26 0 
Total Intensity 5287 -0.26427 0.31828 0.00438 (-0.27555, -0.25299) -60.37 0 
Ratio Statistic s 4967 -0.0427 0.23876 0.00339 (-0.05143, -0.03397) -12.6 0 
Print-Tip LOESS 5287 -0.00182 0.27425 0.00377 (-0.01153, 0.00790) -0.48 0.63 
Global LOESS 5287 -0.00188 0.3079 0.00423 (-0.01279, 0.00903) -0.44 0.657 
Global Iterative 
Linear Regression 
5287 0.05439 0.32805 0.00451 (0.04276, 0.06601) 12.05 0 
Print-Tip Iterative 
Linear Regression 
5287 0.0429 0.30041 0.00413 (0.03225, 0.05354) 10.38 0 
Iterative Log-Mean 
Centering 
5287 0.06335 0.31003 0.00426 (0.05237, 0.07434) 14.86 0 
 
As the data presented in Table 3 obviates, both implementations of the LOESS normalization 
algorithm generated mean log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� values, which could be considered 0.0 with a very high 
degree of certainty. This discovery is of significance since it indicates the LOESS methods corrects 
the inherent dye bias observed in Figure 26 above, satisfying the   second afore mentioned metric 
of successful normalization. Further scrutiny of the LOESS normalization strategy’s performance 
required the qualitative assessment of the print-tiplog2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� distributions in order to assure that 
printing associated anomalies are corrected for. Furthermore this general assessment of print-
group suitability serves as the final metric in determining the optimal normalization strategy, as 
the prior assessments of Anderson-Darling Statistics (normality approximation) and Student’s T-
Test (appropriate centering of ratio distribution) yielded convincing, yet inconclusive results.  
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 Figure 27: Normalization effect on print-group. The effect of select normalization strategies (Print-Tip LOESS, Global 
LOESS and Ratio Statistics) on the log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� distribution for data from array 41-T displayed as a function of print-tip 
group (block) with reference to then native (pre-normalization) distribution in the same format (top left panel).  
 
 
 Utilizing this qualitative, and evidently crucial, representation of the post-normalization 
log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� data as a function of a print group, the Print-Tip LOESS method emerged as the optimal 
method of normalization. Though the Ratio Statistics method did indeed yield the most normal 
ratio distribution by the Anderson-Darling test, it becomes obvious by examining Figure 27 the 
Ratio Statistics method cannot resolve print-tip associated bias, and in fact appeared to 
exacerbate the overall array noise via inflation of the deviation of print-groups.  Further scrutiny 
of Figure 27 in detail yields a previously uncharacterized ratio trend at the print-group level, where 
there is a progressive decrease in the Cy3 dye bias as the block number increases. While the Global 
LOESS method satisfies the need to center the overall distribution of these ratios about µ = 0, the 
trend still exists in the data, observable as a slight offset as print block number increased. Print-
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Tip LOESS normalization totally resolves this trend (Figure 27) while simultaneously returning both 
the whole array (Table 3) and individual print group ratio means to the condition µ = 0. 
Additionally, the resulting distribution of log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� values after Print-Tip LOESS normalization 
yields a distribution with markedly improved normality (Table 2) and as such, Print-Tip LOESS 
normalization was utilized as the normalization strategy of choice for both array data sets in this 
study.  
 
Cross-Slide Statistical Significance Analysis 
 
 Once data normalization  was completed, the duplicate arrays on each slide (top and 
bottom) were averaged to yield one ORF expression value per slide, using a standard arithmetic 
mean, assigning a null value for any ORF which had a missing expression value on one or both 
within slide replicate arrays. Following averaging of on-slide replicates, the final matrix of ORF 
indexing information [array address data, Spot ID, ORF name, YGD ID and ORF description] and 
subsequent expression values for each slide were added to an MEV project and displayed in a 
Multiple Array Viewer, where all further analysis occurred. Initial observations of the data at large 
indicated a number of unique features associated with global intensity distribution over each 
slide. Specifically, three slides in particular exhibited markedly different patterns of expression as 
compared to the remainder of the data set at large. Using the MEV’s implementation of a Sample 
Distance Matrix Utility (Kimmel & Olivier, 2006), the Euclidean Distance between samples as a 
function of their ORF expression characteristics was calculated and a distance matrix generated 
in an all vs. all fashion, yielding Figure 28. 
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 2 3 2 4 2 7 2 9 3 4 636 3 5 3 6 3 7 3 9 4 0 4 1 4 2 4 3 
2 3 0 35.8 56.2 33.9 32.5 31.9 44.7 94.4 91.2 42.4 41.1 35.8 32.5 104.1 49.6 
2 4 35.8 0 60.1 30.9 34.6 35.7 4 8 98.2 95.1 48.6 47.3 4 4 41.4 106.5 54.5 
2 7 56.2 60.1 0 58.4 49.7 54.1 52.4 96.3 93.4 57.9 58.5 55.3 53.1 104 62.5 
2 9 33.9 30.9 58.4 0 32.6 3 5 45.9 94.9 91.9 46.9 45.4 41.6 38.8 102.4 51.9 
3 32.5 34.6 49.7 32.6 0 31.5 35.3 80.8 78.3 39.3 38.3 35.1 32.5 87.5 43.9 
4 31.9 35.7 54.1 3 5 31.5 0 34.3 94.2 90.9 40.1 38.2 34.1 30.2 102.2 47.5 
636 44.7 4 8 52.4 45.9 35.3 34.3 0 91.1 87.9 41.1 39.8 3 6 32.2 100.1 47.8 
3 5 94.4 98.2 96.3 94.9 80.8 94.2 91.1 0 28.7 94.9 96.7 101 99.4 174.7 119.4 
3 6 91.2 95.1 93.4 91.9 78.3 90.9 87.9 28.7 0 91.6 93.2 97.6 9 6 171.5 115.9 
3 7 42.4 48.6 57.9 46.9 39.3 40.1 41.1 94.9 91.6 0 36.7 48.9 41.8 100.5 49.4 
3 9 41.1 47.3 58.5 45.4 38.3 38.2 39.8 96.7 93.2 36.7 0 37.8 34.7 108.7 51.7 
4 0 35.8 4 4 55.3 41.6 35.1 34.1 3 6 101 97.6 48.9 37.8 0 18.6 115.4 54.9 
4 1 32.5 41.4 53.1 38.8 32.5 30.2 32.2 99.4 9 6 41.8 34.7 18.6 0 109.8 49.7 
4 2 104.1 106.5 104 102.4 87.5 102.2 100.1 174.7 171.5 100.5 108.7 115.4 109.8 0 77.4 
4 3 49.6 54.5 62.5 51.9 43.9 47.5 47.8 119.4 115.9 49.4 51.7 54.9 49.7 77.4 0 
 
 
 
Figure 28: Sample relatedness. Sample distance matrix 
displayed as both raw Euclidean Distance Score {defined here 
as the distance D, between two samples such that  𝐷𝐷 =
�(𝑄𝑄1 − 𝑞𝑞1)2 + (𝑄𝑄2 − 𝑞𝑞2)2 + ⋯+ (𝑄𝑄𝑖𝑖 − 𝑞𝑞𝑖𝑖)2, for all ‘i’  
expression values within the arrays}, given above, and then 
scaled {0,1} distance for all samples in the data set (right) 
where black represents 0 and red indicates 1. 
 
 
 Examining the figure above it is evident that there are considerable differences in the 
information content of arrays 35, 36 and 43 as compared to the remainder of the data set. This 
trend indicates that there are systemic deviations in expression on these particular slides over 
many ORFs either because of experimental bias, such as an uncharacteristic alteration in genomic 
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expression caused by environmental factors, or perhaps an issue associated with sample 
preparation. Further examination of these slides in particular revealed that the post normalization 
histogram (Figure 29), and subsequent box plots of the expression data distribution (Figure 30), 
confirmed a highly irregular pattern of expression as compared to a typical array from the same 
population. 
 
 
Figure 29: Expression FC distributions for questionable arrays. Frequency distribution overlays of 𝐿𝐿𝑄𝑄𝐿𝐿2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� values 
for the subject slides in question {35,36,43} as compared to a typical slide from the data set, specifically population 2 
{37}. Curiously, the overall distribution of expression ratios is not strikingly dissimilar between the typical slide, 37, and 
the slide in question, 43, indicating either significant effect on similarity caused by outliers who’s density is not readily 
visualized in this representation, or significant differential pressure within the semi-normally distributed transcriptome 
of the array.  
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 Figure 30: Print group distributions for questionable arrays. Comparison of Print-Tip group distributions via box plot 
representation of the three subject slides (35,36,43} and the typical slide {37}. Though the y-scales of each plot slightly 
differ, there was clearly a significant increase in the print-group standard deviation (~4x) of the subject slides, and as a 
result are expected to contain significantly greater bias than the remainder of the data set.  
 
 Given these indicators, further analysis of these slides would likely have contributed to 
far greater slide-dependent bias (or in the case of slides 35 and 36, dye-swap generated bias) and 
as a result were excluded from all further downstream analysis in addition to cross-slide 
significance. Thus, after removing these three slides, as well as 27 and 63622, the final data set 
consisted of slides {23, 24, 29, 3, 4, 37, 39, 40, 41, and 43}, which were then examined for 
significant ORFs using three methods of cross-slide statistical significance; the Student’s T-Test, 
Significance Analysis of Microarrays (SAM) and Rank Products (RP) using the parameterization 
discussed previously in Methods. Resulting significant genes for each method are given in 
22 Since the remainder of the downstream analysis requires manipulation of the data in MEV, these slides 
were excluded due to the inability to weight their expression values since top and bottom averaging of 
on-slide arrays was not possible due to the loss of >10% of ORFs in the data pre-processing and 
normalization efforts for a particular on-slide array duplicate. Unfortunately, TIGR MEV has yet to 
implement support for weighting of the raw expression data in a meaningful fashion. Additionally, the loss 
of such arrays is not of significant detriment to the analysis itself for two reasons; primarily the loss of 
expression value significance of the biological replicates since there is only one technical replicate 
available to derive expression data from, and secondly, further examining Figure X.X, both slides appeared 
relatively distant from the remainder of the data set.  
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complete tables found in Appendix C (Tables C.1, C.2, and C.3), in addition to being represented 
graphically as a Venn diagram depicting relative quantities of significant ORFs discovered by each 
of the three methods below.  
 
Figure 31. Discovery rate of significant genes via three methods.  Schematic illustrating the relative proportion of 
statistically significant ORFs as determined by each of the three methods. Importantly the congruence between the 
methodologies, expressed as the number of ORFS detected by the enclosed methods, is provided within the overlap 
regions.   
 
 As expected, there is a significant degree of consensus between the two t-based methods 
employed, SAM and the T-Test, while the Rank Product method appears to be the outlier of the 
three methods (yielding a large number of significant ORFs, which are generally not in congruence 
between the T-Test and SAM methods).  Another representation of the disparity between these 
results is given below in Figure 32, which illustrates the data congruency between the methods 
using average linkage cluster analysis of the Pearson’s correlation coefficient distance.   
Rank Products 
N = 560
T-Test 
N=539
SAM 
N = 207
N = 211 
N = 130 
N = 207 
N = 148 
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 Figure 32: Clustergram of significance tests.  Dendogram of clusters created to describe the relative similarity of ORFs 
found significant by each method.  
 
This observation is anticipated because of the disparity between the underlying algorithms used 
(T-Test and Rank), and is in congruence with similar observations in the literature (Hong & 
Breitling, 2008). However, when considering the small sample size of the data set (n = 10 biological 
replicates), emphasis must be placed on the lack of reliability of the t-based methods, which are 
prone to bias introduced from both the overall high degree of noise, and the estimation of 
variance (Jeffery, Higgins, & Culhane, 2006). Additionally, it has been previously reported that the 
Rank Product algorithm demonstrates significant noise resistance while simultaneously discerning 
significant genes in data sets with low sampling size (Breitling, Armengaud, Amtmann, & Herzyk, 
2004) (Jeffery, Higgins, & Culhane, 2006). Thus, the Rank Product method was expected to yield 
the most optimal performance in this application given the data characteristics observed thus far 
in this study. As a result, the 560 ORFs discovered as significant using the Rank Product technique 
were considered for use in the later downstream analysis.  
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Cluster Analysis 
 
 After reduction of the data set from a total of 6580 to a more manageable 560 ORFs (a 
91.49% reduction in data size) using the Rank Products method of cross slide significance, several 
clustering techniques were applied to further reduce the expression data into closely related 
subsets with significantly reduced dimensionality. Application of the classical, Hierarchal 
Clustering technique was initially attempted to elucidate overall trends in expression, applying 
the simple observation that related genes tend to be expressed at similar levels. Furthermore, 
this basic method of clustering is appropriate in this setting given that the data does not contain 
temporal or multi-condition dimensionality, thus similar (statistically significant using the Rank 
Product method) expression across all samples should be observed for each gene.  
 Hierarchal clustering was applied to these data using two widely employed distance 
metrics (Euclidean and Manhattan) in addition to varying methods of linkage (Complete and 
Average).  
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A) B)  
Figure 33: Euclidean distance clustering. Dendograms of clustered significant ORFs using the Euclidean Distance metric 
and Average (A) and Complete (B) Linkage. Examining the Complete Linkage results from a top-down approach, there 
appears to be a curious association of under-expressed ORFs with over-expressed ORFs in the high-level cluster. 
Furthermore, while Average Linkage correctly associated over-expressed and under-expressed ORFs into an 
appropriate 2-cluster model, A number of ORFs remain unclassified by either of the two principles daughter clusters.   
 
 Apparent in the Euclidean Distance metric data was a lack of appropriative association of 
over-and under-expressed ORFs into similarly expressed clusters at the highest levels of cluster 
differentiation. This observation indicates that, independent of linkage type, the Euclidean 
distance metric is inappropriate in this application, likely due to the relatively high degree of noise, 
which remained in the data set. While several of the highly differentiated daughter clusters may 
prove informative, given their relatedness, there is clear difficulty in utilizing this distance metric 
for the  correct differentiation of over and under-expressed ORFs. However, when the Manhattan 
distance metric is applied (Figure 34), there is clearly an increased distinction between over and 
under-expressed ORFs in the high level clusters seemingly independent of linkage method.  
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A) B)  
Figure 34: Manhattan distance clustering.  Dendograms of clustered significant ORFs using the Manhattan distance 
metric and Average (A) and Complete (B) Linkage methods.  
 
 Examining the dendograms presented above, the utilization of Average Linkage with the 
Manhattan Distance Metric appears to derive a similar set of higher-level relationships as that of 
the Euclidean Distance method and Complete Linkage (Figure 34.B). However, using Manhattan 
Distance in conjunction with Complete Linkage, there appears excellent definition between the 
over and under-expressed ORF populations as well as complete assortment of both sub-sets of 
the data into principle clusters after two daughter nodes were created.  Thus, via qualitative 
assessment of the dendogram of Figure 34.B, there are clearly well defined regions of co-
expressed genes, which exhibit uniform expression characteristics across all samples in the data 
set presented.  
The casual observations from these dendograms may be contextualized further with a 
more quantitative method of data enrichment, by calculating the support each daughter cluster 
lends to the parent node. This statistical confidence measure in cluster refinement utilized 
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resampling of the data with replacement (commonly referred to as bootstrapping), which yielded 
the actual relationship between daughter clusters and parent nodes. By resampling the data, the 
measure of confidence of these cluster relationships subsequently increases as the number of 
resampling iterations increases. Furthermore, while the cluster assignment will not vary, as this is 
a function of the selected distance and linkage metric, a better understanding of the actual 
relationship dynamics between clusters at varying levels will be conveyed. Displaying the Support 
Tree of the Hierarchal Cluster from Figure 34.B, it becomes obvious that there was considerably 
more variability in the clusters generated for ORFs as opposed to samples (Figure 35). 
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Figure 35: Clustering with Support Trees.  Support tree constructed for the cluster given in Figure 34.B, using 
Manhattan Distance and Complete linkage. Support trees for both genes and samples were constructed using 100 
iterations each of the bootstrap method discussed previously and ordered for node leaf optimization.  
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 Of note in examining Figure 35 in further detail was the occasional highly supportive, but 
low level groups of gene clusters, combining two or three ORF clusters which yield significantly 
more support for the parent node than the vast majority of the deepest clusters generated. This 
observation is substantive since it indicates these particular ORFs are highly similar in either mean 
expression, or more importantly, expression trend over all samples in the study.  
 Another curious feature of the data was the relatively high degree of association between 
the samples, with sample tree support ranging from 50%-100% as opposed to 0%-80% observed 
within the gene tree, though this observation may be more a function of the significantly smaller 
data size in comparing samples. Furthermore, the sample tree clearly reduces the samples into 
two distinct subclasses, delimiting population 1 and population 2 arrays. Interestingly, the data 
also suggests significant congruence between select biological replicates, including strong 
congruence between arrays 24-20, 37-39 and 40-41. This particular view of the data was also 
amenable to displaying the apparent discordance between array 43 from the other arrays of 
population 2, indicating qualitatively the inherent expression variability between biological 
replicates.  
While informative to an extent, these qualitative observations of the data at large must 
be taken in context with the statistical significance of those clusters generated at each hierarchal 
level of the dendogram. Consider, for example, the ORFs clustered near the transition between 
over and under expressed ORFs, an expanded view of which is shown in detail in Figure 36.  While 
the discrimination between the two principle clusters is defined explicitly between YNL242W and 
YOR291W, it appears from examining the neighboring ORFs, that there was considerable 
similarity in expression within this region, and as a result the clusters generated within this locality 
is not as significant as other regions of the dendogram.  
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 Figure 36: Expansion of figure 34.b cluster.  Expanded view of the dendogram presented in Figure 34.B, illustrating the 
median region between the principle over and under-expressed ORF clusters.  
 
In light of this observation, and in general to address the issue of discerning which level of the 
hierarchal cluster is significant in differentiating like from unlike ORFs, a Figure Of Merit (FOM) 
was applied, in an effort to determine the appropriate number of clusters which are required to 
achieve this objective. 
Recall that the FOM approach, introduced in detail previously, reduces the data set by 
one cluster iteratively, such that the predictive power of the subset of samples with respect to 
biological significance in generating clusters of similar ORFs is tested. Generally, the results from 
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such an algorithm applied to the data yields the quantifiable effect of increasing the initial cluster 
size estimate as a function of constant sample size, using a jackknife approach, with an ideally 
small FOM indicating relatively high predictive power. (Yeung, Haynor, & Ruzzo, Validating 
clustering for gene expression data, 2001) Unfortunately the FOM technique was only supported 
for the K-Means/Medians Clustering and the Cluster Affinity Search Technique (CAST). The 
resulting FOMs for both methods are given below in Figure 37. 
A) B) 
  
Figure 37: Figures of Merit. Figures of Merit for the (A) K-Medians Clustering technique (calculated using 20 iterations 
of the FOM algorithm with a MaxClusters = 50) and the (B) CAST method of cluster analysis (using a threshold step of 0.01) 
 
 Examining Figure 37 in further detail, it becomes obvious there are significant differences 
in the number of clusters needed to attain a similar FOM between the two clustering techniques. 
Ideally, from Figure 37.A, the K-Median method will perform optimally when using 13 initial 
clusters upon method execution, yielding an adjusted FOM of 4.136, and consequently the lowest 
observed FOM score standard deviation. Conversely, the CAST technique requires as many as 30 
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clusters to attain an FOM of 4.209. Thus, from these observations, clustering using these methods 
becomes more informative, since the ideal hypothesized quantity of clusters was previously 
established before initiating the clustering process. Utilizing the FOM generated estimate of 13 
initial clusters, K-Medians clustering was applied to the data set, with the resulting expression 
graphs (an MEV rendered view of the expression trend over each sample of all ORFs in a particular 
cluster as a function of expression ratio log2 �
𝐶𝐶𝐶𝐶5𝑖𝑖
𝐶𝐶𝐶𝐶3𝑖𝑖
� provided below in Figure 38. As an 
observational note, when using both K-Medians and the CAST technique, the generation of a 
complete dendogram of all clusters created was prohibited, since both methods ignore the 
relationship between highest level clusters, treating each as independent, discrete collections of 
like-elements.  
Figure 38: K-Mean Clustering. Expression graphs of the 13 clusters yielded from executing the K-Medians clustering 
technique on the data set. K-Medians was employed as the media ORF value is it is widely assumed the median value 
is more resistant to technical noise than the mean as an indicator of overall ORF expression activity. (Klebanov & 
Yakovlev, 2007). Furthermore the data is organized such that each individual sample corresponds to a ‘column’ of data 
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points, arranges such that the arrays from population 1 (recall Appendix B) comprise the left-most elements of each 
table, with the population 2 arrays comprising the right-most elements. Note: Figure is referenced in the later text by 
sub-panel, where cluster one is denoted as Figure 38.1, etc. 
 
 Examining the data presented in Figure 38, a number of unique features become obvious, 
namely the disproportionate number of clusters created for over (2) and under-expressed (11) 
ORFs. These data are significant in that the K-Medians clustering technique has elucidated several 
critical features of the data set which assist in understanding the overall characteristics of the 
expression data at large. Firstly, examining the predominantly over-expressed clusters (Figures 
38.1,2), the major difference between the two is the tendency for significant over expression to 
be categorized either as population 1 arrays (Figure 38.1) or population 2 arrays (Figure 38.2). This 
finding is substantive, since it implicates the order performed during the wet-bench study (the 
primary differentiator between population 1 & 2 arrays), is potentially responsible for differential 
expression patterns. 
 A similar trend, however which is much less profound, is observed within the clusters of 
down-regulated ORFs (Figure 38.3-13), with the noted exception of significantly more unique 
clusters, all of which bear overall down-regulated trends, but with markedly different 
topographical features. Notably a universal feature inherent within the clusters such that if a gene 
is significantly down-regulated in the population 1 arrays, it also tends to be consequently 
marginally down-regulated in the population 2 arrays. Additionally, there does appear to be a lack 
of discrimination with the two up-regulated ORF clusters, as there are clearly some negative Fold-
Change elements present within the data. However, these are apparently not significant enough 
to discriminate a further cluster. This observation is substantial in and of itself since it indicates 
there is considerably less heterogeneity within the under-expressed ORFs as discovered by K-
Medians Clustering.   
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 Utilizing the FOM estimate of 30 clusters as previously discussed, a CAST analysis could 
be performed on the data set and subsequently expect similar results as yielded by the K-Median 
technique, since similar, non-hierarchal centric logic is employed. The resulting application the 
CAST technique yielded 30 clusters, which are displayed in the same manner as the K-Medians 
clustering results, given below in Figure 39.  
 
Figure 39: Cluster Affinity Search Technique.  Expression graphs for the 30 clusters identified by the CAST method using 
an affinity threshold of 0.75 for cluster boundary determination (attaining the 30 idealized clusters as prescribed by the 
FOM).  
 
The data presented in Figure 39. (Subpanels 1-30) above indicates qualitatively non-ideal cluster 
recognition using this technique, with the bulk of the ORFs (~88%) contained within four clusters 
proper. This poor discrimination is not entirely unexpected since the natural result of the CAST 
technique is to describe clusters of genes given a particular affinity threshold, in a multiple-
condition environment. (Ben-Dor, Shamir, & Yakhini, 1999) This effect is contextualized by the 
data presented in Figure 39, where clusters identified with generally low ORF member counts (all 
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clusters excepting 2 and 10) demonstrate strikingly independent and varied features as a function 
of sample number. While this technique is ideally suited to resolve subtle trends inherent in 
multivariate microarray data set, in this particular application this ability is of benefit, since the 
CAST algorithm specifically identifies clusters of genes whose expression differs across both 
dimensions (gene and sample). Thus, the informative data yielded from this technique is that of 
data reduction, indicating which genes have the greatest amount of variance across multiple 
samples. As a result these genes may be discarded since, while they are statically significant, 
contribute the least to classical clustering methods (as is evident in Figure 39 and the expansion 
of the dendogram, given in Figure 36), since these differences indicate between-biological sample 
expression variance. Ordinarily these trends are putatively significant given their implications for 
gene expression pattern discovery, however since the biological conditions of this assay remain 
constant, both channels are expected to maintain homogenous expression patterns over 
biological replicates.   
 
Singular Value Decomposition Data Reduction Strategies 
 
 After completion of traditional clustering methods, which yielded significant 
understanding of the features inherent in the data, further effort was placed on determining 
which of these artifacts were of significance. Using Principle Component Analysis (PCA), 
Correspondence Analysis (CA) and Terrain Expression Mapping (TRN), each an implementation of 
the more general Singular Value Decomposition (SVD) methodology, the data was further reduced 
in an effort to determine which features of the expression data was of statistical significance. 
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Principle Component Analysis 
 
 Perhaps the most widely utilized implementation of SVD for microarray data reduction, 
the Principle Component Analysis attempts to reduce the data dimensionality via representation 
of the experimental variability via fractioning of the data set into components. In this manner, 
principle components were identified using the PCA application in MEV employing the underlying 
methodology described previously, and subsequently ordered by descending variability 
encapsulation. Thus, the first three components are represented as the spatial coordinates (‘x’, 
‘y’, and ‘z’) of each element in the data set, which is then plotted in three-axial space. The resulting 
3-D plot for the PCA on the data set derived in this study is given below as Figure 40, using median 
centering. Null or missing values were computationally imputed using the k-nearest neighbors 
method with a 10,000 neighbor sampling pool.  (Bremmer, et al., 2005) 
 
Figure 40: Principal Component Analysis. The resulting plot of this analysis on three axis, indicating the effect of the 
first three components on variability capture within the data set. Note; for this rendering over-expressed genes are 
colored as (blue) and under (yellow). 
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 While the assumption in employing the PCA method was based upon a single component 
encompassed the majority of the data’s variability, two seemingly equally important components 
were obviated by the distribution of ORFs in the figure above. Examining the data from the three 
dimensional projection in further detail, there is clearly a strong degree of association between 
the two discrete populations and their respective distributions dispersed on the negative and 
positive planes of the x-axis (shown as the grey axis in Figure 40 and labeled ‘1’). Applying a color-
coding schema to these two discrete populations to aid in visualization, there exists a clear 
association between the two, roughly  parallel planes of distribution, along the X-axis (in grey), 
and a more vague, loosely associated relationship with the y ( blue) and z (pink) axis. The 
characteristics of these associations are better represented in the planar overlay of each series of 
axis, given below in Figure 41.A,B,C. 
 
79 
 
Figure 41: PCA: Two-Dimensional component overlays. These planar views indicate the relationship of the first three 
Principle Components, where (A) the x-axis = Component 1, and y axis = Component 2; (B),x-axis = Component 2, y-axis 
= Component 3; (C), x-axis = Component 1, y-axis = Component 3. Also provided is the Eigenvalues for the first 10 
components calculated as well as the total (as %) of data set variability accounted for by each component and finally 
the total (as %) variability accounted for by the first two and three components combined.  
 
The data collectively indicates the initial trend observed using the 3-d rendering of all axis 
in the spatial environment, Figure 41, is substantive, particularly given the strong association of 
the data to the x-axis (Figure 41.B, where the x-axis exists traversing the intersection of the y and 
z axis (Cartesian coordinates i = {0,0} )of the plane depicted). Furthermore, the degree of 
association between the data and the first three axis is quite good, with most (>75%) of the 
Eigenvalues encapsulated by three initial components. This result is important, since a high degree 
of Eigenvalue associations to a small number of components validates the use of the PCA 
approach in general. Interestingly, when the same blue/yellow color scheme was applied to the 
K-Medians result, it becomes evident that PCA correctly (generally) assorted the data set into 
discrete, over (blue) and under (yellow) expressed populations of ORFs (Figure 42). 
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Figure 42: K-Median clustering with PCA enrichment. K-Medians cluster result from Figure 38, with the PCA derived 
color schema imposed.  
 
 While this particular representation of the data serves to highlight an already-established 
trend of the data set (the discrete assortment into over and under-expressed ORF sub-groups), 
further scrutiny of the distribution of ORFs on the three PCs plotted in Figure 41 is required. 
Indeed, while difficult to visualize initially, the data suggests a small reservoir of putatively 
informative ORFs which tend not to associate with any of the three PCs analyzed in detail. 
Additionally these ORFs exhibit a general tendency to associate with each other, indicating the 
possibility of further assortment of the distribution into two additional clusters, exhibited in 
Figure 43.A-D 
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Figure 43: PCA: Unique isolates. The identification of two additional clusters of interest generated from the PCA analysis 
discussed above. Shown in these representations are the two-dimensional planar views of principal component plots 
for Principal Components A) {1,2}, B) {2,3}, C) {1,3} and D) the 3-dimensional plot of the three principal components 
discovered previously. The new clusters identified are identified by the magenta and teal colored ORFs, and are outlined 
in each representation by a red box as a visual aid.  
 
 Interestingly these two groups of ORFs, when imposed on the K-Medians cluster result 
previously discussed, tend to assort into clusters which are notably heterogeneous in differential 
expression initially (Tables 4 and 5). While this feature is not altogether unanticipated, as a cursory 
examination of these clusters’ expression patterns (demonstrated graphically in Figure 43) 
indicates that these clusters do have a significant degree of expression pattern dissimilarity, it is 
of profound interest that these particular ORF reservoirs tend to cluster together quite distinctly.  
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Table 4: K-Means/PCA Sub-cluster 2. PCA sub-cluster result imposed on K-Medians cluster #2, indicating the relative 
homogeneity of expression ratio (where FC µ ≥0.67) within the up-regulated sub-cluster (purple) in comparison to the 
bulk remainder of the K-Median Cluster where FC µ ≈ 0.33. Note; an additional 57 up-regulated ORFs are cropped from 
this particular representation of the data.  
 
 
 
 
Table 5: K-Means/PCA Sub-cluster 6. The down-regulated PCA-derived sub-cluster as imposed on K-Medians Cluster 
#6, exhibiting similar inter-cluster homogeneity (sub-cluster FC  µ ≈ -0.7 as opposed to the bulk remainder of the cluster 
where µ ≈ -0.35)  as the up-regulated sub-cluster in table X.X above.    
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Correspondence Analysis 
 
 Similar to Principal Component Analysis, Correspondence Analysis (CA) seeks to reveal 
the principal axis of the high-dimensional space (i.e. the raw expression values), subsequently 
allowing for projection of the most meaningful data in a lower dimensionality representation as a 
function of variance responsibility. Application of this technique to the data allows for the 
generation of a three-dimensional representation of this dimensionality reduced data, where the 
distance of the ORF on the plot corresponds proportionately to the increase in variance. In 
particular, this variance in CA is encapsulated by the χ2statistic of the row of ORF hybridizations 
(biological replicative samples in this data set), and as such the distance between individual points 
in the decomposed space is representative not of Euclidean Distance, but rather the χ2distance, 
decomposed into the three most informative principal axis. (Fellenburg, et al., 2001) However, 
unlike PCA, utilization of CA increases the information content of this the χ2 distance matrix is 
enriched via the plotting of samples as a function of relatedness to ORFs, again relying on 
decomposition of the column (i.e. samples) χ2statistic over all rows (i.e. ORFs). Thus, in this 
manner, the proportional relatedness of samples to corresponding informative ORFs was 
established using the χ2 distance metric and a three dimensional representation of the resulting 
plot as a function of distance from the principal axis, generating the plot given below in Figures 
44.A-C 
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Figure 44: CA data renderings. Correspondence Analysis plots rendered using three principal axis, with data views 
shown of the CA analysis as applied to A) ORFs, B) Samples, and C) an overlay of both ORFs and Samples on the same 
plot. Note, the established color schema from the Principle Component Analysis results is continued in these data 
above, where Blue= down-regulated, Yellow = up-regulated, Purple = up-regulated sub-cluster, and Teal = down-
regulated sub-cluster.  
 While distinct in the overall mechanism of variance decomposition, CA yields strikingly 
similar results with respect to differentiation of over and under-expressed ORFs as well as 
correctly differentiating between populations 1 and 2 arrays. In particular, referencing Figure 
44.B, excellent discrimination of samples into population 1 and 2 array clusters was attained, as 
well as further segregation of the more disparate members of each sample class, such as 43. 
However, cursory analysis of the distribution of ORFs using the three-axial representation 
indicated less class discrimination between over and under-expressed ORFs, as well as few 
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spatially relevant ORFs associated with a sample’s local region. Though initially unclear, the cause 
of this artifact may have been caused by the small sampling size,  both in terms of the number of 
samples as well as the reduced subset of ORFs, with which the method was applied. This 
observation appears substantive by the available literature which reports on application of CA 
onto very large expression experiments of multivariate sampling type (reviewed in (Fellenburg, et 
al., 2001), (Kishino & Waddell, 2000), and (Qihua, et al., 2004)). Thus, it was anticipated that CA 
yielded less-informative clusters of related, variance contributing ORFs, if at all, when 
benchmarked against the highly suggestive results from PCA. 
 While initially unconvincing of its value, the resulting data from CA in the three-axial 
representation above in Figures 44.A-C was able to similarly identify and segregate to some extent 
the two, variance and subsequently information rich sub-clusters, identified by PCA. This degree 
of cross-method correlation is vital to both validate the technical approach of decomposition 
methods in general, as well as validation of the resulting data even further. In particular, these 
features became clearer using a planar representation of the first three highest-inertia axis, given 
below in Figure 45.A-C. 
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Figure 45: CA Planar views. Two-dimensional planar views of the information rich three-axial view of genes and samples 
from Figure 44.C, which demonstrates the relationship of the first three axis to each other in addition to a tabular 
representation of the Inertia values calculated by CA. Given above is the A) plot of axis 1 and 2, B) plot of axis 2 and 3, 
C) and plot of axis 1 and 3. Additionally sub-clusters discovered in during PCA are indicated using red containers, 
maintain the color scheme established previously.  
 
 A cursory glance of Figures 45.A-C indicates that while both the over and under-expressed 
gene sub-clusters are identifiable, there is much less distinction from the data set proper. 
Additionally the sub-cluster homogeneity decreases significantly with respect to relatedness of 
variance quantity, likely due in part to the implementation of the χ2distance metric for plotting 
genes and samples.  As compared to the data from PCA, these results indicate that while the sub-
clusters were identified as having generally more variance than the remainder of the data set, 
these clusters are far less resolved as discovered by CA. Upon closer examination, the data 
obviates a casual association between the up-regulated ORF sub-cluster (colored purple) and 
sample 37, indicated by a local distribution of the sub-cluster ORFs about array # 37 in all three of 
the axis examined. However, since the data set under investigation is monovariate in nature, this 
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result merely implicates sample 37 has having contributed the bulk of the variation to this sub-
cluster, with sample 37 exhibiting increased slide to slide variability as a whole as compared to 
the remainder of the samples.  
 
Terrain Mapping 
 
 Continuing in the vein of Singular Value Decomposition, a further data reduction and 
significant cluster discover strategy was employed, ultimately generating an information-rich 
landscape of lower complexity than the data-set proper. Terrain Mapping was employed as 
previously discussed in an effort to emphasize highly-related clusters of expression patterns using 
several of the distance metrics employed already in this work. Recall that Terrain Mapping 
generates a landscape of networked expression data elements by first creating a correlation 
matrix using a user defined distance metric, and then filtering for the most correlated ORFs which 
then go on to construct a two-dimensional scatter plot. The scatter plot of correlated ORFs gains 
a z-axis term by integration of overlapping or very-near ORFs into a Gaussian kernel, with height 
indicative of the number of ORFs contributing to kernel generation. (Kim, et al., 2001) 
 In order to determine the optimal method utility, a number of distance metric was 
employed (including the previously discussed Euclidean and Manhattan Distance, and Pearson 
Correlation), with varying degrees of success. Overall the Euclidean and Manhattan distance 
methods yielded ideal segregation of the data set by actual expression value, exhibited by Figures 
46.A,B below. 
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Figure 46: Expression landscapes. Terrain Mapping generated landscapes of expression data (in units of Fold Change) 
applying the A) Euclidean, with general form of 𝑎𝑎(𝑇𝑇,𝐹𝐹) = �∑ (𝑠𝑠𝑖𝑖 − 𝑣𝑣𝑖𝑖)2𝑚𝑚𝑖𝑖=1 and B)  Manhattan distance, with general form 
of𝑎𝑎(𝑇𝑇,𝐹𝐹) = ∑ (𝑠𝑠𝑖𝑖 − 𝑣𝑣𝑖𝑖)2𝑚𝑚𝑖𝑖=1 , metrics in generating the initial correlation matrix. 20 Neighbors were utilized for distance 
matrix construction, with red links indicating a highly correlated pair of genes which exceed a threshold of 𝑄𝑄 ≥ 0.9,
𝑤𝑤ℎ𝑎𝑎𝑒𝑒𝑎𝑎 { 0 < 𝑄𝑄 < 1 }, delimiting regions of genes with very similar patterns of expression. In order to maintain 
continuity with previous low-dimensionality techniques, the same color scheme is employed in these renderings, where 
Blue= down-regulated, Yellow = up-regulated, Purple = up-regulated sub-cluster, and Teal = down-regulated sub-
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cluster. As a visual aid, white containers delimit the unique sub-clusters identified in PCA and subsequently confirmed 
with CA previously. 
 
  A common theme indicated in Figure 46 using both distance metrics was the accurate 
segregation of the bulk data set into generally two discrete populations, representing over and 
under-expressed genes. The two methods become divergent however with respect to the 
relatedness of sub-clusters (indicated topographically as peaks in the terrain below the genes 
planar distribution), as is evident in the significant increase in linkage observed in Figure 46.A, 
employing the Euclidean distance metric, as compared to the relatively sparse network of links 
observed in Figure 46.B with Manhattan distance metric, despite identical thresholds. 
Interestingly, observation of the resulting terrains generated by both distance metrics indicated 
excellent discrimination of the two highly interesting sub-clusters (identified by white containers), 
isolated by both dimensionality-reducing methods previously applied.   
 In addition to the two most commonly used distance metrics (presented by the terrains 
provided above in Figure 46), several additional methods of correlation matrix generation were 
utilized in an attempt to reveal as yet undiscovered significant patterns of expression data.  
Alternative distance metrics employed included Pearson Correlation, Pearson Squared, Kendall’s 
Tau, and Average Dot Product, yielding the terrains given below in Figure 47.A-D. 
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 A) Using the Average Dot Product method , 
which takes the mean of the total sum of the 
products for all elements in a given binary 
system, defined here as 𝑠𝑠 ⋅ 𝑣𝑣 = ∑ (𝑇𝑇𝑖𝑖𝐹𝐹𝑖𝑖)𝑛𝑛𝑖𝑖=1
𝑛𝑛
23. Applied to the data a relatively 
uniform bi-modal distribution results, with 
the greatest kernel density concentrated in 
the up-regulated, centroid region, isolating a 
unique cluster of ORFs, indicated as pink 
dots encircled by a pink container. 
Importantly, an additional cluster identifies 
itself in the periphery of the up-regulated 
ORF terrain region, identified as blue-grey, 
encircled with a corresponding container. In 
this particular terrain poor overall 
connectivity was observed, with red lines 
indicating a network strength of 0.75 (scaled 
between 0,1). 
 
B) Terrain of expression data generated 
using Pearson’s’ Squared Correlation metric, 
which squares the uncentered Pearson’s’ 
correlation (where σ is the deviation from ‘0’ 
not the deviation of the mean), in order to 
emphasize strongly associating patterns of 
expression to cluster together24. In this 
representation, the critical informative 
region of highest kernel  density occurs in 
the center of the topography, with 
participating ORFs indicated in green and 
encircled accordingly. This particular terrain 
generated significantly more association 
between elements, with red links indicating 
network strength of 0.95.  
 
23 (Arfken, 1985) 
24 (Saeed, et al., 2003) 
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 C) Terrain generated using classical 
Pearson’s’ Correlation coefficient, ‘r’25, with 
red links indicated network strength of 0.95 
or greater. While there is a considerable 
degree of fragmentation of the data, notably 
into three obscure regions, no unique, 
readily isolatable clusters are discovered 
given an overall high degree of noise within 
the terrain and close proximity of local 
perturbing elements to kernels of 
moderately high density.   
 
 
D) Application of the Kendall’s Tau distance 
metric, defined here as 𝜏𝜏 =  𝑛𝑛𝑐𝑐−𝑛𝑛𝑑𝑑1
2
𝑛𝑛(𝑛𝑛−1) 25F26, 
which may be interpreted generally as the 
correlation based on the tendency that two 
expression vectors will vary similarly over 
each element in the data set. Departure 
from this tendency indicates a decrease in 
the rank of relatedness, and increases the 
overall distance metric value, ‘τ’, which 
scales such that -1 ≤ τ ≤ 1. In this particular 
representation, red lines indicate network 
relatedness strength of 0.90 or better. 
Figure 47: Terrains using several distance metrics.  Resulting terrains generated using four alternative metrics for 
element distance calculation. For each method applied 20 Neighbor elements were employed to calculated the 
correlation matrix, with the general color scheme adopted to maintain continuity (recall where Blue= down-regulated, 
Yellow = up-regulated, Purple = up-regulated sub-cluster, and Teal = down-regulated sub-cluster).  
 
While the extensively data-rich terrain mappings yielded several varying patterns of 
topography, Figure 47 may be broken down into the most meaningful elements for efficient 
analysis. The most notable feature of the data was the discrete assortment, with varying degrees 
of efficiency, of differentially expressed genes by the four distance metrics applied. Perhaps the 
most discriminating results were the terrains generated using the Average Dot Product (ADP) 
25 (Stigler, 1988) 
26 (Kendall, 1938) 
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distance metric, where complete discrimination between over and under-expressed ORFs was 
attained, as well as the generation of two unique, high density sub-clusters, indicated in Figure 
47.A by blue-grey and pink containers. These two sub-clusters are of interest since they exhibit 
terrain topography independent of the remainder of the data set, indicating the likelihood of a 
high degree of homogeneity within each cluster with respect to pattern of expression. The 
identities of genes contained within these clusters were attained from the terrain and described 
below in Table 6 (demonstrated graphically with Figure 48). 
Table 6: Dot Product terrain sub-cluster: Gene summaries. Average Dot Product terrain generated sub-clusters of 
interest derived from the local topographical distribution given in Figure 47.A 
Color ID Name FC µ 
  YCR030C Ycr030cp,III -0.64918 
  YAR042W ankyrin repeat,I -0.67306 
  YJL148W unshared RNA polymerase I subunit,X -0.70742 
  YFL039C Actin,VI -0.62403 
  YKR084C Hbs1p,XI -0.64041 
  YHR153C sporulation protein,VIII -0.64672 
  YML123C inorganic phosphate transporter, transmembrane protein,XIII -0.81662 
  YOL144W Nucleolar protein required for 60S ribosome biogenesis,XV -0.8869 
  YJR162C Yjr162cp,X -0.93801 
  YMR153W Component of karyopherin docking complex of the nuclear pore complex,XIII -0.70875 
  YJL051W Yjl051wp,X -0.77497 
  YOR225W Yor225wp,XV -0.78218 
  YNR029C Ynr029cp,XIV -0.49859 
  YDR347W 37 kDa mitochondrial ribosomal protein,IV -0.54923 
  YMR063W involved in sporulation,XIII -0.56209 
  YDL113C Ydl113cp,IV -0.44991 
  YKL060C aldolase,XI -0.46624 
  YGR191W histidine permease,VII -0.48763 
  YLR078C ER-to-Golgi v-SNARE,XII -0.58708 
  YPR072W member of the NOT complex, a global negative regulator of transcription,XVI -0.60713 
  YKL123W Ykl123wp,XI -0.60923 
  YOR119C similar to a C.elegans ZK632.3 protein,XV -0.57859 
  YLR156W Ylr156wp,XII -0.57864 
  YDR192C 
42-kD protein associated with nuclear pore complexes; Nup42p is structurally related to 
the FG-nucle,IV -0.58636 
  YBR042C Probable membrane-bound small GTPase,II -0.21337 
  YJL097W Yjl097wp,X -0.25814 
  YNL309W Interacts with the putative transcription factor Sin3p,XIV -0.16182 
  YFL012W Yfl012wp,VI -0.1898 
  YGL036W Mtc2p,VII -0.26646 
  YHL020C negative regulator of phospholipid biosynthesis,VIII -0.39586 
  YFL023W Yfl023wp,VI -0.41569 
  YOR087W Yor087wp,XV -0.42237 
  YNL025C C-type cyclin associated with the Ssn3p cyclin-dependent kinase,XIV -0.37736 
  YGR172C Golgi integral membrane protein, interacts with Ypt proteins,VII -0.35414 
  YNL272C GDP/GTP exchange factor for Sec4p,XIV -0.36037 
  YDL176W Ydl176wp,IV -0.36115 
  YPR196W Ypr196wp,XVI -0.68082 
  YGL120C RNA helicase,VII -0.7111 
  YDR324C Ydr324cp,IV -0.7959 
  YLR119W may be involved in RNA export from nucleus,XII -0.49113 
  YGR095C 
Putative 3'->5' exoribonuclease; component of exosome complex of 3'->5' 
exonucleases,VII -0.43178 
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  YMR091C involved in nuclear protein targeting,XIII -0.43869 
  YIL155C glycerol-3-phosphate dehydrogenase, mitochondrial,IX -0.45435 
  YPL146C Ypl146cp,XVI -0.29724 
  YPL025C Ypl025cp,XVI -0.30176 
  YAL034C-B empty,I -0.30873 
  YOR148C spliceosome-associated protein,XV -0.28831 
  YOR164C Yor164cp,XV -0.26678 
  YEL046C Threonine Aldolase,V -0.27554 
  YAL017W   -0.28476 
  YBR062C Ybr062cp,II -0.34956 
  YDR501W Plm2p,IV -0.32479 
  YPL042C a cyclin(SSN8)-dependent serine/threonine protein kinase,XVI -0.32993 
  YDR334W DEAH-box protein, putative RNA helicase,IV -0.32042 
  YPL061W Cytosolic Aldehyde Dehydrogenase,XVI -0.30909 
  YML127W Yml127wp,XIII -0.31171 
  YHR120W mutS homolog involved in mitochondrial DNA repair,VIII -0.32024 
 
 
Figure 48: Dot product terrain sub-cluster: Expression profile. Expression graph of both sub-clusters from Table 6, 
overlaid in the same planer region, with the x-axis corresponding to samples ID and the y-axis corresponding to actual 
Fold Change.  
 
Examining the data derived from extraction of the two clusters of interest from the ADP 
terrain in the manner exhibited above in Table 6 and Figure 48, allows for the both the 
demonstration of the anticipated homogeneity of expression pattern and further elucidates the 
logic employed in their isolation. As compared to the bulk of the expression data, these two 
transcriptionally down-regulated reservoirs of genes exhibit significant dependencies on the 
biological source of the transcriptome examined (either as a member of the population 1 or 2 
sample sub-sets). This finding had substantive implications with result to the heterogeneity of the 
genetic material as a whole, and was monitored with scrutiny for additional implications in the 
downstream analysis.  
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While seemingly indiscriminate when compared to the well-defined clusters generated 
by the Average Dot Product terrain, Pearson’s’ Squared Correlation (PSC) metric did generate a 
terrain which isolated a highly networked, yet fully resolved region of similar genes, as illustrated 
by Figure 47.B. Once isolated from the bulk topography these genes displayed significant 
heterogeneity with respect to fold change, as demonstrated empirically in Table 7 with 
corresponding expression graph given in Figure 48, below. 
Table 7: Pearson’s terrain sub-cluster: Gene summaries. High-affinity ORF cluster located at the approximate center 
of the terrain generated using the Pearson’s’ Squared Correlation distance metric 
Color ID Name FC µ FC σ 
  YLR054C Ylr054cp,XII 0.3862936 0.483598 
  YGR248W Sol4p,VII 0.34930462 0.622196 
  YBL092W Ribosomal protein L32,II 0.33154646 0.725315 
  YPR064W Ypr064wp,XVI 0.28834435 0.249104 
  YER102W Ribosomal protein S8B (S14B) (rp19) (YS9),V -0.31260625 0.276984 
  YOR067C glycosyl transferase,XV -0.33425763 0.492319 
  YPR161C CDC28/cdc2 related protein kinase,XVI -0.33671743 0.553349 
  YHL008C Potential formate transporter nirC,VIII -0.35172266 0.336648 
  YNL048W Required for N-linked oligosaccharide assembly,XIV -0.35328805 0.334233 
  YDR044W Coproporphyrinogen III oxidase,IV -0.44450182 0.346223 
  YJR084W Yjr084wp,X -0.48925585 0.674903 
  YHR067W Yhr067wp,VIII -0.559934 0.623886 
 
Figure 49: Pearson’s terrain sub-cluster: Expression profile. Corresponding expression graph of all ORFs presented 
above in Table 7, trended as a function of sample number (x-axis) with units of Fold Change (y-axis) 
 
While the data presented above (Table 7 and Figure 49) fully describes the attributes of 
the PSC terrain cluster both with respect to fold change characteristics and overall pattern of 
expression as a function of sample number, there lacks a clear basis for these gene’s high intra-
cluster relatedness. One possible explanation for the occurrence of this artifact within the data is 
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the occasional tendency of this particular distance metric to cluster strongly positively and 
negatively correlated genes or expression patterns to cluster together. (Saeed, et al., 2003) 
Interestingly, the second Pearson’s’ distance metric applied (traditional Pearson’s’ 
Correlation (PC), Figure 47.C), generated a remarkably different terrain morphology as compared 
to Figure 47.B. Notably, the Pearson’s squared metric isolated with far greater resolution the over 
and under-expressed principle gene clusters, whereas classical Pearson’s yielded a far more 
disparate terrain distribution. Additionally, Figure 47.b demonstrates a landscape of genes which 
exhibits a large degree of polarity, having significantly greater network strength in the two regions 
(generally opposite from the other) with almost completely homogenous gene landscapes. 
Though the topography displayed in Figure 47.C tends to indicate a weak cluster of generally 
under-expressed genes (indicated by a sparse region of connectivity between the principle 
clusters), there are no obvious clusters of significance generated using this distance metric. 
Curiously, the fourth distance metric applied, Kendall’s Tau (KT) (Figure 47.D), yielded a 
topography of the two principle clusters which exhibited a similar, polarized distribution of the 
data as was observed in Figure 47.C.  This observation was partially expected, as Kendall’s method 
is similar in nature to the PC approach, in that magnitude of expression is ignored in favor of 
determining similar patterns of expression. Since the data was known to vary across samples with 
respect to total fold change, the consistency of this observation was exploited to generate clusters 
of meaningful expression data using this method. However, examining the resulting topography 
(Figure 47.D), no new clusters of interesting genes with an associated high degree of connectivity 
were discovered using the KT distance metric. Rather, Kendall’s method did yield a large degree 
of relatedness (as indicated by the red network where a threshold of 0.90 is used) between genes 
previously identified as significant using the AVD and PSC distance metrics 
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GO Enrichment 
 
 While the primary goal of the study thus far has been to determine statistically significant 
genes from generally noisy microarray data and describe patterns of related expression profiles 
using quantitative statistical methodologies, the remainder of this analysis seeks to determine the 
biological context and implications of the expression characteristics observed within the data set 
using qualitative data enrichment. Perhaps the most widely employed method for adding this 
qualitative dimension to a data set consistent of empirical measures of ORF expression activity is 
by utilizing the Gene Ontology (GO) to associate relevant terms to each ORF, which describe its 
role and localization within the cell. For this particular work, GO mapping was attempted using 
several different techniques and resources in an effort to best represent the terms of interest as 
they related to expression characteristic.  
Initial GO term mapping proceeded using the Saccharomyces Genome Database’s GO Slim 
Mapper, a web-based method for ORF-term association using a subset of the highest levels of 
each of the three ontologies, Molecular Function (MF), Cellular Component (CC), and Biological 
Process (BP). (Consortium G. , 2004)  Slim Mapping yielded substantive results for Yeast GO Slim 
and Macromolecular Complex (MC) term associations to the 549 ORFs in the data set queried, 
tabulated below in Table 8.A-C & 9. In order to identify significantly differentiated high-level GO 
terms, the ratio observed term prevalence is compared to the whole-genome term association, 
expressed as a ratio and subsequently color-coded for visualization purposes whereby green 
indicates a relative increase in term prevalence within the observed dataset and concordantly red 
indicates the relative decrease in overall dataset GO term prevalence.  
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Table 8.A : Molecular Function GO mapping. ORF Mapping to the Molecular Function ontology slim terms indicating 
the term, the corresponding observed and expected prevalence in the yeast genome27and relative change in term 
frequency. In this particular representation, the term prevalence calculates the % of the query or genome which is 
associated with a particular GO slim term, where total queried ORFS = 549 and total genome ORFs = 6607.  
Term Obs. Count 
Obs. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑶𝑶𝑶𝑶𝑶𝑶𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑸𝑸𝑪𝑪𝑻𝑻𝑻𝑻𝑸𝑸 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶 � Exp. Count 
Exp. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑬𝑬𝑬𝑬𝑬𝑬𝑻𝑻𝑬𝑬𝑪𝑪𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑮𝑮𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶� 
Ratio 
�
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑶𝑶𝑶𝑶𝑶𝑶
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑬𝑬𝑬𝑬𝑬𝑬
� 
DNA binding 23 0.041894 331 0.050098 0.836242 
enzyme regulator activity 25 0.045537 210 0.031784 1.432691 
helicase activity 7 0.01275 82 0.012411 1.027345 
hydrolase activity 68 0.123862 770 0.116543 1.062797 
isomerase activity 5 0.009107 56 0.008476 1.074519 
ligase activity 14 0.025501 166 0.025125 1.014967 
lipid binding 6 0.010929 71 0.010746 1.017009 
lyase activity 12 0.021858 83 0.012562 1.739943 
molecular_function 208 0.378871 2794 0.422885 0.895919 
motor activity 1 0.001821 16 0.002422 0.752163 
nucleotidyltransferase activity 10 0.018215 72 0.010898 1.671473 
other 7 0.01275 304 0.046012 0.277113 
oxidoreductase activity 26 0.047359 271 0.041017 1.154612 
peptidase activity 14 0.025501 110 0.016649 1.531677 
phosphoprotein phosphatase activity 4 0.007286 48 0.007265 1.002884 
protein binding 50 0.091075 531 0.080369 1.133202 
protein kinase activity 15 0.027322 128 0.019373 1.410306 
RNA binding 19 0.034608 292 0.044196 0.783074 
signal transducer activity 4 0.007286 44 0.00666 1.094055 
structural molecule activity 35 0.063752 349 0.052823 1.206909 
transcription regulator activity 32 0.058288 319 0.048282 1.207233 
transferase activity 61 0.111111 634 0.095959 1.157904 
translation regulator activity 0 0 52 0.00787 0 
transporter activity 28 0.051002 375 0.056758 0.898584 
triplet codon-amino acid adaptor activity 0 0 299 0.045255 0 
 
 
Table 8.B: Cellular Component GO mapping. ORF Mapping to the Cellular Component ontology using the same table 
convention and calculations as presented in Table 8.A 
Term Obs. Count 
Obs. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑶𝑶𝑶𝑶𝑶𝑶𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑸𝑸𝑪𝑪𝑻𝑻𝑻𝑻𝑸𝑸 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶 � Exp. Count 
Exp. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑬𝑬𝑬𝑬𝑬𝑬𝑻𝑻𝑬𝑬𝑪𝑪𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑮𝑮𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶� 
Ratio 
�
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑶𝑶𝑶𝑶𝑶𝑶
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑬𝑬𝑬𝑬𝑬𝑬
� 
cell cortex 11 0.020036 114 0.017254 1.161234 
cell wall 5 0.009107 97 0.014681 0.620341 
cellular bud 15 0.027322 172 0.026033 1.04953 
Cellular component 101 0.183971 1600 0.242167 0.759685 
chromosome 26 0.047359 323 0.048888 0.96873 
cytoplasm 315 0.57377 3121 0.472378 1.214643 
cytoplasmic membrane-bounded vesicle 8 0.014572 104 0.015741 0.925739 
cytoskeleton 17 0.030965 205 0.031028 0.997992 
endomembrane system 32 0.058288 319 0.048282 1.207233 
endoplasmic reticulum 37 0.067395 363 0.054942 1.226668 
extracellular region 0 0 25 0.003784 0 
Golgi apparatus 15 0.027322 191 0.028909 0.945126 
membrane 91 0.165756 952 0.14409 1.150367 
membrane fraction 16 0.029144 198 0.029968 0.972494 
microtubule organizing center 6 0.010929 71 0.010746 1.017009 
mitochondrial envelope 24 0.043716 307 0.046466 0.940816 
mitochondrion 92 0.167577 1104 0.167096 1.002884 
nucleolus 19 0.034608 310 0.04692 0.737605 
nucleus 160 0.291439 1870 0.283033 1.029699 
Other 11 0.020036 489 0.074012 0.270717 
peroxisome 4 0.007286 62 0.009384 0.776426 
plasma membrane 21 0.038251 277 0.041925 0.912371 
ribosome 29 0.052823 353 0.053428 0.988679 
27 Derived from the raw GO Slim Mapping tab-delimited source file current version  as of 7 November 2009 
(http://downloads.yeastgenome.org/literature_curation/, as ‘go slim mapping.tab’)  
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site of polarized growth 18 0.032787 217 0.032844 0.998262 
vacuole 20 0.03643 208 0.031482 1.157174 
 
Table 8.C: Biological Process GO mapping. ORF Mapping to the Biological Process ontology using the same table 
convention and calculations as presented in Table 8.A 
Term Obs. Count 
Obs. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑶𝑶𝑶𝑶𝑶𝑶𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑸𝑸𝑪𝑪𝑻𝑻𝑻𝑻𝑸𝑸 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶 � Exp. Count 
Exp. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑬𝑬𝑬𝑬𝑬𝑬𝑻𝑻𝑬𝑬𝑪𝑪𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑮𝑮𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶� 
Ratio 
�
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑶𝑶𝑶𝑶𝑶𝑶
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑬𝑬𝑬𝑬𝑬𝑬
� 
biological process 147 0.26776 2064 0.312396 0.857116 
cell budding 6 0.010929 84 0.012714 0.859615 
cell cycle 49 0.089253 505 0.076434 1.167714 
cell wall organization 17 0.030965 164 0.024822 1.24749 
cellular amino acid and derivative metabolic process 21 0.038251 251 0.03799 1.00688 
cellular aromatic compound metabolic process 7 0.01275 83 0.012562 1.014967 
cellular carbohydrate metabolic process 27 0.04918 224 0.033903 1.4506 
cellular component morphogenesis 13 0.023679 165 0.024974 0.948181 
cellular homeostasis 11 0.020036 138 0.020887 0.95928 
cellular lipid metabolic process 26 0.047359 249 0.037687 1.256626 
cellular protein catabolic process 10 0.018215 187 0.028303 0.643562 
cellular respiration 9 0.016393 99 0.014984 1.094055 
chromosome organization 30 0.054645 382 0.057817 0.945126 
chromosome segregation 6 0.010929 139 0.021038 0.519479 
cofactor metabolic process 21 0.038251 163 0.024671 1.550471 
conjugation 9 0.016393 116 0.017557 0.93372 
cytokinesis 9 0.016393 119 0.018011 0.91018 
cytoskeleton organization 18 0.032787 218 0.032995 0.993683 
DNA metabolic process 36 0.065574 392 0.059331 1.105219 
generation of precursor metabolites and energy 20 0.03643 182 0.027547 1.322484 
heterocycle metabolic process 14 0.025501 175 0.026487 0.962769 
meiosis 18 0.032787 149 0.022552 1.453845 
membrane organization 21 0.038251 258 0.039049 0.979561 
mitochondrion organization 21 0.038251 299 0.045255 0.84524 
nucleus organization 9 0.016393 63 0.009535 1.71923 
other 14 0.025501 746 0.112911 0.225851 
peroxisome organization 3 0.005464 48 0.007265 0.752163 
protein complex biogenesis 16 0.029144 144 0.021795 1.337179 
protein folding 8 0.014572 86 0.013016 1.119498 
protein modification process 47 0.08561 522 0.079007 1.083576 
pseudohyphal growth 2 0.003643 65 0.009838 0.370296 
response to chemical stimulus 32 0.058288 392 0.059331 0.982417 
response to stress 55 0.100182 547 0.082791 1.210061 
ribosome biogenesis 34 0.061931 396 0.059936 1.033274 
RNA metabolic process 85 0.154827 1062 0.160739 0.963222 
signal transduction 18 0.032787 235 0.035568 0.9218 
sporulation resulting in formation of a cellular spore 14 0.025501 132 0.019979 1.276398 
transcription 53 0.096539 592 0.089602 1.077423 
translation 28 0.051002 392 0.059331 0.859615 
transport 90 0.163934 992 0.150144 1.09185 
transposition 12 0.021858 46 0.006962 3.139463 
vacuole organization 3 0.005464 45 0.006811 0.802307 
vesicle organization 8 0.014572 59 0.00893 1.631811 
vesicle-mediated transport 30 0.054645 353 0.053428 1.022771 
vitamin metabolic process 11 0.020036 92 0.013925 1.438921 
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Table 9: Macromolecular Complex GO mapping. ORF Mapping to Macromolecular Complex Terms displayed as a 
function of prevalence in the yeast genome28 and relative change in frequency. The same format convention and 
calculation is used as given in Table 8a-c. 
Term Obs. Count 
Obs. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑶𝑶𝑶𝑶𝑶𝑶𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑸𝑸𝑪𝑪𝑻𝑻𝑻𝑻𝑸𝑸 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶 � Exp. Count 
Exp. Prevalence 
�
𝑻𝑻𝑻𝑻𝑻𝑻𝑻𝑻 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑬𝑬𝑬𝑬𝑬𝑬𝑻𝑻𝑬𝑬𝑪𝑪𝑻𝑻𝑶𝑶
𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑮𝑮𝑻𝑻𝑪𝑪𝑪𝑪𝑻𝑻𝑻𝑻 𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶� 
Ratio 
�
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑶𝑶𝑶𝑶𝑶𝑶
𝑷𝑷𝑻𝑻𝑻𝑻𝑶𝑶𝑻𝑻𝑻𝑻𝑻𝑻𝑪𝑪𝑬𝑬𝑻𝑻𝑬𝑬𝑬𝑬𝑬𝑬
� 
 CVT complex 1 0.001821494 1 0.000151 12.03461 
 mitochondrial proton-transporting ATP synthase, 
catalytic core 
1 0.001821494 2 0.000303 6.017304 
 acetolactate synthase complex 1 0.001821494 2 0.000303 6.017304 
 carbamoyl-phosphate synthase complex 1 0.001821494 2 0.000303 6.017304 
 MutSbeta complex 1 0.001821494 2 0.000303 6.017304 
 high affinity iron permease complex 1 0.001821494 2 0.000303 6.017304 
 Holliday junction resolvase complex 1 0.001821494 2 0.000303 6.017304 
 Nic96 complex 2 0.003642987 4 0.000605 6.017304 
 RNA polymerase I core factor complex 2 0.003642987 4 0.000605 6.017304 
 Golgi transport complex 3 0.005464481 8 0.001211 4.512978 
 nucleotide-excision repair factor 1 complex 1 0.001821494 3 0.000454 4.011536 
 transcription factor TFIIIB complex 1 0.001821494 3 0.000454 4.011536 
 1,3-beta-glucan synthase complex 1 0.001821494 3 0.000454 4.011536 
 mitochondrial proton-transporting ATP synthase, 
stator stalk 
1 0.001821494 3 0.000454 4.011536 
 gamma-tubulin small complex, spindle pole body 1 0.001821494 3 0.000454 4.011536 
 signalosome 2 0.003642987 6 0.000908 4.011536 
 mitochondrial oxoglutarate dehydrogenase complex 1 0.001821494 3 0.000454 4.011536 
 CCR4-NOT core complex 3 0.005464481 9 0.001362 4.011536 
 MBF transcription complex 1 0.001821494 3 0.000454 4.011536 
 karyopherin docking complex 1 0.001821494 3 0.000454 4.011536 
 RecQ helicase-Topo III complex 1 0.001821494 3 0.000454 4.011536 
 ribonuclease H2 complex 1 0.001821494 3 0.000454 4.011536 
 NuA3 histone acetyltransferase complex 1 0.001821494 3 0.000454 4.011536 
 SAS acetyltransferase complex 1 0.001821494 3 0.000454 4.011536 
 SBF transcription complex 1 0.001821494 3 0.000454 4.011536 
 UTP-C complex 2 0.003642987 6 0.000908 4.011536 
 Snt2C complex 1 0.001821494 3 0.000454 4.011536 
 alpha DNA polymerase:primase complex 2 0.003642987 7 0.001059 3.43846 
 t-UTP complex 2 0.003642987 7 0.001059 3.43846 
 nucleotide-excision repair factor 3 complex 2 0.003642987 8 0.001211 3.008652 
 tRNA-intron endonuclease complex 1 0.001821494 4 0.000605 3.008652 
 mitochondrial proton-transporting ATP synthase 
complex, coupling factor F(o) 
3 0.005464481 12 0.001816 3.008652 
 HIR complex 1 0.001821494 4 0.000605 3.008652 
 ESCRT I complex 1 0.001821494 4 0.000605 3.008652 
 ESCRT III complex 1 0.001821494 4 0.000605 3.008652 
 signal peptidase complex 1 0.001821494 4 0.000605 3.008652 
 cytoplasmic dynein complex 1 0.001821494 4 0.000605 3.008652 
 alpha,alpha-trehalose-phosphate synthase complex 
(UDP-forming) 
1 0.001821494 4 0.000605 3.008652 
 protein kinase CK2 complex 1 0.001821494 4 0.000605 3.008652 
 chromatin accessibility complex 1 0.001821494 4 0.000605 3.008652 
 AP-2 adaptor complex 1 0.001821494 4 0.000605 3.008652 
 glutamyl-tRNA(Gln) amidotransferase complex 1 0.001821494 4 0.000605 3.008652 
 nuclear mitotic cohesin complex 1 0.001821494 4 0.000605 3.008652 
 cyclin-dependent protein kinase holoenzyme 
complex 
4 0.007285974 17 0.002573 2.831673 
 CCR4-NOT complex 3 0.005464481 13 0.001968 2.777217 
 RNA polymerase I transcription factor complex 2 0.003642987 9 0.001362 2.674357 
 DNA-directed RNA polymerase I complex 3 0.005464481 14 0.002119 2.578845 
 RNA polymerase I upstream activating factor 
complex 
1 0.001821494 5 0.000757 2.406922 
 nuclear cohesin complex 1 0.001821494 5 0.000757 2.406922 
 DNA replication factor C complex 1 0.001821494 5 0.000757 2.406922 
28 Derived from the raw GO Slim Macromolecular Complex Mapping tab-delimited source file current version  as of 7 November 
2009 (http://downloads.yeastgenome.org/literature_curation/, as ‘go protein complex slim.tab’)  
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 transcription factor TFIID complex 3 0.005464481 15 0.00227 2.406922 
 holo TFIIH complex 2 0.003642987 10 0.001514 2.406922 
 chromatin assembly complex 2 0.003642987 10 0.001514 2.406922 
 mitochondrial respiratory chain complex II 1 0.001821494 5 0.000757 2.406922 
 mitochondrial proton-transporting ATP synthase 
complex 
4 0.007285974 20 0.003027 2.406922 
 Rad17 RFC-like complex 1 0.001821494 5 0.000757 2.406922 
 Elg1 RFC-like complex 1 0.001821494 5 0.000757 2.406922 
 CURI complex 1 0.001821494 5 0.000757 2.406922 
 Rhp55-Rhp57 complex 1 0.001821494 5 0.000757 2.406922 
 GPI-anchor transamidase complex 1 0.001821494 5 0.000757 2.406922 
 proton-transporting ATP synthase complex, catalytic 
core F(1) 
1 0.001821494 5 0.000757 2.406922 
 Nup82 complex 1 0.001821494 5 0.000757 2.406922 
 PAS complex 1 0.001821494 5 0.000757 2.406922 
 nuclear pore 10 0.018214936 51 0.007719 2.359727 
 cytoplasmic exosome (RNase complex) 2 0.003642987 11 0.001665 2.188111 
 TRAPP complex 2 0.003642987 11 0.001665 2.188111 
 transcription factor complex 13 0.023679417 73 0.011049 2.143149 
 transcription factor TFIIIC complex 1 0.001821494 6 0.000908 2.005768 
 SSL2-core TFIIH complex portion of NEF3 complex 1 0.001821494 6 0.000908 2.005768 
 SSL2-core TFIIH complex portion of holo TFIIH 
complex 
1 0.001821494 6 0.000908 2.005768 
 Ino80 complex 2 0.003642987 12 0.001816 2.005768 
 Piccolo NuA4 histone acetyltransferase complex 1 0.001821494 6 0.000908 2.005768 
 MCM complex 1 0.001821494 6 0.000908 2.005768 
 Swr1 complex 2 0.003642987 13 0.001968 1.851478 
 NuA4 histone acetyltransferase complex 2 0.003642987 13 0.001968 1.851478 
 signal recognition particle, endoplasmic reticulum 
targeting 
1 0.001821494 7 0.001059 1.71923 
 actin filament 1 0.001821494 7 0.001059 1.71923 
 proteasome core complex, beta-subunit complex 1 0.001821494 7 0.001059 1.71923 
 Nup107-160 complex 1 0.001821494 7 0.001059 1.71923 
 Ctf18 RFC-like complex 1 0.001821494 7 0.001059 1.71923 
 mitochondrial large ribosomal subunit 6 0.010928962 45 0.006811 1.604614 
 exocyst 1 0.001821494 8 0.001211 1.504326 
 nuclear exosome (RNase complex) 2 0.003642987 16 0.002422 1.504326 
 vacuolar proton-transporting V-type ATPase, V1 
domain 
1 0.001821494 8 0.001211 1.504326 
 Arp2/3 protein complex 1 0.001821494 8 0.001211 1.504326 
 Smc5-Smc6 complex 1 0.001821494 8 0.001211 1.504326 
 Set1C/COMPASS complex 1 0.001821494 8 0.001211 1.504326 
 post-mRNA release spliceosomal complex 1 0.001821494 8 0.001211 1.504326 
 exosome (RNase complex) 2 0.003642987 17 0.002573 1.415836 
 DNA-directed RNA polymerase II, holoenzyme 6 0.010928962 53 0.008022 1.362408 
 oligosaccharyltransferase complex 1 0.001821494 9 0.001362 1.337179 
 RSC complex 2 0.003642987 18 0.002724 1.337179 
 preribosome, small subunit precursor 1 0.001821494 9 0.001362 1.337179 
 cytosolic small ribosomal subunit 7 0.012750455 64 0.009687 1.316285 
 mitochondrial ribosome 9 0.016393443 83 0.012562 1.304958 
 polysome 2 0.003642987 19 0.002876 1.266801 
 small-subunit processome 5 0.009107468 48 0.007265 1.253605 
 nuclear telomere cap complex 1 0.001821494 10 0.001514 1.203461 
 proteasome regulatory particle, base subcomplex 1 0.001821494 10 0.001514 1.203461 
 DASH complex 1 0.001821494 10 0.001514 1.203461 
 spliceosomal complex 6 0.010928962 62 0.009384 1.16464 
 DNA replication preinitiation complex 2 0.003642987 21 0.003178 1.146153 
 90S preribosome 8 0.014571949 85 0.012865 1.132669 
 chromatin remodeling complex 10 0.018214936 108 0.016346 1.114316 
 histone acetyltransferase complex 4 0.007285974 44 0.00666 1.094055 
 nuclear nucleosome 1 0.001821494 11 0.001665 1.094055 
 cytoplasmic mRNA processing body 2 0.003642987 22 0.00333 1.094055 
 preribosome 12 0.021857923 133 0.02013 1.085829 
 mitochondrial small ribosomal subunit 3 0.005464481 34 0.005146 1.061877 
 commitment complex 1 0.001821494 12 0.001816 1.002884 
 DNA-directed RNA polymerase II, core complex 1 0.001821494 12 0.001816 1.002884 
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 mitochondrial respiratory chain complex IV 1 0.001821494 12 0.001816 1.002884 
 SWI/SNF complex 1 0.001821494 12 0.001816 1.002884 
 U2-type catalytic step 1 spliceosome 1 0.001821494 12 0.001816 1.002884 
 ribosome 29 0.052823315 357 0.054034 0.977601 
 replication fork protection complex 2 0.003642987 25 0.003784 0.962769 
 U2-type spliceosomal complex 4 0.007285974 53 0.008022 0.908272 
 clathrin vesicle coat 1 0.001821494 14 0.002119 0.859615 
 ribonucleoprotein complex 50 0.091074681 712 0.107764 0.845127 
 cytosolic ribosome 12 0.021857923 177 0.02679 0.815906 
 pre-replicative complex 1 0.001821494 15 0.00227 0.802307 
 proteasome core complex 1 0.001821494 15 0.00227 0.802307 
 mRNA cleavage and polyadenylation specificity 
factor complex 
1 0.001821494 15 0.00227 0.802307 
 proteasome complex 3 0.005464481 47 0.007114 0.768166 
 anaphase-promoting complex 1 0.001821494 16 0.002422 0.752163 
 histone deacetylase complex 2 0.003642987 33 0.004995 0.72937 
 U4/U6 x U5 tri-snRNP complex 2 0.003642987 33 0.004995 0.72937 
 DNA-directed RNA polymerase III complex 1 0.001821494 17 0.002573 0.707918 
 stress granule 1 0.001821494 17 0.002573 0.707918 
 SLIK (SAGA-like) complex 1 0.001821494 17 0.002573 0.707918 
 microtubule 2 0.003642987 36 0.005449 0.668589 
 Sin3-type complex 1 0.001821494 18 0.002724 0.668589 
 U1 snRNP 1 0.001821494 19 0.002876 0.6334 
 transcription elongation factor complex 1 0.001821494 19 0.002876 0.6334 
 SAGA complex 1 0.001821494 20 0.003027 0.60173 
 mRNA cleavage factor complex 1 0.001821494 20 0.003027 0.60173 
 preribosome, large subunit precursor 2 0.003642987 40 0.006054 0.60173 
 proteasome storage granule 1 0.001821494 21 0.003178 0.573077 
 condensed nuclear chromosome kinetochore 2 0.003642987 44 0.00666 0.547028 
 proteasome regulatory particle 1 0.001821494 22 0.00333 0.547028 
 spindle microtubule 1 0.001821494 22 0.00333 0.547028 
 cytoplasmic microtubule 1 0.001821494 22 0.00333 0.547028 
 small nuclear ribonucleoprotein complex 3 0.005464481 67 0.010141 0.538863 
 mediator complex 1 0.001821494 23 0.003481 0.523244 
 cytosolic large ribosomal subunit 4 0.007285974 98 0.014833 0.491209 
 box C/D snoRNP complex 2 0.003642987 52 0.00787 0.46287 
 U2-type prespliceosome 1 0.001821494 28 0.004238 0.429807 
 ubiquitin ligase complex 2 0.003642987 58 0.008779 0.414986 
 kinetochore 2 0.003642987 58 0.008779 0.414986 
 vesicle coat 1 0.001821494 33 0.004995 0.364685 
 small nucleolar ribonucleoprotein complex 2 0.003642987 105 0.015892 0.229231 
 
This data is suggestive that a number of high-level GO terms were influenced by the 
corresponding mapped expression data. Of particular interest is the number if highly influenced 
terms contained in the macromolecular complex superstructure, where a large degree of term 
enrichment is observed, particularly when contrasted against the three classical GO term 
hierarchies (Tables 8a-c) where only the biological process term ‘transposition’ is influenced with 
any degree of significance relative to the bulk hierarchy of terms. This finding, while qualitative at 
best since such an abstract hierarchy of terms were analyzed, was suggestive that the [PSI+] state 
may influence protein-protein interactions particularly in the assembly of protein assemblies 
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required for vital cellular homeostasis activities. Though a robust literature base (discussed at 
length during the introduction to this work) asserts the role of the [PSI+] state as a primary 
effector on several classes of protein interactions, such a spatially diverse survey of all 
macromolecular assembly participants has likely not been investigated previously, thus this 
observation should be further expounded by continued molecular and protein function 
experimentation.  
While the data presented in the four tables above (Tables 8.A-C,9) describe a high-level 
survey of the Gene Ontology term associations within the subset of genes of significance currently 
being investigated, a comprehensive overview of all GO terms associated with each gene will 
greatly enrich the analysis. From this data it is evident that several, high level GO terms appear to 
be selectively influenced relative to the basal genome term association frequency, and as a result 
a more detailed GO analysis was warranted.  Though the data does suggest  directed GO term 
differential expression as result of the prion state, it is possible that chance alone is responsible 
for differential expression associated with specific high-level GO terms, as no statistical 
confidence test adequate to assure GO term association frequency with such a small sample size. 
As a result, further GO analysis identified significant terms as well as their concordant statistical 
confidence and associated relationships to clusters of similar gene expression using the TEASE 
method.  
 
TEASE Analysis 
 
 As previously introduced, the Expression Analysis Systematic Explorer, implemented in 
the TIGR Multiple Experiment Viewer framework, in conjunction with hierarchal clustering (Tree-
EASE, or TEASE), seeks to initially cluster similarly expressed ORFs and then subsequently identify 
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statistically significant GO terms using EASE, reviewed in (Hosack, Dennis, Sherman, Lane, & 
Lempicki, 2003), at each node in the dendogram hierarchy. The Rank Products identified 
significant genes were analyzed as discussed previously via TEASE using literature-suggested 
parameterization as a baseline and the final operational configuration specific in the methods 
section.  The expression data set was enriched with the Yeast Genome Database GO Slim 
Mapping, yielding several biologically and statistically significant nodes using Fisher's exact test.  
To aid in visualization, the up and down regulated primary clusters are represented separately 
below in Figures 50.A, B. These depictions of the data demonstrate clustering using the 
Manhattan distance metric with Complete Linkage used to perform hierarchal clustering of Rank 
Product identified significant genes, followed by GO Slim term enrichment29.  
29 YGD GO Slim Term Mapping File retrieved last 3-16-10 
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Figure 50.A: Up-Regulated genes TEASE. Up-Regulated genes clustered using the Manhattan distance metric with 
Complete linkage. For visualization of node significance, a gradient is utilized whereby the average node p-value (from 
Fisher's Exact test) is color coded as described in the schematic above. Additionally, the cluster color schema (right hand 
side of dendogram) is further extended from prior analysis, allowing cross-method identification of gene assortment 
 
 Resulting from mapping of these higher-level ontology terms representing broad 
categories of physiological processes, components and functions,  a number of similarly expressed 
clusters of genes  also demonstrated subsequent biological similarity. These nodes, exhibit a 
strong statistical correlation between expression and GO term mapping homology, with the five 
most statistically significant term associations extracted below in Table 10.a for each cluster ID 
(correlating to the numerical identifiers in Figure 50.a above).  After examination of all relevant 
term-node mappings that not all terms are significant at acceptable levels of confidence, as 
indicated by the subsequent p-value. However, the data presented in Table 10.a suggests that in 
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several cases, the assumption that similarly expressed genes share common physiological roles 
appears well founded by the data.  
Table 10.A: Up-regulated TEASE GO results. Select nodes exhibiting strong statistical association to select GO terms 
within the Up-regulated ORF data set where 'Cluster ID' maps concordantly to identified node in Figure 50.a, 'GO Slim 
Term' is the term of interest, and 'p' is the p-value from Fisher's Exact test. Terms are delineated as significant where p 
< α and α= 0.01 by shading with green, significant where p < α and α= 0.05 by shading in yellow, and terms considered 
insignificant are indicated in red.  
 
Cluster ID GO Slim Term p 
1 
Transporter activity 0.00303 
Meiosis 0.006085 
Plasma membrane 0.01591 
Cell cycle 0.02705 
Protein binding 0.08621 
2 
Electron transport 0.000837 
Transcription 0.001857 
RNA metabolic process 0.02887 
Transferase activity 0.04327 
Peroxisome 0.04779 
3 
Electron transport 0.000538 
Transcription 0.006424 
Peroxisome 0.03634 
Transferase activity 0.04892 
Heterocycle metabolic process 0.05739 
4 
Peroxisome 0.001805 
Cytoskeleton 0.002694 
Cytoskeleton organization and biogenesis 0.004384 
Transcription 0.01027 
Cell cortex 0.01544 
5 
Transporter activity 0.004008 
Mitochondrion 0.00436 
Lipid metabolic process 0.02511 
Oxireductase activity 0.02782 
Membrane 0.04601 
 
Similarly, the down-regulated genes were enriched with GO terms via slim mapping, 
graphically represented on the hierarchally clustered data in Figure 50.b. Additionally, 
significantly enriched nodes (eight in total) were identified as numerically described in 
Figure 10.b and expounded in detail in Table 10.b. 
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Figure 50.B: Down-regulated genes TEASE. Down-Regulated genes clustered by composite EASE score and projected 
as a dendogram using the Manhattan distance metric with Complete linkage. For visualization of node significance, a 
gradient is utilized whereby the average node p-value (from Fisher's Exact test) is color coded as described in the 
schematic above. Additionally, the cluster color schema (right hand side of dendogram) is further extended from prior 
analysis, allowing cross-method identification of gene assortment 
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Table 10.B: Down-regulated TEASE GO results. Select nodes exhibiting strong statistical association to select GO terms 
within the down-regulated ORF data set where 'Cluster ID' maps concordantly to identified node in Figure 50.b, 'GO 
Slim Term' is the term of interest, and 'p' is the p-value from Fisher's Exact test. Terms are delineated as significant 
where p < α and α= 0.01 by shading with green, significant where p < α and α= 0.05 by shading in yellow, and terms 
considered insignificant are indicated in red.  
 
Cluster ID GO Slim Term p 
1 
DNA Binding 0.006724 
Nucleus 0.008058 
Transcription regulation activity 0.008183 
Response to stress 0.009993 
DNA metabolic process 0.01067 
2 
DNA binding 0.00506 
Response to stress 0.01044 
Protein kinase activity 0.03407 
Transcription 0.07913 
Cytoplasmic membrane-bound vesicle 0.1344 
3 
Ribosome biogenesis and assembly 0.008612 
RNA metabolic process 0.01584 
RNA binding 0.02017 
Nucleolus 0.04019 
Structural molecule activity 0.05593 
4 
Protein folding 0.004192 
Transcription 0.01208 
Endomembrane system 0.03006 
Translation 0.03079 
Protein binding 0.03848 
5 
Protein folding 0.003028 
Response to stress 0.00434 
Translation 0.007849 
Protein binding 0.01075 
Other 0.01794 
6 
Translation 0.002916 
Other 0.01701 
Protein binding  0.0176 
Ribosome 0.02101 
Protein folding 0.02672 
7 
Protein folding 0.01043 
Protein binding 0.01336 
Other 0.09098 
Response to stress 0.09429 
Lipid metabolic process 0.1247 
8 
Transposition 0.002893 
Protein binding 0.00561 
Protein folding 0.009169 
Conjugation 0.01993 
other 0.02563 
  
Curiously, there appears to better overall statistical significance observed in GO terms 
enriched in the Up-regulated GO term mapping (Figure 50.a, Table 10.a), as opposed to the down 
regulated ORF subset GO term mapping (Figure 50.b and Table 10.b), despite more qualitatively 
observed nodes within the latter. This trend is characterized below in Table 11, where the number 
of terms significant with varying degrees of confidence (α = 0.01 and α = 0.05), or not considered 
not statistically significant (NS), are divided by the total number of terms associated with the 
nodes scrutinized, expressed as a ratio.  
108 
Table 11: TEAS-GO term association frequencies. Comparison between the aggregate number of statistically significant 
genes   
Association 
p-value 
Up-Regulated ORFs Down regulated ORFs 
Term 
count 
Total 
terms �
𝑇𝑇𝑎𝑎𝑒𝑒𝑆𝑆𝑠𝑠𝑈𝑈𝑈𝑈−𝐿𝐿𝐹𝐹𝐿𝐿𝑇𝑇𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐿𝐿
𝑇𝑇𝑎𝑎𝑒𝑒𝑆𝑆𝑠𝑠𝑇𝑇𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝐶𝐶𝐹𝐹𝑇𝑇𝑛𝑛𝐹𝐹 � Term count Total terms �𝑇𝑇𝑎𝑎𝑒𝑒𝑆𝑆𝑠𝑠𝐷𝐷𝐹𝐹𝐷𝐷𝑛𝑛−𝐿𝐿𝐹𝐹𝐿𝐿𝑇𝑇𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐿𝐿𝑇𝑇𝑎𝑎𝑒𝑒𝑆𝑆𝑠𝑠𝑇𝑇𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝐶𝐶𝐹𝐹𝑇𝑇𝑛𝑛𝐹𝐹 � 
0.01 11 25 0.44 14 40 0.35 
0.05 12 25 0.48 20 40 0.50 
NS 2 25 0.08 6 40 0.15 
  
Collectively, the data presented above in Figures 50.a,b and Tables 10.a,b indicate several 
high level GO terms selectively influenced by multiple, independent nodes of similar expressed 
ORFs, with a tendency for better correlation with the Up-regulated ORFs and their respective GO 
term mapping (Table 11).  As result, a complete mapping of the GO ontology to better identify 
functional relationships within the observed gene expression data was warranted.  Due to 
complexities associated with annotating high dimensionality flat files in MEV, the complete GO 
term mapping was conducted in a separate, stand-alone software package more suited to the 
iteration through a significant volume of term associations, introduced previously as GoMiner30 
(Zeeberg, et al., 2003)  
 Functional annotation of the data set was achieved using GoMiner to map the entire Gene 
Ontology database of term associations31 as previously discussed. To maintain the statistical 
integrity of this exercise, GO term associations to ORFs were limited to specific evidence codes, 
including any experimental evidence codes (EXP, IDA, IPI, IMP, IGI, and IEP)32, and some 
computational analysis evidence codes (ISS, ISO, ISA, ISM, IGC, and RCA), subsequently excluding 
term associations with no traceable author statement (GO Evidence Code: NAS), no biological 
data available (ND), and associations inferred from electronic annotation only, with no additional 
30 Curated by the Genomics and Bioinformatics Group (GBG) of LMP, NCI, NIH and the Medical Informatics 
and Bioimaging group of BME, Georgia Tech/Emory University 
31 Utilizing the 10 June 2010 build of the GO data base curated by the GO consortium and available for 
review and download at http://archive.geneontology.org/ 
32 See the GO Evidence Code Decision Tree for a complete discussion of all GO evidence codes, available 
for review at: http://www.geneontology.org/GO.evidence.tree.shtml 
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curation or surveillance (IEA). As a result, the GOminer enriched ORF term associations carry not 
only statistical significance (as calculated by a 1-tailed Fisher's exact test), but also data reliability 
assured b y the requirement of human annotation.  
The resulting annotation landscape is demonstrated below for both under and over expressed 
ORFs with respective p-value from Fisher's Exact test and False Discovery Rate for each GOP term 
and corresponding GO ID.  
Table 12.A: Down-regulated genes GO mapping with GoMiner. GO term associations mapped to the under-expressed 
data subset demonstrating the GO ID and subsequent Term description, Total number of each term mapped to the 
6536 genes of the S. cerevisiae genome, number of under-expressed ORFs mapped to each term and subsequent p-
value from Fisher's exact and corresponding False Discovery Rate.  Additionally, to include as many potential 
informative terms as possible, term associations with a p-value less than 0.90 ( or a more generally a 90% chance of 
arbitrary term association ) are include for consideration. As a visual aid, lower p-value and False Discover Rates are 
highlighted in green, and progressively higher p-value s and FDRs are indicated in the gradual shift to red. 
GO ID Term Total Under P-Value FDR 
943 retrotransposon nucleocapsid 94 4 0.002 0.8 
3964 RNA-directed DNA polymerase activity 50 3 0.003 0.5 
3887 DNA-directed DNA polymerase activity 63 3 0.0057 1.2667 
51268 alpha-keto amide reductase activity 1 1 0.0058 1.5714 
51269 alpha-keto ester reductase activity 1 1 0.0058 1.5714 
6821 chloride transport 1 1 0.0058 1.5714 
15248 sterol transporter activity 1 1 0.0058 1.5714 
34061 DNA polymerase activity 66 3 0.0065 1.5 
32196 transposition 137 4 0.0079 1.36 
32197 transposition, RNA-mediated 137 4 0.0079 1.36 
8233 peptidase activity 160 4 0.0134 2.6182 
4540 ribonuclease activity 96 3 0.018 3.4333 
16779 nucleotidyltransferase activity 125 3 0.0357 5.5538 
4032 aldehyde reductase activity 7 1 0.0402 5.7857 
4518 nuclease activity 141 3 0.0482 6.1867 
4177 aminopeptidase activity 9 1 0.0514 6.275 
4033 aldo-keto reductase activity 10 1 0.057 6.2588 
8028 monocarboxylic acid transmembrane transporter activity 14 1 0.0789 7.3889 
15718 monocarboxylic acid transport 15 1 0.0842 7.2947 
34605 cellular response to heat 184 3 0.0911 7.38 
15698 inorganic anion transport 17 1 0.0949 7.3143 
8238 exopeptidase activity 18 1 0.1002 7.2 
9408 response to heat 204 3 0.1151 7.4261 
5319 lipid transporter activity 22 1 0.1212 7.4833 
5768 endosome 107 2 0.1287 7.392 
9266 response to temperature stimulus 218 3 0.1332 7.3231 
32266 phosphatidylinositol 3-phosphate binding 25 1 0.1365 7.2222 
6820 anion transport 26 1 0.1416 6.8828 
16903 oxidoreductase activity, acting on the aldehyde or oxo group of donors 26 1 0.1416 6.8828 
16772 transferase activity, transferring phosphorus-containing groups 355 4 0.1504 6.8467 
5545 phosphatidylinositol binding 34 1 0.1811 7.729 
31329 regulation of cellular catabolic process 44 1 0.228 8.7188 
16788 hydrolase activity, acting on ester bonds 289 3 0.2373 8.6303 
46943 carboxylic acid transmembrane transporter activity 53 1 0.268 9.0824 
5342 organic acid transmembrane transporter activity 56 1 0.2809 9.1829 
35091 phosphoinositide binding 58 1 0.2893 9.0778 
324 fungal-type vacuole 183 2 0.2901 8.3897 
323 lytic vacuole 183 2 0.2901 8.3897 
322 storage vacuole 183 2 0.2901 8.3897 
5737 cytoplasm 3771 24 0.3036 8.45 
46942 carboxylic acid transport 62 1 0.306 8.119 
151 ubiquitin ligase complex 62 1 0.306 8.119 
9894 regulation of catabolic process 64 1 0.3141 8.0744 
43603 cellular amide metabolic process 65 1 0.3182 7.9545 
9628 response to abiotic stimulus 344 3 0.326 7.8933 
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5543 phospholipid binding 67 1 0.3262 7.7522 
5515 protein binding 652 5 0.3313 7.6511 
8289 lipid binding 72 1 0.3459 7.6875 
5626 insoluble fraction 209 2 0.3466 7.396 
5624 membrane fraction 209 2 0.3466 7.396 
16616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 73 1 0.3498 7.3333 
15849 organic acid transport 76 1 0.3613 7.2846 
5773 vacuole 216 2 0.3617 7.1509 
6508 proteolysis 224 2 0.3787 7.2185 
16614 oxidoreductase activity, acting on CH-OH group of donors 82 1 0.3836 7.16 
6979 response to oxidative stress 85 1 0.3945 7.1607 
1950 plasma membrane enriched fraction 91 1 0.4158 7.2737 
267 cell fraction 246 2 0.4246 7.2138 
70011 peptidase activity, acting on L-amino acid peptides 108 1 0.4721 7.5322 
42493 response to drug 123 1 0.5174 7.84 
4672 protein kinase activity 135 1 0.5508 7.9869 
6725 cellular aromatic compound metabolic process 141 1 0.5667 7.9065 
33554 cellular response to stress 513 3 0.5872 7.9333 
3723 RNA binding 701 4 0.5991 7.85 
22892 substrate-specific transporter activity 340 2 0.5992 7.7323 
30163 protein catabolic process 343 2 0.6041 7.6515 
5840 ribosome 350 2 0.6154 7.6119 
51716 cellular response to stimulus 544 3 0.6285 7.5824 
16740 transferase activity 731 4 0.6338 7.4957 
6511 ubiquitin-dependent protein catabolic process 170 1 0.6361 7.4029 
19941 modification-dependent protein catabolic process 172 1 0.6405 7.3211 
5783 endoplasmic reticulum 368 2 0.6433 7.225 
43632 modification-dependent macromolecule catabolic process 175 1 0.647 7.1562 
6811 ion transport 178 1 0.6533 7.0838 
51603 proteolysis involved in cellular protein catabolic process 182 1 0.6616 7.0587 
44424 intracellular part 5011 29 0.6691 7.0368 
16773 phosphotransferase activity, alcohol group as acceptor 186 1 0.6697 6.9532 
5215 transporter activity 396 2 0.6837 6.9154 
5622 intracellular 5038 29 0.6983 6.881 
16301 kinase activity 207 1 0.7092 6.8375 
43565 sequence-specific DNA binding 213 1 0.7196 6.7926 
42221 response to chemical stimulus 462 2 0.7648 6.9146 
43285 biopolymer catabolic process 470 2 0.7733 6.8699 
34641 cellular nitrogen compound metabolic process 249 1 0.7749 6.7905 
3676 nucleic acid binding 1080 5 0.7833 6.7318 
5623 cell 5413 31 0.7898 6.5931 
44464 cell part 5413 31 0.7898 6.5931 
16787 hydrolase activity 901 4 0.7946 6.5205 
5575 cellular_component 5422 31 0.8009 6.4764 
9057 macromolecule catabolic process 501 2 0.804 6.4222 
16021 integral to membrane 274 1 0.8069 6.3714 
16491 oxidoreductase activity 279 1 0.8128 6.3196 
31224 intrinsic to membrane 281 1 0.8151 6.2645 
22891 substrate-specific transmembrane transporter activity 287 1 0.8218 6.2255 
6950 response to stress 738 3 0.8241 6.1663 
44257 cellular protein catabolic process 292 1 0.8272 6.1083 
9056 catabolic process 774 3 0.8492 6.0866 
22857 transmembrane transporter activity 324 1 0.8582 6.0327 
5634 nucleus 1989 9 0.8726 6.0121 
3677 DNA binding 349 1 0.8786 5.986 
50896 response to stimulus 1046 4 0.884 5.9465 
42180 cellular ketone metabolic process 362 1 0.8881 5.9 
Term Mapping Significance Summary 
 
term p-value % of term mappings 
≤0.01 9.80 
≤0.05 14.71 
>0.05 75.49 
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Table 12.B: Up-regulated genes GO mapping with GoMiner. GO term associations mapped to the over-expressed data 
subset demonstrating the GO ID and subsequent Term description, Total number of each tern mapped to the 6536 
genes of the S. cerevisiae genome, number of under-expressed ORFs mapped to each term and subsequent p-value 
from Fisher's exact and corresponding False Discovery Rate.  Additionally, to include as many potential informative 
terms as possible, term associations with a p-value less than 0.90 ( or a more generally a 90% chance of arbitrary term 
association ) are include for consideration. As a visual aid, lower p-value and False Discover Rates are highlighted in 
green, and progressively higher p-value s and FDRs  are indicated in the gradual shift to red. 
GO ID Term Total Over P-Value FDR  
46316 gluconokinase activity 1 1 0.0033 3.8 
31225 anchored to membrane 4 1 0.013 7.3333 
46658 anchored to plasma membrane 4 1 0.013 7.3333 
324 fungal-type vacuole 183 3 0.0205 5.4333 
323 lytic vacuole 183 3 0.0205 5.4333 
322 storage vacuole 183 3 0.0205 5.4333 
5773 vacuole 216 3 0.0315 6.4286 
329 fungal-type vacuole membrane 88 2 0.0327 5.8 
5199 structural constituent of cell wall 14 1 0.0448 6.2444 
10494 stress granule 16 1 0.051 6.3 
5737 cytoplasm 3771 16 0.0569 6.2182 
5774 vacuolar membrane 123 2 0.06 5.9167 
31505 fungal-type cell wall organization 20 1 0.0634 6.0462 
44437 vacuolar part 130 2 0.0661 5.6429 
31226 intrinsic to plasma membrane 28 1 0.0877 6.52 
5811 lipid particle 40 1 0.123 8.025 
3964 RNA-directed DNA polymerase activity 50 1 0.1514 9.1294 
44459 plasma membrane part 60 1 0.179 9.6667 
3887 DNA-directed DNA polymerase activity 63 1 0.1871 9.4632 
34061 DNA polymerase activity 66 1 0.1951 9.32 
44424 intracellular part 5011 18 0.2369 9.9524 
16788 hydrolase activity, acting on ester bonds 289 2 0.2428 9.6909 
5623 cell 5413 19 0.2525 9.0667 
44464 cell part 5413 19 0.2525 9.0667 
5622 intracellular 5038 18 0.2547 8.792 
5575 cellular_component 5422 19 0.2606 8.5846 
16791 phosphatase activity 93 1 0.264 8.3259 
943 retrotransposon nucleocapsid 94 1 0.2665 8.1 
4540 ribonuclease activity 96 1 0.2714 7.869 
44444 cytoplasmic part 2828 11 0.2804 7.7 
43332 mating projection tip 103 1 0.2881 7.5419 
5618 cell wall 106 1 0.2952 7.0471 
30312 external encapsulating structure 106 1 0.2952 7.0471 
9277 fungal-type cell wall 106 1 0.2952 7.0471 
42578 phosphoric ester hydrolase activity 108 1 0.2999 6.9257 
44463 cell projection part 109 1 0.3022 6.7889 
5937 mating projection 114 1 0.3137 6.7622 
42995 cell projection 115 1 0.316 6.6053 
16772 
transferase activity, transferring phosphorus-containing 
groups 355 2 0.3244 6.5538 
42493 response to drug 123 1 0.3341 6.525 
16779 nucleotidyltransferase activity 125 1 0.3385 6.4488 
5783 endoplasmic reticulum 368 2 0.3403 6.2952 
5935 cellular bud neck 135 1 0.3603 6.3163 
32196 transposition 137 1 0.3645 6.0756 
32197 transposition, RNA-mediated 137 1 0.3645 6.0756 
4518 nuclease activity 141 1 0.373 6.0391 
8233 peptidase activity 160 1 0.4117 6.183 
51301 cell division 171 1 0.4331 6.1917 
5933 cellular bud 178 1 0.4463 6.1592 
16773 phosphotransferase activity, alcohol group as acceptor 186 1 0.4611 6.284 
16301 kinase activity 207 1 0.4981 6.3333 
5739 mitochondrion 1122 4 0.5133 6.3154 
30427 site of polarized growth 220 1 0.5197 6.2528 
7047 cell wall organization 225 1 0.5278 6.0545 
45229 external encapsulating structure organization 225 1 0.5278 6.0545 
70882 cell wall organization or biogenesis 257 1 0.5767 6.2036 
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31224 intrinsic to membrane 281 1 0.6101 6.2947 
5886 plasma membrane 284 1 0.6141 6.1966 
5730 nucleolus 286 1 0.6168 6.1153 
31090 organelle membrane 637 2 0.6319 6.0967 
3723 RNA binding 701 2 0.6861 6.2131 
5198 structural molecule activity 354 1 0.6971 6.1903 
16740 transferase activity 731 2 0.7094 6.1333 
3 reproduction 396 1 0.7385 6.2344 
16020 membrane 1146 3 0.7534 6.1723 
43231 intracellular membrane-bounded organelle 3693 11 0.774 6.0746 
43227 membrane-bounded organelle 3693 11 0.774 6.0746 
42221 response to chemical stimulus 462 1 0.7928 6.0559 
16787 hydrolase activity 901 2 0.8171 6.0174 
31981 nuclear lumen 553 1 0.8505 5.9943 
44425 membrane part 623 1 0.8841 5.9831 
3676 nucleic acid binding 1080 2 0.8926 5.9194 
5515 protein binding 652 1 0.8958 5.8521 
Term Mapping Significance Summary 
term p-value % of term mappings 
≤0.01 1.37 
≤0.05 12.33 
>0.05 86.30 
  
Importantly, a hallmark characteristic of the term mappings observed was the poor 
overall association of gene clusters to terms with a high degree of statistical confidence, as 
indicated by the vast majority of the terms mapped to genes with p-values insignificant at α = 0.05 
for both over and under-expressed data sets (Tables 12.a,b, term frequency panel). In order to 
strengthen the identification of significant GO terms, both using the expression data as well as 
inter-relatedness within the GO term hierarchy,  a secondary utility within the GOminer 
application was employed to visualize spatially, related GO terms. The VennMasterbeta utility 
(reviewed previously in (Kestler, Muller, Gress, & Buchholz, 2005)), enabled the visualization of 
these complex relationships established between enriched GO terms and the underlying 
expression data, yielding a pseudo-Venn diagram demarcating the relatedness of putatively 
significant (where p <0.1) enriched GO terms. The resulting VennMaster representations of the 
enriched terms within the three principal Gene Ontology categories; Molecular Function (Figure 
51.a), Biological Process (Figure 51.b) and Cellular Component (Figure 51.c) are given below.  
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 Figure 51.A: VennMaster rendering of MF terms. VennMaster representation of the Molecular Function 
enriched terms with Fisher's Exact test p < 0.2 
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 Figure 51.B: VennMaster rendering of BP terms. VennMaster representation of enriched terms within the 
Biological Process hierarchy using a Fisher's Exact test p value cutoff of 0.20  
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 Figure 51.C: VennMaster rendering of CC terms. VennMaster representation of enriched terms within the 
Cellular Component hierarchy using a Fisher's Exact test p value cutoff of 0.20 
 
A casual observation of these results indicated good congruence with the data generated 
from the GO enrichment analysis via GoMiner, in that there are few, similarly expressed genes, 
which share related GO terms. For example, figure 51.b describes several clusters of terms with 
seemingly a high degree of GP term associations, however with few participating gene members, 
indicating these inter-related groups likely are not of significant biological value. Importantly, 
further analysis indicates that several (5) genes are associated with the S. cerevisiae 
retrotransposon complex (figure 51.c).  
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Meta-Analyses 
 
Pathway Analysis: Metabolic Pathway Mapping 
 
 While typically disregarded during whole-transciptome expression level analyses as 
necessary ‘housekeeping’ functions, surveillance of the yeast metabolism with respect to [PSI+] 
influences was achieved using the SGD’s Saccharomyces cerevisiae biochemical pathways utility. 
Briefly, the 562 element RP identified gene list (with corresponding expression levels) were 
mapped to the most recent version 33 of the yeast metabolomics map. Of 562 possible genes, only 
80 were identified as participants in known or putative and experimentally verified metabolic 
processes. Importantly, the corresponding expression levels of the subset of 80 genes tended to 
exclude significant fold changes observed in the remainder of the distribution; this behavior is 
summarized as tabulated statistics for both gene populations below in table 13. 
Table 13: Overall differential expression magnitude. Expression level descriptive statics for the 562-gene query list and 
resulting 80-gene metabolomic map associations.  
 bulk population metabolomic subset 
Max 1.078 0.626 
Min -0.938 -0.755 
Median -0.251 -0.258 
Mean -0.048 -0.058 
 
33 http://pathway.yeastgenome.org/YEAST/overview-expression-map, rendered using Pathway Tools v 
15.0 as compiled by P.D. Karp et al at the Bioinformatics Research Group (SRI International, Menlo Park 
CA) 
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This data implies there is overall, less overall differential expression occurring between 
the [psi-] and [PSI+] states because of metabolic processes and activity thereof. However, when 
analyzing the complete transcription activity-metabolome mapping we observe that there are 
indeed several pathways, which exhibit differential expression activity in multiple aspects of the 
yeast metabolism. An overview of all expression activity discovered is depicted graphically in the 
BioCyc rendering below (figure 52).  
 
Figure 52: Whole-Metabolome expression data enrichment. Whole-metabolism mapping of [PSI+] differential gene 
expression data where over-expressed gene products are shown on a red-scale and down-regulated elements on a 
blue-scale. 
 
While it is important to reflect on the observation that overall expression changes are 
quite low (FC < 1 are typical), globally there does appear a tendency towards overall down-
regulation, albeit at a conservative level, of most metabolic pathways (as indicated by the 
dominance of blue-colored vectors in the figure 52 rendering). While the causal element of this 
occurrence is unclear based on available data, this observation is not consistent with other yeast 
prion variants where well-controlled metabolic studies have failed to show any significant prion 
involvement in basic cellular processes. (URE2 reviewed in (Chen, Sawyer, & Perrett, 2011) and 
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PrPc reviewed in (Li, Dong, & Harris, 2004)) Interestingly, despite general down-regulation of most 
metabolic processes, a handful of specific pathways appear to exhibit somewhat consistent up-
regulation of critical elements (Figure 53a the TCA cycle), or a mixture of differential regulation 
throughout most critical elements of the pathway (Figure 53b,c the aerobic respiration and 
inositol phosphate biosynthesis processes respectively).  
A)  
 
B)  
 
C)  
 
 
Figure 53A, B, C: Select pathway enrichments.  Select metabolic pathways enhanced with differential expression data 
as previously described and utilizing the same color schema imposed on Figure 52.  
 
Though seemingly unrelated, these particular pathways are indirectly related to both the 
maintenance of cellular homeostasis via regulation of cellular respiration under aerobic 
conditions (TCA and AR/ETC) as well as the anticipated response to cellular damage vis a vis  
priming of the inositol phosphate biosynthesis pathway, a necessary precursor to phospholipid 
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membrane repair. Indeed, in recent work another yeast prion, [MOT3+], has been identified in is 
prion state has having an important role in transcription regulation, conferring added feedback 
control to budding yeast to promote multicellular growth under specific metabolic circumstances. 
(Holmes, Lancaster, Lindquist, & Halfmann, 2013). Importantly, the [MOT3+] prion yields a 
significant degree of regulatory control as it functions as a transcription factor; a critical class of 
regulatory elements that comprise the DNA to protein translation machinery and of which the 
prion investigated in this work, [PSI+], is a critical member. Thus, based on these results, it is 
theorized that one aspect by which [PSI+] confers additional capacity to manage homeostatic 
insult by a variety environmental stressors is associated with basic cellular metabolic functions.   
 
Pathway Analysis: Cell Signaling Network Mapping 
 
Based upon the moderate success of mapping expression data to the entire yeast 
metabolome to all published and curated intra and inter cell-signaling networks using the 
GenMapp pathways exploration tool. For this analysis, GenMapp-CS was pre-loaded with the RP-
identified significant gene set and queried against the Saccharomyces cerevisiae WikiPathways 
database. (Kelder, et al., 2009)   Extension of the GenMapp tool to access the entire WikiPathways 
repository for this organism afforded cross-platform validation of metabolic pathway expression 
data mapping as well as discovery of new pathways concerning every described and curated 
cellular signaling network. WikiPathways conveniently organized these networks and systems as 
cellular processes, physiological process, and molecular function in addition to the metabolic 
processes already queried using the SGD tool.  (Pico, et al., 2008) Extension of expression data 
mapping to this pathway database both confirmed the putatively significant metabolic processes 
identified earlier during the SGD metabolomic analysis as well as identified four additional 
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pathways harboring varying degrees of differential transcriptomic expression. These four 
pathways are summarized below in terms of degree of expression mapping where 100% indicates 
complete differential expression and 0% indicates no transcriptomic difference between the two 
strains.  
 
Table 14: Pathway enrichment rates. Enrichment rates of four process maps identified using the S.cerevisiae cellular 
signaling network pathways via WikiPathways and the RP-identified differential gene expression data set.  
 Pathway / Process 
 DNA Replication Cell Cycle & 
Division 
MAPK Proteasome 
Degradation 
Total Constituents 52 149 126 63 
Differentially 
Expressed 
4 8 4 7 
Rate 7.7% 5.4% 3.2% 11.1% 
 
Though overall process enrichment ends to be quite low relative to literature reported pathway 
analyses34, there was a noted increase in the proteasome degradation process, which directly 
processes deleterious products of the [PSI+] read-through caused by translational infidelity.  
34 An excellent demonstration of which was reviewed in (Zambon, et al., 2005) who investigated 
gene expression patterns during the cell cycle as regulated by cAMP and kinase A using 
GenMapp as the central modality for pathway analysis  
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Figure 54: Proteasome degradation pathway enrichment. Proteasome degradation mechanism overlaid with 
differentially expressed gene data from this study using GenMapp, colored either as up or down regulated as per the 
classical color scheme.  
 
Interestingly, this pathway in particular demonstrates localized up regulation of several 
histone H2A variants in the [PSI+] state, indicating activity in both DNA folding & repair (Choe, 
Kolodrubetz, & Grunstein, 1982) as well as non-classical transcriptional regulation via repressed 
promoter activation. (Zhang, Roberts, & Cairns , 2005) The remaining transcriptomic activity of 
this process suggests selective control of specific members of the 20s and 26s proteasome 
complexes, though with very little obvious pressure in either assembly due in part to the lack of 
obvious consensus of transcriptomic regulation across the various structural elements of either 
proteasome.   
 The remaining three pathways which demonstrated some degree of expression activity 
from Table 14, tended to exhibit transcriptomic regulation of a largely nonspecific in nature. 
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Single-protein differentially expression in specific pathway elements or regions was replete, and 
on the whole no significant data presented which suggested a specific, concerted regulatory event 
resultant of the prion state, [PSI+] or lack thereof, [psi-].  
 
Differential expression homology modeling 
 
 As this study sought to elucidate the potential for transcriptomic involvement in 
propagation or regulation of the [PSI+] state in yeast, a meaningful approach for a priori analysis 
of the expression results collected in this work was mapping of genomic expression to previously 
published microarray data collected under a variety of experimental conditions. This analysis was 
accomplished using the Serial Pattern of Expression Level Locator (SPELL) expression data search 
engine accessed via the Saccharomyces Genome Database35.  Due to the nature of this analysis, 
only a small query set of genes yielded a meaningful result, thus only the top 10% ( 28 up and 28 
down regulated genes) of differentially expressed genes from the RP-filtered 560 member set 
were queried. Additionally, as the SPELL pattern-matching algorithm assumes homogenous co-
expression through each query, each subset of up or down-regulated genes were analyzed 
separately. Using this approach, a significant data set identified by this method should result in 
similar expression patterns for both subsets queried.  The results of this analysis is summarized 
below in table 15, where the highest-scoring (greatest weight) data sets as indicated by PMID, 
MIAME (Brazma, et al., 2001) compliant data set tags, and their associated weight. 
 
 
35 SPELL @ SGD version 2.0.3 using the search engine reported previously (Hibbs, et al., 2007) and 
implemented using the Ruby on Rails framework, C++, and Java;  hosted at Stanford University 
Department of Genetics  
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Table 15: Data set associations. Top ten data set associations for up and down regulated gene sets queried using the 
SPELL search engine. Note; commonalities between both differentially expressed data sets despite occurring in different 
reported experiments are colored accordingly.  
 Up-Regulated Gene Set Down-Regulated Gene Set 
Rank PMID Weight Tag(s) PMID Weight Tag(s) 
1 17389876 1.00% Filamentous growth 16923813 0.60% chemical stimulus, signaling 
2 16122766 0.60% chemical stimulus 16381818 0.60% carbon utilization 
3 15989963 0.60% RNA catabolism 18953355 0.60% amino acid utilization, carbon utilization, starvation 
4 16969341 0.60% carbon utilization 22697265 0.60% not yet curated 
5 15496405 0.60% 
carbon utilization, 
fermentation, 
nitrogen utilization, 
oxygen level 
alteration 
18931682 0.60% osmotic stress, stress, transcription 
6 10811893 0.50% 
protein 
phosphorylation, 
signaling 
18953355 0.60% carbon utilization 
7 18424442 0.50% oxidative stress, stress 15988024 0.50% 
histone modification, 
ubiquitin or ULP 
modification 
8 16507144 0.50% 
chemical stimulus, 
oxidative stress, 
stationary phase 
maintenance, stress 
16023114 0.50% histone modification 
9 17560372 0.50% 
chemical stimulus, 
protein 
phosphorylation, 
signaling, stress 
18953355 0.50% amino acid utilization, carbon utilization, starvation 
10 11179418 0.50% chemical stimulus 14595107 0.50% 
osmotic stress, protein 
phosphorylation, signaling, 
stress 
 
In order to investigate if the query size had an effect on experiment agreement a subset size of 
5% and 20% of the gene list were also investigated, the result of which indicated a query size of ~ 
30 genes was ideal based upon both list agreement and experiment weight. While this particular 
analysis did yield several consistent data set classifiers between both differentially expressed gene 
lists. However, the overall nature of these classifiers, such as ‘stress’ or ‘chemical stimulus’ are 
generally vague, and don’t in and of themselves implicate specific aspects of similar experiments 
as having definitive commonalities with the differential expression data evaluated herein. 
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Moreover, the lack of any data set agreement between the up and down regulated gene list 
queries is highly suggestive that a similar expression profile has yet to be observed in the scientific 
community at large and reported to any microarray data repository queried. Thus, based on these 
findings the differential expression of [PSI+] relative to an identical strain of [psi-] yeast does elicit 
a novel pattern of transcriptomic information.  
While the expression data has been applied thus far to a number of sources of biological 
and experimental data yielding results that collectively suggest several putative modalities of 
[PSI+] involvement in yeast cellular structure and function, a major unresolved issue persists 
within the data set at large.  Attention must be given to the overall Fold Change trend exhibited 
by the expression data collected (Appendix C, Table C.2), namely the significantly lower overall 
degree of differential expression, since the Fold Change range for these ORFs ranges from 1.08762 
to -.93801. Taken in the context of classical microarray analysis methods, these 560 ORFs would 
not ordinarily be considered of interest for further study, since a typical threshold of FC ≥ 2 is 
usually applied when determining if a gene is indeed differentially expressed. (Southern E. M., 
2001)  This concept of significant expression change is based on the premise that there must be a 
significantly increased number of mRNA transcript copies to effect a protein expression increase 
of physiological significance.  
A possible explanation for this occurrence is the conditions under which the [PSI+] state 
was induced during each biological microarray repetition. A dearth of biochemical data appears 
in the literature, which implicates the [PSI+], and other prions of budding yeast as conferring 
selective immunity against certain environmental conditions detrimental to wild type yeas strains. 
Moreover, low overall absolute levels of differential expression are likely a product of averaging 
expression levels over a typically large number of biological repetitions, (in this case 6). While 
individual biological assays (e.g. individual growth events) do in fact yield significantly 
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differentially expressed genes (maximum gene up-regulation was observed at FC = 5.32 whereas 
down-regulation minima occurred at FC = -4.74), these differential expression events were 
ultimately excluded when the t-based significance testing was applied across biological replicates.  
Interestingly, a novel hypothesis has emerged and gained recent support from within the field of 
prion biology whereby prions of budding yeast, notably [PSI+] and [MOT3+] act as vehicles for 
epigenetic inheritance of beneficial proteomic elements via a simple mechanism of meiotic re-
assortment and fixing of beneficial traits, ultimately enabling prion-independent heritability. 
(Halfmann R. , et al., 2013) (Tuite & Cox, 2007) (Alberti, Halfmann, King, Kapila, & Lindquist, 2009) 
(Bateman & Wickner, 2013). Thus, based upon these recent discoveries of prion behavior and due 
to the nature and design of the microarray assay conducted, it is entirely plausible that significant 
differential expression events were indeed occurring within each unique biological repetition. 
However, these events were essentially non-observable when looking at the project as a whole in 
the classical sense because the new heritable element became fixed after several growth cycles, 
and as a result was no longer differentially expressed when a new biological repetition attempted 
to reproduce the selective differential expression observed previously.   
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Conclusion 
 
Whole-transcriptomic surveillance via cDNA microarrays has blossomed from a simple blotting 
technique original described by Edwin Southern in 1975 to a ubiquitous and indispensable 
technique routinely employed for purposes of life sciences research as well as clinical diagnoses. 
In the present work the differential genomic expression of [PSI+] prion and wild type 
Saccharomyces cerevisiae was surveyed over a series of biological repetitions with the overall goal 
of elucidating potential genomic pressures as a result of the prion state. To achieve this goal a 
data analysis pipeline inclusive of raw-image processing through expression data meta-analysis 
was developed and validated for utilization on cDNA arrays for this application. In particular, 
relative gene expression values were attained from different arrays of multiple vendor formats 
using appropriate analysis methodologies as directed by a composite quality analysis 
methodology. Significant genes across biological replicates were identified via the t-based Ranked 
Products metric, following which classical microarray analytical techniques were applied to the 
data including clustering and singular value decomposition techniques. In order to apply 
biologically relevant context to these transcriptomic expression patterns, Gene Ontology 
annotations and mapping of the metabolic and cellular signaling pathways were applied to the 
data set. Finally, in an effort to determine if similar patterns of expression had been observed and 
reported by others in the research community, all publically available S. cerevisiae microarray data 
was searched for homologs patterns of gene expression using the novel SPELL search engine.  
 Through this work a number of challenges were identified and overcome, mainly relating 
to unifying the biological significance of independent cDNA arrays carried out by multiple 
individuals, over several years of study using different array manufacturers and formats. To 
address this an intuitive quality analysis pipeline was implemented which enabled the semi- 
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automated classification and discard of probes or whole arrays of insufficient quality or 
consistency.  Future implementations of this approach towards this application should rely on a 
single source of arrays using a standardized set of procedures executed by sufficiently trained 
technicians in order to improve overall data quality, assay yield and statistical reliability. Moreover 
this study would be benefited by the inclusion of other classical transcriptomic analysis 
methodologies such as real-time PCR (qPCR) or the more recently described method RNAseq, the 
latter of which analyzes the differential expression of essentially all nucleic acid based transcripts.  
(Morin, et al., 2008). A further extension of this work would entail the leverage of protein-based 
analysis methodologies such as differentially 2d/3d PAGE coupled with MS/MS analysis. Putative 
differentially expressed proteins as well as the prion itself could then be monitored in-vivo using 
various fluorescently tagged co-localization techniques or classical antibody-based labeling in 
vivo. However, based upon the set of results presented herein a framework has been developed 
and utilized for cDNA microarray analysis and meaningful biological function annotation. This 
analysis pipeline could be directly applied to subsequent logical extensions of this work which 
alters the yeast growing conditions to provoke a response to specific environmental stressors  and 
potentially illicit a more substantive genomic response from the [PSI+] prion. 
Collectively these results failed to show a definitive, highly significant and biologically 
consistent pattern of differential genomic expression because of the [PSI+] prion referencing an 
identical [psi-] control genome. Despite the widely reported involvement of the [PSI+] prion by 
others in a number of inter-related systems of cellular or molecular function at the proteomic 
level, these results are suggestive that the prion state is preserved, maintained and primarily 
effects using an exclusively protein-only effector modality. An important caveat to this assertion 
is that the single homeostatic condition under which both [PSI+] and wt [psi-] strains were 
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cultured was insufficient to provoke a concerted genomic response from the conserved [PSI+] 
prion which likely has little or no regulatory involvement under ideal growth conditions. 
However, despite this principal finding, there were indeed low levels of differential 
genomic expression identified in specific gene families as discovered by the various analysis 
methods applied to the data set. Notably, several structural elements such as the retrotransposon 
nucleocapsid assembly, proteasome degradation complex and DNA repair, replication and 
storage machinery all exhibited small reservoirs of conserved differential expression as a result of 
the prion state. Additionally, involvement of the prion in fundamental cellular functions such as 
cell cycle maintenance, basic metabolic processes such as the TCA cycle, aerobic respiration and 
energy balance, and phospholipid bilayer assembly were observed using the various tools 
employed during this analysis. Importantly, a comprehensive survey of all reported and 
appropriately documented microarray-based studies using S. cerevisiae failed to show a definitive 
correlation between the [PSI+] expression pattern observed in this work and any previously 
reported. This suggests if there is a novel [PSI+]-mediated genomic regulatory mechanism present 
at a low level, it is indeed novel and intrinsic to this biological condition exclusively. 
 Indeed, this particular prion, as well as others previously characterized, are 
extraordinarily intriguing, highly conserved, members of the yeast cytosol, which tend to confer 
unique adaptive abilities, enhanced homeostatic regulatory functions and improved lineage 
fidelity via a poorly understood, essentially epigenetic inheritance mechanism. The notion that 
such a vastly complex additional layer of biological information is remarkable, and once fully 
understood and reduced to a predictive model of behavior, would further erode the classical 
central dogma of information further still, ultimately facilitating a drastically different, and much 
improved, approach to diagnosing and treating prion-based disease in humans.   
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Appendix A 
 
 
 A major focus on this work was the determination of an optimal microarray image analysis 
utility to be employed for use in this study. A crucial aspect, as selection of the ideal spot analysis 
software and by definition, edge detection algorithm, is justified given the nature of the 
microarray study employed. Proper image analysis via a robust utility both reduces downstream 
normalization workload, generating more credible data, but also serves to mitigate the effect of 
the noisy arrays analyzed in this study. Several commercially available image analysis suites, such 
as GeneSpring GX1 (Agilent Technologies, Santa Clara, CA) and ImaGene2 (BioDiscovery, El 
Segundo, CA), provide several methods of edge detection supported by full parameterization of 
the analysis, stunning visuals, and robust quality control and downstream analysis pipelines. The 
primary limitation to using commercially available “all-in-one” microarray analysis suites is the 
cost prohibitive nature of the site license for the software ( typically >$10,000),  tending to be 
outside of the budget for most researchers in under-graduate academic laboratories. However 
there is a wealth of publically available and “free to academic users” image analysis utilities which 
employ different implementations of similar algorithms as their commercialized counterparts. 
This investigation employs four of the most popular methods (summarized in Table A.1) employed 
frequently in biological labs for ad hoc microarray image analysis, and utilizes statistical 
methodologies from relevant literature to determine the optimal analysis utility for the 
microarrays included in this study. 
 
 
1 http://www.chem.agilent.com/en-US/Products/software/lifesciencesinformatics/genespringgx/Pages/default.aspx 
2 http://www.biodiscovery.com/index/contactus 
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 Table A.1 Microarray Image Analysis Utilities employed in this investigation with relevant defining characteristics.   
 
APPLICATION  SPOT 
SEGMENTATION 
ALGORITHM (S) 
QUALITATIVE METRICS OUTPUT FORMAT 
MAIA  Seeded Region 
Growing 
(Adaptive Circle) 
Numerous (Durbin-Watson, Contamination, 
Symmetry, etc.), flagging (Automatic and 
Manual) 
Tab delimited text, 
{.txt} 
SPOTFINDER  Histogram, Otsu, 
Fixed Circle  
P-value, QC Score cumulative, QC Score 
Channels A/B, flagging (Automatic & Manual) 
Tab delimited text, 
{.MEV, .SFD } 
SCANALYZE  Fixed Circle  Correlation between mean channel intensities, 
SNR, Komogorov-Smirnov statistic, Sobel 
operator p-value, Flagging (Manual) 
Tab delimited text 
{.dat} 
MASQOT Seeded Region 
Growing 
Numerous (SNR, CV, QC Score etc.), Flagging 
(Automatic + Manual) 
 Tab delimited text 
{.mdata ;  .gpr } 
 
 While the four utilities presented in Table 1 were ultimately selected for this investigation, 
a number of freely available applications were initially examined for feasibility including; {SPOT3, 
Magic4, Dapple5, SpotReader6, GridGrinder7, a Number of MatLab executable utilities including 
{F-Scan8, AMIA9, ARMADA10, MatArray11, and P-Scan12}, and spotSegmentation13 (Bioconductor, 
implemented in the R Statistical Software Environment ) }. The principle reason for disqualifying 
a particular utilities for incorporation into this investigation was issues centered around ease of 
use, robustness of the core algorithm  (i.e. resistance to noise), and lack of options  and 
parameterization to optimize the image analysis process. Furthermore, a number of spot 
segmentation algorithms utilizing alternative methods of spot boundary detection, reviewed in 
3 http://www.jainlab.org/downloads.html 
4 http://www.bio.davidson.edu/projects/magic/magic.html 
5 http://www.cs.wustl.edu/~jbuhler/research/dapple/ 
6Trial Version tested only,  http://www.nilesscientific.com/welcome.nhtml  
7 http://gridgrinder.sourceforge.net/ 
8 http://abs.cit.nih.gov/fscan/ 
9 http://www.pnl.gov/statistics/AMIA/ 
10 http://195.251.6.234/armada/ 
11 http://www.ulb.ac.be/medecine/iribhm/microarray/toolbox/ 
12 http://abs.cit.nih.gov/pscan/README_p-scan.htm 
13 http://www.bioconductor.org/packages/2.4/bioc/html/spotSegmentation.html 
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(Lehmussola, Ruusuvuori, & Yli-Harja, 2006), were investigated, including Markov Random Field 
modeling (Demerikaya, Asyali, & Shoukri, 2005), Adaptive Ellipse boundary detection (Rueda & 
Qin, 2005), kernel density estimation (Bae & Kim, 2008), Integration of multiple information 
channels (Margaritis, K, & Kafetzopoulos, 2006), various probabilistic approaches (Gottardo, 
Besag, Stephens, & Murua, 2006), and several techniques using clustering approaches (Rueda & 
Qin, 2005), (Wu & Yan, Microarray image processing based on clustering and morphological 
analysis, 2003), (Daskalakis, et al., 2007), (Yu-Ping, Gunampally, & Wei-Wen, 2005).  However, 
there are significant challenges in employing these robust mechanisms of spot segmentation, 
namely the availability of the complete algorithm for testing, virtually no support or 
troubleshooting, and poor overall documentation apart from the initial peer reviewed work. Thus 
while there are significantly more robust methods of microarray image analysis available, they 
lack the sophistication afforded by a developed user interface, and are not efficient at processing 
an entire data set in a reasonable amount of time (most algorithms reviewed required significant 
manual user input to segment and extract spot intensities in only a small region of the array at a 
time).   
 In order to determine the optimal method for spot segmentation and intensity extraction, 
an independent statistical methodology is applied in such a manner to consider the quantitative 
success of image analysis and intensity extraction. An ideal method, which analyzes the critical 
aspects of image-extracted microarray data, is proposed by Wang, Ghosh, and Guo in a 2001 
article published in the Journal of Nucleic Acids Research. This method integrates the key aspects 
of processed spot data into one descriptive, composite score defined as qcom, derived as given 
below in Table A.2 (Wang, Ghosh, & Guo, 2001). 
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Table A.2  Composite Quality Score derivations for each constituent of the composite score 
SPOT QUALITY 
METRIC 
DERIVATION DEFINITIONS (UNITS) 
SPOT SIZE (QSIZE) 
𝑞𝑞𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 =  𝑒𝑒�−|𝐴𝐴−𝐴𝐴0|𝐴𝐴0 � 𝐴𝐴 = Spot Area in (pixels) 𝐴𝐴0 = Average Area of all Spots (pixels) 
SIGNAL : NOISE 
RATIO (𝒒𝒒𝑺𝑺𝑺𝑺𝑺𝑺) 𝑞𝑞𝑆𝑆𝑆𝑆𝑆𝑆 =  � 𝐼𝐼𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝐼𝐼𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 + 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏� 𝐼𝐼𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠= Mean Channel Intensity of the spot 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏= Mean Background Intensity local to the 
spot 
LOCAL 
BACKGROUND 
VARIABILITY 
(𝒒𝒒𝒃𝒃𝒃𝒃𝒃𝒃𝒃𝒃) 
𝑞𝑞𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 =  � 𝑓𝑓1𝐶𝐶𝐶𝐶𝑏𝑏𝑏𝑏𝑏𝑏� 𝑓𝑓1 = Normalization factor satisfying 𝑞𝑞𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 {𝑀𝑀𝐴𝐴𝑀𝑀} =  1 
𝐶𝐶𝐶𝐶𝑏𝑏𝑏𝑏𝑏𝑏= or the coefficient of variation, defined as 
�
𝜇𝜇𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝛿𝛿𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
� 
EXTREME LOCAL 
BACKGROUND  
(𝒒𝒒𝒃𝒃𝒃𝒃𝒃𝒃𝒃𝒃) 
𝑞𝑞𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 =  𝑓𝑓2 �1 − � 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏
�𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏 + 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏��� 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏= Mean Background Intensity local to the spot 
𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏= Mean Global Background Intensity 
𝑓𝑓2= Normalization factor satisfying 
𝑞𝑞𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 {𝑀𝑀𝐴𝐴𝑀𝑀} =  1 
SATURATION 
FACTOR (𝒒𝒒𝒔𝒔𝒔𝒔𝒔𝒔) 
𝑞𝑞𝑆𝑆𝐴𝐴𝑆𝑆=  �1, 𝑖𝑖𝑓𝑓 𝑝𝑝𝑖𝑖𝑝𝑝𝑒𝑒𝑝𝑝𝑆𝑆𝑆𝑆𝑠𝑠𝑆𝑆𝑆𝑆𝑆𝑆𝑠𝑠𝑠𝑠𝑆𝑆 < 10%0,         𝑖𝑖𝑓𝑓 𝑝𝑝𝑖𝑖𝑝𝑝𝑒𝑒𝑝𝑝𝑆𝑆𝑆𝑆𝑠𝑠𝑆𝑆𝑆𝑆𝑆𝑆𝑠𝑠𝑠𝑠𝑆𝑆 ≥ 10% Where 𝑝𝑝𝑖𝑖𝑝𝑝𝑒𝑒𝑝𝑝𝑠𝑠𝑆𝑆𝑠𝑠𝑆𝑆𝑆𝑆𝑆𝑆𝑠𝑠𝑠𝑠𝑆𝑆 is the number of pix   65535 
SPOT SIZE (QSIZE) 
𝑞𝑞𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 =  𝑒𝑒�−|𝐴𝐴−𝐴𝐴0|𝐴𝐴0 � 𝐴𝐴 = Spot Area in (pixels) 𝐴𝐴0 = Average Area of all Spots (pixels) 
 
Since all of the qualitative descriptors given in Table A.2, except for Spot Size, are in terms 
of single channel intensities, these values must be further modified to represent both channels 
used in these microarrays. Thus, two methods for averaging are proposed as follows;  
Geometric Mean: Weighted Mean: 
𝑞𝑞𝑠𝑠 𝑏𝑏𝑀𝑀 =  ��𝑞𝑞𝑠𝑠 𝐶𝐶𝐶𝐶5 × 𝑞𝑞𝑠𝑠 𝐶𝐶𝐶𝐶3� 𝑞𝑞𝑠𝑠 𝑊𝑊𝑀𝑀 =  ���𝑞𝑞𝑠𝑠 𝐶𝐶𝐶𝐶5  × � 𝐵𝐵𝐵𝐵𝐵𝐵𝐶𝐶𝐶𝐶5𝐵𝐵𝐵𝐵𝐵𝐵𝐶𝐶𝐶𝐶5 + 𝐵𝐵𝐵𝐵𝐵𝐵𝐶𝐶𝐶𝐶3�� + �𝑞𝑞𝑠𝑠 𝐶𝐶𝐶𝐶3 × � 𝐵𝐵𝐵𝐵𝐵𝐵𝐶𝐶𝐶𝐶3𝐵𝐵𝐵𝐵𝐵𝐵𝐶𝐶𝐶𝐶5 + 𝐵𝐵𝐵𝐵𝐵𝐵𝐶𝐶𝐶𝐶3��� 
Where, and are the quality metrics for each channel, and   , are the mean background intensities local to the spot for 
each channel.  
 
Using the weighted mean allows for the dye bias attributable to nonspecifically bound dye in the 
region local to the spot to be taken into account in the overall trend of qcom scores. Thus it 
becomes apparent using the weighted mean distribution of qcom scores for an array if correction 
is needed to negate the bias introduced by unequal ratios of dye in the region, subsequently 
preventing skewing of the data. Following selection of a quality metric averaging method, the 
composite quality score (qcom) is derived as; 
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𝑞𝑞𝑐𝑐𝑠𝑠𝑐𝑐 =  ��𝑞𝑞𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 × 𝑞𝑞𝑆𝑆𝑆𝑆𝑆𝑆 × 𝑞𝑞𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 × 𝑞𝑞𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏�1/4� × 𝑞𝑞𝑆𝑆𝐴𝐴𝑆𝑆 
Using this particular derivation of qcom, as the authors suggest, equally weights each of 
the four quality metrics, and then applies the saturation threshold to determine of a spot  has too 
few significant pixels to statistically analyze. (Wang, Ghosh, & Guo, 2001) Thus, by examining the 
overall distribution of qcom scores as a function of log2 �𝐶𝐶𝐶𝐶5𝐶𝐶𝐶𝐶3�, a pattern should emerge which 
indicates that the majority of scores are centered about the condition log2 �𝐶𝐶𝐶𝐶5𝐶𝐶𝐶𝐶3� = 0. 
Furthermore, since qcom scores spots on a scale of {0,1}, there should subsequently exist a 
decrease in variability about the condition log2 �𝐶𝐶𝐶𝐶5𝐶𝐶𝐶𝐶3� = 0 as the qcom score approaches qcom = 1.  
Spot analysis proceeded by performing image analysis on every array outlined in Table B.1 using 
all four image analysis utilities with optimal parameterization. In general; each utility was 
validated initially on three arrays to determine the optimal combination of parameters and ideal 
edge boundary detection algorithm. The resulting parameterization for all four utilities examined 
is summarized in Table A.3  
Table A.3 Image Analysis Utilities employed in this investigation, the edge detection algorithm employed and respective 
parameterization.  
APPLICATION ALGORIT
HM 
SPOT SIZE 
(PIXELS) 
BACKGROUN
D 
CORRECTION 
QC FILTER ADDITIONAL 
PARAMETERS 
TIGR 
SPOTFINDER 
3.1.1 
Histogram 12 Yes Threshold = 1*medianBKG 
+ 1*StdDevBkg 
Top bkg cutoff = 10% 
MASQOTSEG 
1.0.1 
Seeded 
Region 
Growing 
SA = 20 
<x< 200 
Yesi QCThresholdii = 0.25 Low Intensity Filter 
Threshold  = 300 
SCANALYZE 
2.5 
Fixed 
Circle 
SA = 80 Yesi None None Applied 
MAIA Adaptive 
Circle 
SA = 20 < x 
< 200 
Yesi QCThresholdii = 0.15 None Applied 
i Background correction applied via conversion of the raw data generated from each of these utilities using the TIGR 
ExpressionConverter 2.0, yielding .MEV files with background corrected Mean and Median channel intensities.  
ii Where the determination of a feature as a spot was assisted using an embedded Quality Control Score within the 
segmentation algorithm, thus the thresholds here delimit spot data from background noise during microarray image 
analysis.  
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Once spot analysis is completed the raw data files are used to calculate qcom scores for 
each array and image analysis application using an excel implementation of the statistical 
derivation previously described. Unfortunately, due to the limited amount of information 
provided in the output file, there is insufficient data available to generate qcom scores for 
ScanAlyze, as a number of the required spot and background characteristics are not provided in 
the raw data output file. A sample of the typical distribution of these scores using both averaging 
technqiues is provided below in Figure A.1.  
             A)                            B) 
 
Figure A.1 An example of the distribution of qcom scores attained from one array using the two different 
averaging functions discussed previously, plotted (A) as a function of the log10 �𝐶𝐶𝐶𝐶5𝐶𝐶𝐶𝐶3�. The shape of distribution of qcom 
scores is described further in a histogram as a function of averaging method (B), indicating a large degree of negative 
skew, preventing the assumption of normality. Note, the ‘0’ qcomScores shown in (A), are not shown in (B). Recall 
Equation X.X, where qcom = 0 is  
 
 While the specific distribution of scores for each array varies slightly, all arrays for which 
qcom scores were generated, yielded a similar overall pattern of qcom score distribution when 
plotted against the log of channel intensity ratios (Figure A.1). As this data suggests, the method 
of averaging has a discernable impact on the overall score distribution across an entire array. 
Table A.4 quantifies the effect of both methods of averaging channel quality indexes, indicating 
that while the weighted mean delivers slightly lower scores (represented as mean and median 
values) and marginally increased coefficient of variation, there is also a slightly lower degree of 
negative skew, confirmed by a comparable decline in kurtosis. However, since there is no 
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statistically significance difference between the mean and media values given the standard 
deviation of these observations, the weighted mean will be used as the comparator method given 
its ability to decrease the amount of skew introduced by qcom score values in the left hand tail of 
the distribution.  
Table A.4. Relevant summary statistics for the distributions of qcom scores, including the mean are respective 
standard deviation, Coefficient of Variation (CV), Median qcom score, and two measures of the skew indicated in Figure 
A.3b (the skew of the distribution as well as kurtosis) 
AVERAGING METHOD MEAN QCOM CV ( 𝑪𝑪𝒗𝒗 = �𝝈𝝈𝝁𝝁�) MEDIAN QCOM SKEWNESS KURTOSIS 
WEIGHTED MEAN 0.6151 ± 0.157 25.52 0.6518 -1.35 2.33 
GEOMETRIC MEAN 0.6369 ± 0.1566 24.59 0.6762 -1.49 2.86 
 
 Plotting the distributions of weighted mean qcom scores for each image analysis method 
and further by array population designation yields Figure A. While the overall distributions of 
scores tend to overlap, a superior spot recognition algorithm emerges for each population of 
arrays.  
 
Figure A.4 Mean array qcom scores attained using each method of spot recognition described previously. 
Shown in the boxplot in addition to the IQR (widest grey box) are the median (circle designation) and its respective 
confidence interval (narrower grey box), as well as the mean (solid horizontal line delimiting the center of the IQR), and 
outliers, labeled individually as asterisks.  
 
Examining the weighted mean qcom score distributions provided in Figure A.4, clearly of 
the three methods, SpotFinder yields the highest scoring, and by definition highest quality image 
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analysis, for population 1 arrays, and MASQOT subsequently yields the highest scoring arrays for 
population 2 arrays. Of interest is the large range in scores observed using the MAIA application 
in analyzing arrays from population 1. Coupled with comparably low scores generated from the 
MASQOT methodology for population1, it is evident from the data that the Seeded growing region 
method (implemented differentially in both methods) does not generate high quality spot data as 
compared to a more traditional, linear method such as the Histogram technique employed by 
SpotFinder. This particular phenomenon may be attributed to the significantly decreased spot 
size, an observation reinforced by the concordant increase in image analysis quality yielded by 
the MASQOT and MAIA methods in the population 2 arrays, which are of a significantly larger size.  
 
Returning to the lack of information to characterize processed array data generated by 
ScanAlyze, there are several methods often employed in determining the relatedness, or 
correlation between log ratios. Thus, by direct comparison, the relatedness of Log2 ratios may be 
examined between two methods of microarray image analysis.  However, without the aid of some 
other metric to determine which method is optimal initially, there is little benefit to employing 
such an investigation, as discussing the similarity of results is meaningless without first 
ascertaining which set of results are optimal. In theory, the disparity between the highest Qcom 
scoring method (determined above as MASQOT and SpotFinder) and the results attained by 
ScanAlyze should indicate the overall tendency of ScanAlyze’s performance in an indirect manner.  
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Appendix B 
 
At the onset of this project, a number of arrays were provided for analysis by the research group 
of I. Evans, representing wet-bench lab work over the course of the study. During this time 
isogenic yeast strains were cultured and analyzed as previously described (Materials and 
Methods), upon which microarray analysis was performed to examine transcriptomic differences 
between the prion containing strain [PSI+] and the wild type yeast, [psi-]. A summary of these 
scanned images is provided in the table below.  
Table B.1.  Data set constituents and supplemental information. Image files indicate the name of the array used after 
splitting the duplicate mega-grids into single grid image files.  
POP. ID ARRAY 
ID 
IMAGE FILES GENE LIST BIOLOGICAL 
SAMPLE 
CHANNEL 
DESIGNATION 
NOTES 
[PSI+] [psi-] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
29 IE1129_635_T.tif  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yeast_GCAT06.gal 
Cy3 Cy5  
IE1129_635_B.tif Cy3 Cy5 Not Useable 
IE1129_532_T.tif Cy3 Cy5  
IE1129_532_B.tif Cy3 Cy5 Not Useable 
24 SZ1124_635_T.tif Cy3 Cy5  
SZ1124_635_B.tif Cy3 Cy5  
SZ1124_532_T.tif Cy3 Cy5  
SZ1124_532_B.tif Cy3 Cy5  
3 SZ7503_635_T.tif Cy3 Cy5  
SZ7503_635_B.tif Cy3 Cy5  
SZ7503_532_T.tif Cy3 Cy5  
SZ7503_532_B.tif Cy3 Cy5  
4 SZ7504_635_T.tif Cy3 Cy5  
SZ7504_635_B.tif Cy3 Cy5  
SZ7504_532_T.tif Cy3 Cy5  
SZ7504_532_B.tif Cy3 Cy5  
27 SZ1127_635_T_tif Cy3 Cy5  
SZ1127_635_B_tif Cy3 Cy5  
SZ1127_532_T_tif Cy3 Cy5  
SZ1127_532_B_tif Cy3 Cy5  
23 13471123_2008-08-06_PMT660-550_635_T.tif Cy3 Cy5  
13471123_2008-08-06_PMT660-550_635_B.tif Cy3 Cy5  
13471123_2008-08-06_PMT660-550_532_T.tif Cy3 Cy5  
13471123_2008-08-06_PMT660-550_532_B.tif Cy3 Cy5  
636 134562636_2008-08-06_PMT660-550_635_T.tif Cy3 Cy5  
134562636_2008-08-06_PMT660-550_635_B.tif Cy3 Cy5  
134562636_2008-08-06_PMT660-550_532_T.tif Cy3 Cy5  
134562636_2008-08-06_PMT660-550_532_B.tif Cy3 Cy5  
 
 
 
 
2 
35 SZ9835_635_T.tif  
 
 
 
 
Cy5 Cy3 Dye Swaps 
SZ9835_635_B.tif Cy5 Cy3 Dye Swaps 
SZ9835_532_T.tif Cy5 Cy3 Dye Swaps 
SZ9835_532_B.tif Cy5 Cy3 Dye Swaps 
36 SZ9836_635_T.tif Cy5 Cy3 Dye Swaps 
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2 
SZ9836_635_B.tif  
 
 
 
384_illumina.gal 
Cy5 Cy3 Dye Swaps 
SZ9836_532_T.tif Cy5 Cy3 Dye Swaps 
SZ9836_532_B.tif Cy5 Cy3 Dye Swaps 
37 SZ9837_635_T.tif Cy3 Cy5  
SZ9837_635_B.tif Cy3 Cy5  
SZ9837_532_T.tif Cy3 Cy5  
SZ9837_532_B.tif Cy3 Cy5  
39 SZ9839_635_T.tif Cy3 Cy5  
SZ9839_635_B.tif Cy3 Cy5  
SZ9839_532_T.tif Cy3 Cy5  
SZ9839_532_B.tif Cy3 Cy5  
40 SZ9840_635_T.tif Cy3 Cy5  
SZ9840_635_B.tif Cy3 Cy5  
SZ9840_532_T.tif Cy3 Cy5  
SZ9840_532_B.tif Cy3 Cy5  
41 SZ9841_635_T.tif Cy3 Cy5  
SZ9841_635_B.tif Cy3 Cy5  
SZ9841_532_T.tif Cy3 Cy5  
SZ9841_532_B.tif Cy3 Cy5  
ADDITIONAL 
ARRAYS 
ADDED MID-
PROJECT TO 
POPULATIO
N 2 
42 IE9842B_532.tif 384 Illumina.gal Cy3 Cy5  
IE9842B_635.tif Cy3 Cy5  
IE9842T_532.tif Cy3 Cy5  
IE9842B_635.tif Cy3 Cy5  
43 IE9843B_532.tif Cy3 Cy5 Slide exhibits 
similar spot 
morphology 
to the dye 
swapped 
arrays 35,36 
IE9843B_635.tif Cy3 Cy5 
IE9843T_532.tif Cy3 Cy5 
IE9843B_635.tif Cy3 Cy5 
 
Arrays which were excluded during the initial pre-processing stage (indicated in the 
‘Notes’ column of Table B.1) exhibit a wide variety of morphological anomalies which could never 
be resolved within the downstream data processing steps. In particular, several arrays had 
problems with the hybridization quality, an example of which is given in Figure B.1a which exhibits 
the lack of Cy3-labeled transcript individually on any hybridized spot. The vast majority of the 
remaining arrays excluded during this stage of analysis demonstrated significant contamination 
with dye-associated artifacts, an example of which is given in Figure B.1b. 
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A) B)  
Figure B.1 Common cDNA microarray artifacts encountered during image analysis. Included are block excerpts 
of array IE1126 (A), which illustrates a failure in proper hybridization or labeling with Cy3, and array IE0077 (B), which 
demonstrates unresolved “dye-blobs”, or aggregates of dye remaining after wet-bench array processing, the with 
density and frequency across the array perturbing both automated spot recognition and manual flagging.  
 
 As indicated in Table B.1, arrays used in this analysis are clustered into two distinct 
populations. While this is partly due to the use of two different .GAL (master gene indexing and 
addressing files), indicating a different spot printing geometry, several distinct morphological 
features indicate that arrays should be segregated into two populations for statistical treatment 
(image and data analysis) as well. Given by the .GAL file name, the arrays are sourced from two 
different manufactures, with the second batch comprising population 2 being supplied by 
Illumina, Inc. (Sand Diego, CA). It is likely the differences between suppliers are due to differing 
microarray fabrication techniques used in the production of each array, thus giving rise to the 
observed variations in spot morphology. Most notable is a significant increase in spot size within 
the population 2, Illumina cDNA microarrays. This increase in spot size also tends to decrease 
overall spot uniformity, with a general increase in overall spot topographical roughness as 
compared to the smaller spots exhibited by arrays in population 1. These and additional 
morphological differences between arrays of the two populations are described in Figure B.2. 
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A) B) 
 
 
 
 
Attribute  Value (pixels) IE1129 (Pop 1) SZ0035 (Pop 2) 
Mean Spot Area 52.8125 ± 10.42 160.9375 ±17.36 
Sample Variance of Spot 
Areas 108.5625 301.2625 
Range, [Min-Max] 33, [37-70] 51, [126-177] 
t-test of the two 
means, 
where; 
𝐻𝐻0 ∶  𝜇𝜇𝑃𝑃𝑃𝑃𝑃𝑃1 =  𝜇𝜇𝑃𝑃𝑃𝑃𝑃𝑃2
𝐻𝐻𝑎𝑎:  𝜇𝜇𝑃𝑃𝑃𝑃𝑃𝑃1 ≠ 𝜇𝜇𝑃𝑃𝑃𝑃𝑃𝑃2 , 
 α =.01 
t Stat = -21.364 
p = 7.0984 x 10-18 
tCritical = 2.787 (Two Tail) 
Figure B.2 A demonstration of the significant difference between morphologies of arrays from populations 1 
and 2. Of interest is the vast differences in morphological characteristics about the spots, illustrated by print-tip block 
excerpts of the same index (Top Mega-Grid, Block index = [3,4]).  An excerpt from the (A) Population 1 arrays (IE1129, 
representative of arrays processed in-lab at RIT during late summer to early fall of 2008), and (B) Population 2 arrays 
(SZ0035, representative of arrays processed beginning at the end of fall 2008, continuing through current). The obvious 
differences in spot morphology are extrapolated upon by a rendering of the topographical rendering (C) of an excerpt 
of the two blocks (yellow highlighted region spanning A, B), allowing for parallel comparison between the two array 
types. The most notable characteristic, a marked increase in spot diameter in Population 2 arrays is quantified using a 
paired t-test (D), clearly indicating the spots in each array type are completely independent, with spots in population 2 
being on average ~300% larger in area.  
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Appendix C 
 
Table C.1 Statistically Significant ORFs as determined using Student’s T-Test Welch’s Approximation for variance 
assumption and p-values calculated using 100 random permutations of the data set, where significance is determined 
by the p-critical value of α = 0.01. The resulting n = 539 ORFs of significance at this confidence level are ordered below 
by descending Fold Change 
ID DESCRIPTION GENE MEAN 
YJR029W Yjr029wp,X 1.078062 
YDR468C tSNARE that affects a Late Golgi compartment,IV 1.006164 
YNL088W topoisomerase II, Top2p localizes to axial cores in meiosis,XIV 0.886799 
YIL120W MFS-MDR transporter,IX 0.701724 
YNR039C Zrg17p,XIV 0.678453 
YNL212W Vid27p,XIV 0.562389 
YPR105C Ypr105cp,XVI 0.547995 
YDR185C Ydr185cp,IV 0.546975 
YDR301W Component of pre-mRNA cleavage factor II (CFII); 150-kDa protein associated with polyadenylation fac,IV 0.527273 
YHL032C glyerol kinase (converts glycerol to glycerol-3-phosphate,VIII 0.520155 
YLR367W Ribosomal protein S22B (S24B) (rp50) (YS22),XII 0.508329 
YGR094W mitochondrial and cytoplasmic valyl-tRNA synthetase,VII 0.4913 
YIL101C transcriptional repressor,IX 0.474573 
YNL281W Hch1p,XIV 0.472367 
YCR024C-A Proteolipid associated with plasma membrane H(+)-ATPase (Pma1p),III 0.465553 
YJR088C Yjr088cp,X 0.463448 
YGL201C component of MCM initiator complex involved in DNA replication,VII 0.46125 
YDR017C Shows homology to basic leucine zipper family of transcription factors,IV 0.457248 
YJR063W A12.2 subunit of RNA polymerase I,X 0.454564 
YER183C 5,10-methenyltetrahydrofolate synthetase,V 0.452467 
YOR230W Transcriptional modulator,XV 0.452327 
YGR278W Ygr278wp,VII 0.450713 
YOL003C Yol003cp,XV 0.448071 
YLR026C Sed5p is a t-SNARE (soluble NSF attachment protein receptor) required in ER to Golgi transport.,XII 0.447072 
YML129C mitochondrial membrane protein,XIII 0.44464 
YDR204W involved in ubiquinone biosynthesis,IV 0.444033 
YMR066W (putative) involved in respiration,XIII 0.441278 
YHR170W cytoplasmic factor required for a late cytoplasmic assembly step of the 60S subunit,VIII 0.438361 
YCR107W Hypothetical aryl-alcohol dehydrogenase (AAD),III 0.43557 
YAR029W membrane protein,I 0.430612 
YNL217W Ynl217wp,XIV 0.426311 
YDL154W MutS homolog involved in chromosome exchange,IV 0.417705 
YOR059C Yor059cp,XV 0.417619 
YDL114W Ydl114wp,IV 0.416841 
YIL063C Yrb2p,IX 0.412974 
YKL005C Ykl005cp,XI 0.412961 
YDR290W Ydr290wp,IV 0.412935 
YBR135W subunit of the Cdc28 protein kinase,II 0.405655 
YHR045W Yhr045wp,VIII 0.405552 
YLR132C Ylr132cp,XII 0.402998 
YDR210W-C TyA gag protein.,IV 0.400562 
YPR110C RNA polymerase III (C) subunit,XVI 0.398209 
YAL064W Yal064wp,I 0.395557 
YPL242C Similar to mammalian IQGAP proteins,XVI 0.393369 
YJR058C Clathrin-associated protein, small subunit,X 0.388574 
YDR178W succinate dehydrogenase membrane anchor subunit,IV 0.388283 
YCL031C involved in rRNA processing,III 0.381027 
YJR048W iso-1-cytochrome c,X 0.378643 
YMR164C Predicted 758 amino acid polypeptide with poly-glutamine and poly-asparagine domains,XIII 0.375863 
YLR088W Possible component of GPI protein transamidase,XII 0.372546 
YHR162W Yhr162wp,VIII 0.372466 
YNL023C Transcription factor homolog; similarity to Drosophila melanogaster shuttle craft protein; similarit,XIV 0.369095 
YGL040C delta-aminolevulinate dehydratase (porphobilinogen synthase),VII 0.367289 
YPL016W Zinc-finger transcription factor,XVI 0.366514 
YFR036W cell division control protein,VI 0.36571 
YDR528W Hlr1p,IV 0.36324 
YJR055W involved in growth at high temperature,X 0.362048 
YFR024C-A Yfr024c-ap,VI 0.360228 
YDR247W Ydr247wp,IV 0.360043 
YNL199C Transcription factor,XIV 0.359259 
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YIL147C histidine kinase osmosensor that regulates an osmosensing MAP kinase cascade and is similar to bacte,IX 0.357292 
YMR030W Ymr030wp,XIII 0.356992 
YMR201C human xeroderma pigmentosum group A DNA repair gene homolog,XIII 0.355599 
YDL224C Possible RNA binding protein. Homolog of Whi3.,IV 0.355364 
YLR025W involved in glucose derepression,XII 0.35484 
YLL050C Cofilin, actin binding and severing protein,XII 0.350937 
YJR109C carbamyl phosphate synthetase,X 0.349276 
YPL278C Ypl278cp,XVI 0.347366 
YFR002W 96 kDa nucleoporin-interacting component,VI 0.346929 
YOR309C Yor309cp,XV 0.345782 
YOR149C involved in plasmid maintenance,XV 0.344382 
YOL117W Yol117wp,XV 0.34285 
YML018C Yml018cp,XIII 0.341639 
YBR127C vacuolar ATPase V1 domain subunit B (60 kDa),II 0.340653 
YER154W involved in cytochrome c oxidase and ATP synthase assembly,V 0.340019 
YNL086W Ynl086wp,XIV 0.338713 
YJR034W involved in cytochrome c oxidase assembly,X 0.33683 
YIR004W involved in peroxisome biogenesis,IX 0.336192 
YLR428C Ylr428cp,XII 0.334448 
YLR252W Ylr252wp,XII 0.33347 
YLR238W Ylr238wp,XII 0.331681 
YEL019C involved in DNA repair,V 0.330968 
YMR320W Ymr320wp,XIII 0.329866 
YFR019W type II PI(4)P5-kinase (PIP4,5 kinase) similar to human PIP5K-II,VI 0.327553 
YNL052W Cytochrome-c oxidase chain Va,XIV 0.32442 
YOL094C Subunit 4 of Replication Factor C; homologous to human RFC 40 kDa subunit,XV 0.323878 
YOL054W Yol054wp,XV 0.321241 
YER103W member of 70 kDa heat shock protein family,V 0.320467 
YGL131C Ygl131cp,VII 0.319445 
YER077C Yer077cp,V 0.318935 
YGL103W Ribosomal protein L28 (L29) (rp44) (YL24),VII 0.318122 
YGL093W component of spindle pole,VII 0.317197 
YKR098C Ubiquitin-specific protease,XI 0.314185 
YDR211W Translation initiation factor eIF-2B epsilon subunit,IV 0.313852 
YOR307C homolog of chloroplast phosphate transporter,XV 0.313027 
YMR289W Ymr289wp,XIII 0.31302 
YOR221C malonyl-CoA ACP transferase,XV 0.312324 
YPL085W vesicle coat component,XVI 0.311289 
YLR390W involved in cell wall biogenesis,XII 0.310755 
YOR117W 26S protease regulatory subunit,XV 0.309825 
YGL042C Ygl042cp,VII 0.307968 
YKR047W Ykr047wp,XI 0.305636 
YLR218C Ylr218cp,XII 0.305436 
YBR273C Ybr273cp,II 0.303464 
YER103W member of 70 kDa heat shock protein family,V 0.302253 
YPL208W Ypl208wp,XVI 0.302038 
YKL092C GTPase-activating protein (GAP) for Rsr1p/Bud1p,XI 0.301139 
YLR415C Ylr415cp,XII 0.299235 
YMR278W Ymr278wp,XIII 0.298676 
YOR096W Ribosomal protein S7A (rp30),XV 0.295902 
YJR082C Yjr082cp,X 0.295221 
YDR441C Apt2p,IV 0.294354 
YNR019W Acyl-CoA cholesterol acyltransferase (sterol-ester synthetase),XIV 0.29384 
YLR183C Tos4p,XII 0.293759 
YJR089W Bir1p,X 0.293729 
YHR212C Yhr212cp,VIII 0.29359 
YBR290W copper transporter,II 0.293319 
YDR411C Ydr411cp,IV 0.29251 
YMR039C transcriptional coactivator,XIII 0.292323 
YBR119W U1 snRNP A protein,II 0.288715 
YPR064W Ypr064wp,XVI 0.288344 
YGR162W mRNA cap-binding protein (eIF-4F), 150K subunit , highly homologous to Tif4632p, homologs of 
mammali,VII 
0.288022 
YOR354C Yor354cp,XV 0.287087 
YNL009W peroxisomal NADP-dependent isocitrate dehydrogenase,XIV 0.286016 
YBR188C splicing factor,II 0.285867 
YKL006C-A intra-Golgi v-SNARE,XI 0.285371 
YIR041W Yir041wp,IX 0.284957 
YLR184W Ylr184wp,XII 0.284757 
YKL081W Translation elongation factor EF-1gamma,XI 0.284327 
YAL039C cytochrome c heme lyase (CCHL),I 0.281797 
YCR057C regulatory protein,III 0.28098 
YKR063C Las1p,XI 0.280775 
YAR008W 34kDa subunit of the tetrameric tRNA splicing endonuclease,I 0.27816 
YAL019W SNF2 protein family,I 0.278074 
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YHR089C small nucleolar RNP proteins,VIII 0.277755 
YJR096W Yjr096wp,X 0.276618 
YGL034C Ygl034cp,VII 0.276553 
YPR137C-A TyA gag protein.,XVI 0.276257 
YBR142W Probable pre-mRNA splicing RNA-helicase,II 0.275999 
YNL263C Similar to NADH dehydrogenases,XIV 0.274743 
YMR199W G(sub)1 cyclin,XIII 0.273241 
YBR181C 40S ribosomal gene product S6B (S10B) (rp9) (YS4),II 0.272932 
YCR097W-A empty,III 0.272787 
YLL038C Ent4p,XII 0.271633 
YBR263W Serine hydroxymethyltransferase, mitochondrial,II 0.269506 
YPR014C Ypr014cp,XVI 0.268354 
YIR025W Yir025wp,IX 0.267832 
YFR055W Yfr055wp,VI 0.267138 
YLL026W 104 kDa heat shock protein,XII 0.266153 
YJR070C Yjr070cp,X 0.265854 
YMR057C Ymr057cp,XIII 0.265532 
YLR212C gamma tubulin-like protein, interacts with Spc98p and Spc97p, the Tub4p-Spc98p-Spc97p complex may 
be,XII 
0.265067 
YGR153W Tos10p,VII 0.264647 
YER140W Yer140wp,V 0.264316 
YJR101W protein of the small subunit of the mitochondrial ribosome,X 0.263682 
YOL131W Yol131wp,XV 0.262369 
YPL109C Ypl109cp,XVI 0.261967 
YKR081C Ykr081cp,XI 0.261608 
YER028C Yer028cp,V 0.260979 
YGR199W dolichyl phosphate-D-mannose protein O-D-mannosyltransferase,VII 0.260744 
YHR150W Yhr150wp,VIII 0.257766 
YGL159W Ygl159wp,VII 0.257494 
YDL204W Ydl204wp,IV 0.257418 
YNL067W Ribosomal protein L9B (L8B) (rp24) (YL11),XIV 0.255972 
YDR316W-B TyB Gag-Pol protein.,IV 0.254864 
YGR049W suppressor of cdc4 mutations,VII 0.254615 
YBR240C Probable Zn-finger protein,II 0.254248 
YFL058W a thiamine regulated pyrimidine precursor biosynthesis enzyme,VI 0.253659 
YDL196W Ydl196wp,IV 0.251206 
YOR326W class V myosin,XV 0.250956 
YIL016W 18.3 kD integral membrane protein,IX 0.250684 
YBR102C Exo84p,II 0.250558 
YCR090C Ycr090cp,III 0.248416 
YOR284W Yor284wp,XV 0.248346 
YMR109W myosin I,XIII 0.246068 
YKR065C Ykr065cp,XI 0.245868 
YPL016W Zinc-finger transcription factor,XVI 0.245488 
YDR410C farnesyl cysteine-carboxyl methyltransferase,IV 0.245329 
YNL303W Ynl303wp,XIV 0.245291 
YLR049C Ylr049cp,XII 0.243978 
YNL179C Ynl179cp,XIV 0.24362 
YML065W 120-kDa (largest) subunit of origin recognition complex (ORC); shows homology to Cdc6p, Cdc18p, 
and,XIII 
0.243286 
YLR210W G(sub)2-specific B-type cyclin,XII 0.242213 
YOR343W-B empty,XV 0.242123 
YGL247W Ygl247wp,VII 0.241803 
YDR112W Ydr112wp,IV 0.240549 
YFR028C soluble tyrosine-specific protein phosphatase,VI 0.239966 
YMR216C Serine Protein Kinase,XIII 0.239455 
YJR020W Yjr020wp,X 0.238921 
YGL094C 135-kDa protein that is subunit of poly(A) ribonuclease,VII 0.237279 
YMR210W Ymr210wp,XIII 0.235947 
YBR147W Ybr147wp,II 0.235173 
YKL042W component of the spindle pole body,XI 0.234602 
YKR062W Small subunit of TFIIE transcription factor,XI 0.233467 
YLR410W-B TyB Gag-Pol protein.,XII 0.233368 
YJR075W putative mannosyltransferase,X 0.233326 
YDR384C Ydr384cp,IV 0.232764 
YLL039C ubiquitin,XII 0.231287 
YGR189C Cell wall protein,VII 0.229675 
YLR256W zinc-finger transcription factor of the Zn(2)-Cys(6) binuclear cluster domain type,XII 0.222164 
YNL250W Contains a purine-binding domain, two heptad repeats and a hydrophobic tail.,XIV 0.22112 
YJL061W 82-kDa protein, with putative coiled-coil domain, has carboxy-terminal domain, containing heptad rep,X 0.221043 
YLR240W phosphatidylinositol 3-kinase,XII 0.22073 
YHR019C Asparaginyl-tRNA synthetase,VIII 0.21886 
YHR033W Pro1p (Gamma-glutamyl kinase),VIII 0.21843 
YDR215C Ydr215cp,IV 0.217689 
YBR221C beta subunit of pyruvate dehydrogenase (E1 beta),II 0.217569 
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YMR019W Binds Sin3p in two-hybrid assay,XIII 0.216584 
YNL204C Transcription factor,XIV 0.215117 
YIR040C Yir040cp,IX 0.214973 
YIL161W Yil161wp,IX 0.214919 
YHR139C sporulation-specific wall maturation protein,VIII 0.213793 
YIL044C ARF GAP with effector function(s),IX 0.212826 
YCR053W threonine synthase,III 0.209782 
YDL048C involved in tRNA splicing,IV 0.209187 
YBL085W BEM1-binding protein,II 0.209175 
YNL202W peroxisomal 2,4-dienoyl-CoA reductase,XIV 0.208989 
YKL203C probable phosphatidylinositol kinase,XI 0.208241 
YOR102W Yor102wp,XV 0.207427 
YLR439W Mitochondrial 60S ribosomal protein L4,XII 0.206595 
YGL091C 35 kDa nucleotide binding protein,VII 0.205321 
YPR043W Ribosomal protein L43A,XVI 0.205219 
YOR387C Yor387cp,XV 0.20492 
YCR077C Pat1p,III 0.203858 
YPL280W Ypl280wp,XVI 0.203161 
YOR271C Yor271cp,XV 0.202348 
YJR074W nuclear protein that interacts with GTP-Gsp1p,X 0.201304 
YHR168W GTP-binding protein,VIII 0.200734 
YOR332W vacuolar ATPase V1 domain subunit E (27 kDa),XV 0.200155 
YDR448W transcription factor, member of ADA and SAGA, two transcriptional adaptor/HAT (histone 
acetyltransfe,IV 
0.199944 
YCL064C catabolic serine (threonine) dehydratase,III 0.199037 
YDR088C involved in mRNA splicing,IV 0.198623 
YOR020C 10 kDa mitochondrial heat shock protein,XV 0.197646 
YML055W subunit of signal peptidase complex, homologous to mammalian protein SPC25,XIII 0.197386 
YGR097W transcriptional activator of the SKN7 mediated 'two-component' regulatory system,VII 0.195661 
YPR024W Mitochondrial member of the CDC48/PAS1/SEC18 family of ATPases,XVI 0.194954 
YMR310C Ymr310cp,XIII 0.194271 
YOR352W Yor352wp,XV 0.193956 
YMR042W transcription factor,XIII 0.193724 
YLR213C Crr1p,XII 0.193693 
YLR314C Septin; component of 10 nm filaments of mother-bud neck,XII 0.193194 
YGL184C Cystathionine beta-lyase,VII 0.193002 
YNL277W homoserine O-trans-acetylase,XIV 0.191769 
YOR170W Yor170wp,XV 0.191708 
YDR172W translation termination factor eRF3,IV 0.190706 
YOR228C Yor228cp,XV 0.189635 
YAL036C similar to Xenopus GTP-binding protein DRG,I 0.189455 
YPR116W Ypr116wp,XVI 0.189371 
YLR032W putative ATPase/DNA helicase,XII 0.188749 
YJR003C Yjr003cp,X 0.188469 
YDR244W 69-kDa protein containing tetratricopeptide repeat (TPR),IV 0.187862 
YEL016C Yel016cp,V 0.186823 
YJL123C Yjl123cp,X 0.186455 
YCL056C Ycl056cp,III 0.1852 
YDR246W Trs23p,IV 0.183992 
YGR219W Ygr219wp,VII 0.18378 
YPR189W Contains 8 copies of the TPR domain,XVI 0.18297 
YER045C Yer045cp,V 0.182749 
YGL001C C-3 sterol dehydrogenase,VII 0.182528 
YER137C Yer137cp,V 0.178473 
YOL031C Yol031cp,XV 0.178258 
YPL276W Ypl276wp,XVI 0.17725 
YIL094C Homo-isocitrate dehydrogenase,IX 0.176307 
YML012W vesicle coat component,XIII 0.175272 
YDL072C Ydl072cp,IV 0.17454 
YGR128C Ygr128cp,VII 0.173595 
YJL052W Glyceraldehyde-3-phosphate dehydrogenase 1,X 0.173351 
YLR346C Ylr346cp,XII 0.170608 
YNL190W Ynl190wp,XIV 0.17045 
YOR348C putative proline-specific permease,XV 0.170193 
YHL038C Cytochrome B pre-mRNA processing protein,VIII 0.169959 
YDR254W chromosome segregation protein,IV 0.163892 
YJL016W Yjl016wp,X 0.163319 
YCR096C Regulatory protein MATa2p (no known function); sequence is the same as the last 119 residues of 
MATa,III 
0.162877 
YMR172W nuclear protein,XIII 0.15978 
YHR081W Yhr081wp,VIII 0.158277 
YFL039C Actin,VI 0.155704 
YDR182W involved in ion homeostasis,IV 0.151992 
YEL059C-A involved in mitochondrial inner peptidase function,V 0.151437 
YPR102C Ribosomal protein L11A (L16A) (rp39A) (YL22),XVI 0.150469 
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YGL087C Similar to ubiquitin conjugating protein family,VII 0.149509 
YPL191C Ypl191cp,XVI 0.148809 
YPL182C Ypl182cp,XVI 0.147641 
YDR130C Cell cycle-dependent filament between nuclei,IV 0.14708 
YHR059W Yhr059wp,VIII 0.146894 
YHL009W-A TyA gag protein.,VIII 0.146653 
YPR147C Ypr147cp,XVI 0.146589 
YPL215W involved in cytochrome-c reductase assembly,XVI 0.144782 
YER065C isocitrate lyase,V 0.141476 
YOR311C Yor311cp,XV 0.141038 
YLR297W Ylr297wp,XII 0.140488 
YDR117C Ydr117cp,IV 0.139927 
YNR065C Ynr065cp,XIV 0.138961 
YJL061W 82-kDa protein, with putative coiled-coil domain, has carboxy-terminal domain, containing heptad rep,X 0.137905 
YLR016C Ylr016cp,XII 0.137335 
YPR131C N-terminal acetyltransferase,XVI 0.13582 
YEL035C Utr5p,V 0.1358 
YCR039C Mating type protein alpha-2,III 0.134541 
YBR091C Nuclear protein involved in mitochondrial intron splicing,II 0.134049 
YLR227W-A TyA Gag protein.,XII 0.131917 
YJL160C Yjl160cp,X 0.128157 
YMR194C-A Ymr194c-ap,XIII 0.127334 
YBR195C p50 subunit of the yeast Chromatin Assembly Factor-I (CAF-I) negative regulator of ras-mediated cAMP,II 0.126766 
YKR088C Ykr088cp,XI 0.126612 
YAL046C Yal046cp,I 0.125274 
YER053C Yer053cp,V 0.119917 
YBR007C Ybr007cp,II 0.11736 
YHR071W G1/S cyclin (weak),VIII 0.109523 
YPL082C putative helicase,XVI 0.109094 
YGL121C Ygl121cp,VII 0.107119 
YDL028C serine/threonine/tyrosine protein kinase (dual specificity), able to autophosphorylate as well as ac,IV 0.105728 
YNL196C Sporulation-specific protein with a leucine zipper motif,XIV 0.093498 
YOL044W 44 kDa phosphorylated integral peroxisomal membrane protein,XV 0.083743 
YNL279W Prm1p,XIV -0.07718 
YIR013C very short and so far mRNA can't be detected,IX -0.10197 
YBR074W Homolog to aminopeptidase Y (S. cerevisiae),II -0.10793 
YMR263W Ymr263wp,XIII -0.11568 
YJR144W (putative) nucleic acid interactor,X -0.11951 
YNL228W Ynl228wp,XIV -0.12029 
YER071C Yer071cp,V -0.12149 
YPR162C 56-kDa subunit of origin recognition complex (ORC),XVI -0.12386 
YJR107W Yjr107wp,X -0.1248 
YPR167C 3'phosphoadenylylsulfate reductase,XVI -0.12612 
YDL090C beta subunit of farnesyltransferase,IV -0.12835 
YPL234C vacuolar ATPase V0 domain subunit c' (17 kDa),XVI -0.13325 
YOL106W Yol106wp,XV -0.13923 
YKL192C mitochondrial acyl carrier protein,XI -0.13987 
YKL106W aspartate aminotransferase, mitochondrial,XI -0.14163 
YOL155C Yol155cp,XV -0.14296 
YPR113W phosphatidylinositol synthase,XVI -0.14487 
YAL058W Calnexin and calreticulin homolog,I -0.14506 
YEL043W Yel043wp,V -0.14549 
YNL327W Cell wall protein. Putatively involved in glucan metabolism,XIV -0.15109 
YJL061W 82-kDa protein, with putative coiled-coil domain, has carboxy-terminal domain, containing heptad rep,X -0.15527 
YJR001W Yjr001wp,X -0.16086 
YMR089C Yta12p,XIII -0.16254 
YOR250C cleavage/polyadenylation factor IA subunit,XV -0.16506 
YLR289W GTPase,XII -0.16618 
YDR375C Mitochondrial ATPase (AAA family),IV -0.16686 
YDR434W Ydr434wp,IV -0.16841 
YBL005W Pleiotropic drug resistance protein 3,II -0.17039 
YJL061W 82-kDa protein, with putative coiled-coil domain, has carboxy-terminal domain, containing heptad rep,X -0.17235 
YPR170C Ypr170cp,XVI -0.17239 
YJL071W Acetylglutamate Synthase,X -0.17466 
YFR049W mitochondrial ribosomal protein,VI -0.17537 
YKR094C Ribosomal protein L40B,XI -0.17562 
YLR239C Ylr239cp,XII -0.1763 
YKL193C Glc7p regulatory subunit,XI -0.17694 
YPL175W N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein,XVI -0.17696 
YAL037W Yal037wp,I -0.17722 
YDR155C cyclophilin peptidyl-prolyl cis-trans isomerase,IV -0.17767 
YJR094C transcription factor involved in meiosis,X -0.17804 
YBR065C (putative) involved in cell wall biogenesis and mRNA splicing,II -0.17891 
YGL024W Ygl024wp,VII -0.18037 
YGR024C Ygr024cp,VII -0.18215 
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YER186C Yer186cp,V -0.18266 
YLR182W transcription factor,XII -0.18311 
YGL142C Gpi10p,VII -0.18321 
YOR144C Efd1p,XV -0.18397 
YLR206W Ent2p,XII -0.18579 
YDR511W Ydr511wp,IV -0.18769 
YML009C Mitochondrial ribosomal protein MRPL39 (YmL39),XIII -0.18796 
YNL142W Ammonia transport protein,XIV -0.18875 
YLR099W-A empty,XII -0.19016 
YFL001W Depressed growth-rate protein,VI -0.19379 
YBR158W Cst13p,II -0.1949 
YNL097C Involved in expression of PHO5,XIV -0.19604 
YHR166C Cell division cycle protein,VIII -0.19692 
YFR051C vesicle coat component,VI -0.19693 
YOR091W Yor091wp,XV -0.19821 
YPR146C Ypr146cp,XVI -0.19838 
YPL052W Ypl052wp,XVI -0.19905 
YIL066C Ribonucleotide reductase (ribonucleoside-diphosphate reductase) large subunit,IX -0.20005 
YJR128W Yjr128wp,X -0.20058 
YBR132C Amino acid permease,II -0.2015 
YLR219W Ylr219wp,XII -0.20225 
YDR428C Ydr428cp,IV -0.20247 
YNL278W Caf120p,XIV -0.20723 
YBR082C ubiquitin-conjugating enzyme,II -0.20889 
YDL158C Ydl158cp,IV -0.20902 
YBL014C member of yeast Pol I core factor (CF) also composed of Rrn11p, Rrn7p and TATA-binding protein,II -0.20936 
YCR018C Transcription regulator,III -0.21277 
YOL029C Yol029cp,XV -0.21368 
YLL021W spindle pole antigen,XII -0.21565 
YJR148W Branched-Chain Amino Acid Transaminase,X -0.21629 
YDR521W Ydr521wp,IV -0.2178 
YKR070W Ykr070wp,XI -0.2241 
YHL048W similar to other subtelomerically-encoded proteins,VIII -0.2256 
YJR008W Yjr008wp,X -0.22581 
YNL220W adenylosuccinate synthetase,XIV -0.22587 
YLL026W 104 kDa heat shock protein,XII -0.22593 
YER031C Ypt31p,V -0.22684 
YMR156C Ymr156cp,XIII -0.22756 
YDR158W aspartic beta semi-aldehyde dehydrogenase,IV -0.22915 
YPR020W Subunit g homolog of ATP synthase,XVI -0.22968 
YNL289W G(sub)1 cyclin that associates with PHO85,XIV -0.23013 
YNL224C Ynl224cp,XIV -0.23016 
YLR283W Ylr283wp,XII -0.23043 
YPL111W arginase,XVI -0.23295 
YNL188W Localizes to the spindle pole body,XIV -0.23369 
YNL112W ATP-dependent RNA helicase of DEAD box family,XIV -0.23387 
YFL039C Actin,VI -0.23506 
YMR285C Ymr285cp,XIII -0.23584 
YBL029C-A empty,II -0.23623 
YNR073C Ynr073cp,XIV -0.23764 
YLR296W Ylr296wp,XII -0.23993 
YML040W TyA Gag protein.,XIII -0.24036 
YOR186W Yor186wp,XV -0.24169 
YIL012W Yil012wp,IX -0.24363 
YOR147W Yor147wp,XV -0.24516 
YER185W Yer185wp,V -0.24546 
YER095W RecA homolog; Rad51p colocalizes to ~ 65 spots with Dmc1p prior to synapsis (independently of ZIP1 a,V -0.24694 
YKL048C protein kinase,XI -0.24935 
YBR080C cytoplasmic protein involved in protein transport between ER and Golgi; ATPase,II -0.24987 
YCR062W NULL,III -0.24991 
YBR206W Ybr206wp,II -0.25233 
YPL007C 60 kDa subunit of TFIIIC (tau60),XVI -0.25258 
YGR129W (putative) involved in pre-mRNA splicing,VII -0.25356 
YML105C signal recognition particle subunit, homologue of mammalian SRP19,XIII -0.25469 
YJL153C L-myo-inositol-1-phosphate synthase,X -0.25606 
YOR124C Ubiquitin-specific protease,XV -0.25968 
YPL119C putative ATP-dependent RNA helicase; Dead box protein,XVI -0.2597 
YDR230W Ydr230wp,IV -0.26508 
YBR277C Ybr277cp,II -0.26554 
YJL048C Yjl048cp,X -0.26585 
YNL308C Binding Protein of Krr1p,XIV -0.26809 
YFL009W part of a ubiquitin ligase complex,VI -0.27184 
YGR258C homolog of xeroderma pigmentosum group G (XPG) protein, copufurifies with transcription factor, 
TFII,VII 
-0.27334 
YGR164W Ygr164wp,VII -0.27429 
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YNL268W lysine permease,XIV -0.27703 
YJL052W Glyceraldehyde-3-phosphate dehydrogenase 1,X -0.2774 
YJL052W Glyceraldehyde-3-phosphate dehydrogenase 1,X -0.28083 
YOR055W Yor055wp,XV -0.28085 
YMR200W putative membrane protein,XIII -0.28471 
YPL075W trans-acting positive regulator of the enolase and glyceraldehyde-3-phosphate dehydrogenase gene 
fam,XVI 
-0.28674 
YLR447C vacuolar ATPase V0 domain subunit d (36 kDa),XII -0.28941 
YMR273C Zds1p,XIII -0.29401 
YCL011C Protein with RNA recognition motifs,III -0.29537 
YEL051W vacuolar ATPase V1 domain subunit D,V -0.29722 
YBR044C mitochondrial protein; (putative) chaperone,II -0.29738 
YOR244W Acetyltransferase in the SAS gene family,XV -0.30349 
YJL219W hexose permease,X -0.30447 
YIR019C cell surface flocculin with structure similar to serine/threonine-rich GPI-anchored cell wall protei,IX -0.30492 
YHR132W-A Yhr132w-ap,VIII -0.30971 
YHR214W-A Yhr214w-ap,VIII -0.31103 
YDR355C Ydr355cp,IV -0.31108 
YKL056C Ykl056cp,XI -0.3112 
YJL135W Yjl135wp,X -0.31134 
YML127W Yml127wp,XIII -0.31171 
YER102W Ribosomal protein S8B (S14B) (rp19) (YS9),V -0.31261 
YMR172C-A Ymr172c-ap,XIII -0.3145 
YMR121C Ribosomal protein L15B (YL10) (L13B) (rp15R),XIII -0.31543 
YER103W member of 70 kDa heat shock protein family,V -0.31591 
YDR319C Ydr319cp,IV -0.31771 
YDR334W DEAH-box protein, putative RNA helicase,IV -0.32042 
YGR100W interacts with Mac1, a transcription factor that regulates genes involved in copper and iron utiliza,VII -0.32067 
YPL153C protein kinase, Mec1p and Tel1p regulate rad53p phosphorylation,XVI -0.32122 
YBL061C Probable Ca++ binding membrane protein (prenylated),II -0.32408 
YDR501W Plm2p,IV -0.32479 
YPR154W Ypr154wp,XVI -0.3282 
YIL086C Yil086cp,IX -0.32854 
YGR169C Ygr169cp,VII -0.3292 
YIR026C protein tyrosine phosphatase,IX -0.33513 
YGR117C Ygr117cp,VII -0.33637 
YGL061C Duo1p,VII -0.33978 
YBR109C Calmodulin,II -0.34607 
YIR022W signal peptidase subunit,IX -0.34778 
YLR224W Ylr224wp,XII -0.35069 
YHL008C Potential formate transporter nirC,VIII -0.35172 
YDL184C Ribosomal protein L41A (YL41) (L47A),IV -0.35176 
YNL048W Required for N-linked oligosaccharide assembly,XIV -0.35329 
YOR213C involved in silencing at telomeres, HML and HMR,XV -0.35348 
YMR122C Ymr122cp,XIII -0.35392 
YOR227W Yor227wp,XV -0.35648 
YKL068W Nuclear pore complex protein homologous to Nup116p,XI -0.35705 
YPL202C Ypl202cp,XVI -0.35757 
YLL026W 104 kDa heat shock protein,XII -0.35758 
YLL039C ubiquitin,XII -0.35793 
YDL124W Ydl124wp,IV -0.35814 
YGR161C Ygr161cp,VII -0.36199 
YDR476C Ydr476cp,IV -0.36267 
YNL198C Ynl198cp,XIV -0.36712 
YNL053W Dual-specificity protein tyrosine phosphatase,XIV -0.37225 
YER006W Yer006wp,V -0.37415 
YPL277C Ypl277cp,XVI -0.37468 
YNL252C mitochondrial ribosomal protein of the large subunit,XIV -0.38099 
YMR186W constitutively expressed heat shock protein,XIII -0.38208 
YKL045W p58 polypeptide of DNA primase,XI -0.3832 
YLR376C Ylr376cp,XII -0.38668 
YIL136W 45-kDa mitochondrial outer membrane protein,IX -0.39217 
YLR065C Ylr065cp,XII -0.39274 
YDL129W Ydl129wp,IV -0.39608 
YDL170W zinc-finger transcription factor of the Zn(2)-Cys(6) binuclear cluster domain type,IV -0.42189 
YDR279W Ydr279wp,IV -0.43057 
YGR095C Putative 3'->5' exoribonuclease; component of exosome complex of 3'->5' exonucleases,VII -0.43178 
YPR193C Histone acetyltransferase,XVI -0.43302 
YMR091C involved in nuclear protein targeting,XIII -0.43869 
YIL054W Yil054wp,IX -0.44009 
YDR044W Coproporphyrinogen III oxidase,IV -0.4445 
YGR234W Yhb1p,VII -0.44612 
YLR262C-A Ylr262c-ap,XII -0.44614 
YIL155C glycerol-3-phosphate dehydrogenase, mitochondrial,IX -0.45435 
YOR314W-A empty,XV -0.46392 
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YDR234W homoaconitase,IV -0.46424 
YKR044W Ykr044wp,XI -0.48095 
YER096W sporulation-specific homolog of csd4,V -0.48273 
YBL066C putative transcription factor,II -0.4871 
YLR119W may be involved in RNA export from nucleus,XII -0.49113 
YJL121C D-ribulose-5-Phosphate 3-epimerase,X -0.49366 
YBR129C involved in mating pathway,II -0.49556 
YER093C-A Yer093c-ap,V -0.49583 
YBR083W transcription factor of the TEA/ATTS DNA-binding domain family, regulator of Ty1 expression,II -0.49649 
YFL013C Yfl013cp,VI -0.50192 
YOR370C Rab geranylgeranyltransferase regulatory subunit,XV -0.50228 
YDR239C Ydr239cp,IV -0.50579 
YML090W Yml090wp,XIII -0.50947 
YFR057W Yfr057wp,VI -0.513 
YLL053C Yll053cp,XII -0.52689 
YLR351C nitrilase superfamily member,XII -0.54235 
YOR199W Yor199wp,XV -0.55216 
YPL096W peptide N-glycanase,XVI -0.55284 
YBL081W Ybl081wp,II -0.56902 
YOR119C similar to a C.elegans ZK632.3 protein,XV -0.57859 
YDR192C 42-kD protein associated with nuclear pore complexes; Nup42p is structurally related to the FG-nucle,IV -0.58636 
YLR078C ER-to-Golgi v-SNARE,XII -0.58708 
YBR012W-B TyB Gag-Pol protein.,II -0.58978 
YCR030C Ycr030cp,III -0.64918 
YBR181C 40S ribosomal gene product S6B (S10B) (rp9) (YS4),II -0.66505 
YLR228C involved in cell wall biogenesis (putative),XII -0.66863 
YIL108W Yil108wp,IX -0.67009 
YPR196W Ypr196wp,XVI -0.68082 
YJL148W unshared RNA polymerase I subunit,X -0.70742 
YOR242C involved in sporulation,XV -0.71122 
YPL171C NAD(P)H dehydrogenase,XVI -0.75453 
YJL051W Yjl051wp,X -0.77497 
YOR225W Yor225wp,XV -0.78218 
YDR324C Ydr324cp,IV -0.7959 
YOL144W Nucleolar protein required for 60S ribosome biogenesis,XV -0.8869 
YJR162C Yjr162cp,X -0.93801 
 
Table C.2 Statistically significant ORFS as determined using the Rank Products method of cross slide significance with 
p-critical value α = 0.01 with 100 random permutations used to calculate p. The resulting n = 560 significant ORFS are 
ordered by descending mean Fold Change below.  
ID DESCRIPTION 
FOLD 
CHANGE  
µ 
YJR029W Yjr029wp,X 1.078062 
YDR468C tSNARE that affects a Late Golgi compartment,IV 1.006164 
YNL088W topoisomerase II, Top2p localizes to axial cores in meiosis,XIV 0.886799 
YDR349C Yps7p,IV 0.815025 
YBR152W U4/U6.U5-associated snRNP protein; contains a PEST proteolysis motif,II 0.749022 
YIL120W MFS-MDR transporter,IX 0.701724 
YNR039C Zrg17p,XIV 0.678453 
YKL159C calcineurin inhibitor,XI 0.671458 
YLR100W 3-keto sterol reductase,XII 0.626096 
YKR085C 22.3 kDa mitochondrial ribosomal large subunit protein YmL20; homologous to L17 of E. coli,XI 0.575096 
YNL212W Vid27p,XIV 0.562389 
YPR105C Ypr105cp,XVI 0.547995 
YDR185C Ydr185cp,IV 0.546975 
YDR301W Component of pre-mRNA cleavage factor II (CFII); 150-kDa protein associated with polyadenylation fac,IV 0.527273 
YHL032C glyerol kinase (converts glycerol to glycerol-3-phosphate,VIII 0.520155 
YKR077W Ykr077wp,XI 0.512335 
YDR145W TFIID subunit,IV 0.508645 
YLR367W Ribosomal protein S22B (S24B) (rp50) (YS22),XII 0.508329 
YDR433W Ydr433wp,IV 0.499849 
YGR094W mitochondrial and cytoplasmic valyl-tRNA synthetase,VII 0.4913 
YDL206W Ydl206wp,IV 0.491186 
YKL175W Ykl175wp,XI 0.476485 
YDR072C inositolphosphotransferase 1,IV 0.475522 
YIL101C transcriptional repressor,IX 0.474573 
YNL281W Hch1p,XIV 0.472367 
YCR024C-A Proteolipid associated with plasma membrane H(+)-ATPase (Pma1p),III 0.465553 
YJR088C Yjr088cp,X 0.463448 
YPR002W Pdh1p,XVI 0.461579 
YGL201C component of MCM initiator complex involved in DNA replication,VII 0.46125 
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YDR017C Shows homology to basic leucine zipper family of transcription factors,IV 0.457248 
YJR063W A12.2 subunit of RNA polymerase I,X 0.454564 
YHR086W putative RNA binding protein, involved in meiosis-specific splicing of the REC107 transcripts in coo,VIII 0.453589 
YER183C 5,10-methenyltetrahydrofolate synthetase,V 0.452467 
YOR230W Transcriptional modulator,XV 0.452327 
YGR278W Ygr278wp,VII 0.450713 
YDL110C Ydl110cp,IV 0.450283 
YOR304C-A Yor304c-ap,XV 0.449276 
YIL125W alpha-ketoglutarate dehydrogenase,IX 0.448265 
YOL003C Yol003cp,XV 0.448071 
YLR026C Sed5p is a t-SNARE (soluble NSF attachment protein receptor) required in ER to Golgi transport.,XII 0.447072 
YJR134C Sgm1p,X 0.445812 
YML129C mitochondrial membrane protein,XIII 0.44464 
YDR204W involved in ubiquinone biosynthesis,IV 0.444033 
YMR066W (putative) involved in respiration,XIII 0.441278 
YJL074C SMC chromosomal ATPase family member,X 0.439693 
YCR092C mutS homolog, forms a complex with Msh2p to repair insertion-deletion mispairs; redundant with 
Pms3/,III 
0.439318 
YHR170W cytoplasmic factor required for a late cytoplasmic assembly step of the 60S subunit,VIII 0.438361 
YOL099C Yol099cp,XV 0.438138 
YJR140C regulator of histone transcription,X 0.436628 
YKL037W Ykl037wp,XI 0.436259 
YCR107W Hypothetical aryl-alcohol dehydrogenase (AAD),III 0.43557 
YAR029W membrane protein,I 0.430612 
YBL007C contains 3 SH3 domains, interacts with Bee1p,II 0.430422 
YCR014C DNA polymerase IV,III 0.426917 
YNL217W Ynl217wp,XIV 0.426311 
YDL154W MutS homolog involved in chromosome exchange,IV 0.417705 
YOR059C Yor059cp,XV 0.417619 
YOR033C exonuclease,XV 0.417436 
YDL114W Ydl114wp,IV 0.416841 
YDR336W Ydr336wp,IV 0.413551 
YIL063C Yrb2p,IX 0.412974 
YKL005C Ykl005cp,XI 0.412961 
YDR290W Ydr290wp,IV 0.412935 
YGR250C Ygr250cp,VII 0.412435 
YOR011W ABC (ATP-binding cassette) protein involved in Uptake of Sterols.,XV 0.411423 
YML081C-A protein associated to the ATP synthase,XIII 0.408165 
YDR096W putative zinc finger protein; repressor of PHR1 transcription,IV 0.407554 
YBR135W subunit of the Cdc28 protein kinase,II 0.405655 
YHR045W Yhr045wp,VIII 0.405552 
YLR132C Ylr132cp,XII 0.402998 
Q0085 ATP synthase subunit 6,Mito 0.402281 
YDR210W-C TyA gag protein.,IV 0.400562 
YDL015C Ydl015cp,IV 0.39922 
YPR110C RNA polymerase III (C) subunit,XVI 0.398209 
YAL064W Yal064wp,I 0.395557 
YPL242C Similar to mammalian IQGAP proteins,XVI 0.393369 
YJL208C mitochondrial nuclease,X 0.39231 
YEL075C Yel075cp,V 0.389993 
YLR058C serine hydroxymethyltransferase,XII 0.389216 
YJR058C Clathrin-associated protein, small subunit,X 0.388574 
YDR178W succinate dehydrogenase membrane anchor subunit,IV 0.388283 
YPR055W 121 kDa component of the Exocyst complex, which is required for exocytosis, and which also contains,XVI 0.388019 
YOL082W Yol082wp,XV 0.386781 
YLR054C Ylr054cp,XII 0.386294 
YGR055W high affinity methionine permease,VII 0.384154 
YNL167C CREB like repressor, bZIP protein that binds to CRE motifs, interacts with Mig1p,XIV 0.383892 
YCL031C involved in rRNA processing,III 0.381027 
YJR048W iso-1-cytochrome c,X 0.378643 
YMR164C Predicted 758 amino acid polypeptide with poly-glutamine and poly-asparagine domains,XIII 0.375863 
YJL131C Yjl131cp,X 0.375764 
YGR108W G(sub)2-specific B-type cyclin,VII 0.374916 
YLR088W Possible component of GPI protein transamidase,XII 0.372546 
YHR162W Yhr162wp,VIII 0.372466 
YNL023C Transcription factor homolog; similarity to Drosophila melanogaster shuttle craft protein; similarit,XIV 0.369095 
YAL014C Yal014cp,I 0.368348 
YGL040C delta-aminolevulinate dehydratase (porphobilinogen synthase),VII 0.367289 
YPL016W Zinc-finger transcription factor,XVI 0.366514 
YFR036W cell division control protein,VI 0.36571 
YDR525W Ydr525wp,IV 0.364672 
YKL085W mitochondrial malate dehydrogenase,XI 0.363964 
YJL214W hexose permease,X 0.363695 
YDR528W Hlr1p,IV 0.36324 
YJR055W involved in growth at high temperature,X 0.362048 
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YFR024C-A Yfr024c-ap,VI 0.360228 
YDR247W Ydr247wp,IV 0.360043 
YDR293C Ssd1p,IV 0.359903 
YLR194C Ylr194cp,XII 0.359353 
YNL199C Transcription factor,XIV 0.359259 
YIL147C histidine kinase osmosensor that regulates an osmosensing MAP kinase cascade and is similar to bacte,IX 0.357292 
YMR030W Ymr030wp,XIII 0.356992 
YBL042C uridine permease,II 0.356275 
YLR138W Putative Na+/H+ antiporter,XII 0.356027 
YMR201C human xeroderma pigmentosum group A DNA repair gene homolog,XIII 0.355599 
YOR103C 16-kDa, epsilon subunit of oligosaccharyltransferase complex; 40% identical to vertebrate DAD1 prote,XV 0.355528 
YDL224C Possible RNA binding protein. Homolog of Whi3.,IV 0.355364 
YLR025W involved in glucose derepression,XII 0.35484 
YDR248C Ydr248cp,IV 0.354549 
YKL105C Ykl105cp,XI 0.353805 
YGR166W involved in cell wall biogenesis,VII 0.352611 
YFL029C Cyclin-dependent kinase-activating kinase,VI 0.352578 
YLL050C Cofilin, actin binding and severing protein,XII 0.350937 
YGR248W Sol4p,VII 0.349305 
YJR109C carbamyl phosphate synthetase,X 0.349276 
YDR224C Histone H2B (HTB1 and HTB2 code for nearly identical proteins),IV 0.348131 
YPL278C Ypl278cp,XVI 0.347366 
YFR002W 96 kDa nucleoporin-interacting component,VI 0.346929 
YDR460W TFIIH subunit Tfb3 , contains ring finger motif; similar to mammalian CAK subunit,IV 0.34581 
YOR267C Yor267cp,XV 0.344108 
YOL117W Yol117wp,XV 0.34285 
YML018C Yml018cp,XIII 0.341639 
YBR127C vacuolar ATPase V1 domain subunit B (60 kDa),II 0.340653 
YER154W involved in cytochrome c oxidase and ATP synthase assembly,V 0.340019 
YFR026C Yfr026cp,VI 0.338664 
YFR008W Yfr008wp,VI 0.338432 
YGR116W transcriptional regulator, interacts with histones, primarily histone H3, possesses nucleosome assem,VII 0.33825 
YHR018C argininosuccinate lyase,VIII 0.33689 
YJR034W involved in cytochrome c oxidase assembly,X 0.33683 
YLL025W Yll025wp,XII 0.333618 
YPR151C Ypr151cp,XVI 0.333501 
YLR252W Ylr252wp,XII 0.33347 
YPL032C (putative) involved in vacuole function,XVI 0.332274 
YLR238W Ylr238wp,XII 0.331681 
YBL092W Ribosomal protein L32,II 0.331546 
YEL019C involved in DNA repair,V 0.330968 
YKR076W (putative) involved in cell wall biogenesis,XI 0.329951 
YFR019W type II PI(4)P5-kinase (PIP4,5 kinase) similar to human PIP5K-II,VI 0.327553 
YNL149C Ynl149cp,XIV 0.327472 
YBR222C Probable AMP-binding protein,II 0.326943 
YDR417C Ydr417cp,IV 0.324756 
YNL052W Cytochrome-c oxidase chain Va,XIV 0.32442 
YOL094C Subunit 4 of Replication Factor C; homologous to human RFC 40 kDa subunit,XV 0.323878 
YBL092W Ribosomal protein L32,II 0.321763 
YOL054W Yol054wp,XV 0.321241 
YGL131C Ygl131cp,VII 0.319445 
YKR067W Ykr067wp,XI 0.318509 
YGL093W component of spindle pole,VII 0.317197 
YOR307C homolog of chloroplast phosphate transporter,XV 0.313027 
YDR144C aspartyl protease related to Yap3p,IV 0.310916 
YGR011W Ygr011wp,VII 0.310379 
YNL318C Member of the hexose transporter family,XIV 0.309888 
YPR139C Ypr139cp,XVI 0.3085 
YHR123W sn-1,2-diacylglycerol ethanolamine- and cholinephosphotranferase,VIII 0.308381 
YIL009W Acyl CoA synthase,IX 0.308298 
YGL042C Ygl042cp,VII 0.307968 
YER004W Yer004wp,V 0.307051 
YGL258W-A empty,VII 0.306097 
YIL014C-A empty,IX 0.30608 
YMR040W Ymr040wp,XIII 0.303837 
YDR053W Ydr053wp,IV 0.303277 
YCL057C-A empty,III 0.302878 
YER103W member of 70 kDa heat shock protein family,V 0.302253 
YDR491C Ydr491cp,IV 0.301741 
YKL092C GTPase-activating protein (GAP) for Rsr1p/Bud1p,XI 0.301139 
YPL140C protein kinase,XVI 0.299801 
YNR052C Putative transcription factor,XIV 0.299221 
YOR339C homolog of ubiquitin carrier protein E2-C,XV 0.2987 
YJL106W Serine/Threonine protein kinase, positively regulated by IME1,X 0.297686 
YKL003C Mitochondrial ribosomal protein MRP17,XI 0.297037 
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YJR082C Yjr082cp,X 0.295221 
YCR087C-A Ycr087c-ap,III 0.292778 
YNL237W Similar to mitochondrial electron transport proteins.,XIV 0.292411 
YLL039C ubiquitin,XII 0.290604 
YIL057C Yil057cp,IX 0.29043 
YBR098W Mms4p,II 0.289348 
YPR064W Ypr064wp,XVI 0.288344 
YNL009W peroxisomal NADP-dependent isocitrate dehydrogenase,XIV 0.286016 
YKL152C Phosphoglycerate mutase,XI 0.28343 
YDR142C Member of beta-transducin-related (WD-40) protein family,IV 0.282754 
YDR042C Ydr042cp,IV 0.280199 
YBR175W Probable GTP-binding protein,II 0.280168 
YIL169C serine-, threonine-rich protein,IX 0.279574 
YMR020W Fms1p,XIII 0.277842 
YLR359W Adenylosuccinate Lyase,XII 0.27701 
YIR031C Malate synthase 2,IX 0.27328 
YPL173W Mitochondrial ribosomal protein MRPL40 (YmL40),XVI 0.271881 
YFL039C Actin,VI 0.271489 
YCR099C Ycr099cp,III 0.270132 
YBR122C Mitochondrial ribosomal protein MRPL36 (YmL36),II 0.268751 
YPR177C Ypr177cp,XVI 0.267924 
YDR352W Ydr352wp,IV 0.267624 
YGL010W Ygl010wp,VII 0.267591 
YGL168W Ygl168wp,VII 0.267236 
YJR070C Yjr070cp,X 0.265854 
YGL083W similar to bovine rhodopsin kinase; suppressor of GTPase mutation,VII 0.265236 
YKR079C Ykr079cp,XI 0.264107 
YIL077C Yil077cp,IX 0.262855 
YJR083C Yjr083cp,X 0.262428 
YJL039C Nup192p,X 0.262013 
YHR161C clathrin assembly protein,VIII 0.260468 
YNL099C Ynl099cp,XIV 0.260465 
YOR233W protein kinase,XV 0.258321 
YGL129C protein of the small subunit of the mitochondrial ribosome,VII 0.257589 
YPL185W Ypl185wp,XVI 0.255973 
YPL073C Ypl073cp,XVI 0.254084 
YPL016W Zinc-finger transcription factor,XVI 0.2527 
YOL122C has been localized to both the plasma membrane and the mitochondrial membrane,XV 0.252639 
YMR316C-A Ymr316c-ap,XIII 0.250391 
YDL203C Ydl203cp,IV 0.248264 
YNR038W putative RNA helicase,XIV 0.247417 
YBR123C transcription factor tau (TFIIIC) subunit 95,II 0.247027 
YBR276C dual specificity protein phosphatase,II 0.246849 
YMR234W ribonuclease H,XIII 0.244345 
YCL009C Small regulatory subunit of Acetolactate synthase,III 0.242794 
YLR093C vacuolar v-SNARE,XII 0.236409 
YBR126C 56 kD synthase subunit of trehalose-6-phosphate synthase/phosphatase complex,II 0.234933 
YPL012W Ypl012wp,XVI 0.23412 
YFL039C Actin,VI 0.232349 
YMR233W Ymr233wp,XIII 0.231109 
YMR307W cell surface glycoprotein 115-120 kDa,XIII 0.22829 
YGR277C Ygr277cp,VII 0.227063 
YPL106C HSP70 family member, highly homologous to Ssa1p and Sse2p,XVI 0.22635 
YOR291W Yor291wp,XV 0.225568 
YDR531W Ydr531wp,IV 0.219989 
YPR137W U3 small nucleolar ribonucleoprotein-associated protein involved in pre-ribosomal RNA processing.,XVI 0.213812 
YNL051W Ynl051wp,XIV 0.212564 
YCR020C Transcription regulator,III 0.203111 
YEL004W similar to Gog5, which is involved in vanadate resistance,V 0.198113 
YFL041W multicopper oxidase, type 1 integral membrane protein,VI 0.190956 
YDR402C Cytochrome P450 56, Dit2p catalyzes oxidation of N-formyl tyrosine to N,N-bisformyl dityrosine in vi,IV 0.19069 
YHR181W Yhr181wp,VIII 0.189339 
YLR024C ubiquitin-protein ligase (E3),XII 0.186677 
YML096W Yml096wp,XIII 0.182719 
YJR012C Yjr012cp,X 0.177628 
YFL065C Yfl065cp,VI 0.176803 
YMR058W multicopper oxidase,XIII 0.172808 
YMR058W multicopper oxidase,XIII 0.172808 
YLR105C tRNA splicing endonuclease subunit,XII 0.167913 
YGL074C Ygl074cp,VII 0.166518 
YLL026W 104 kDa heat shock protein,XII 0.163231 
YIL053W DL-glycerol-3-phosphatase,IX 0.160424 
YCL037C RNA binding protein with La motif,III 0.151159 
YDR447C Ribosomal protein S17B (rp51B),IV 0.140308 
YDR475C Ydr475cp,IV 0.139164 
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YNL280C sterol C-14 reductase,XIV 0.133343 
YKL013C involved in cortical actin patch integrity,XI 0.124904 
YJL155C Fructose-2,6-biphosphatase,X 0.079974 
YDR459C Ydr459cp,IV 0.02034 
YNL242W Required for sporulation.,XIV 0.005238 
YGR223C Ygr223cp,VII -0.08671 
YPR188C putative light chain for Myo1p,XVI -0.11734 
YDR343C Hexose transporter,IV -0.15031 
YNL219C mannosyltransferase,XIV -0.15068 
YNL309W Interacts with the putative transcription factor Sin3p,XIV -0.16182 
YML077W Bet5p/18kD component of TRAPP,XIII -0.16917 
YFL012W Yfl012wp,VI -0.1898 
YOR238W Yor238wp,XV -0.19283 
YER068W putative zinc finger protein,V -0.19411 
YGL097W pheromone response pathway suppressor,VII -0.2013 
YPL264C Ypl264cp,XVI -0.20526 
YMR316C-B Ymr316c-bp,XIII -0.20948 
YBR042C Probable membrane-bound small GTPase,II -0.21337 
YBL091C methionine aminopeptidase 2,II -0.21732 
YIL039W Yil039wp,IX -0.22076 
YKL075C Ykl075cp,XI -0.23892 
YMR293C Ymr293cp,XIII -0.23982 
YIL158W Yil158wp,IX -0.24002 
YMR184W Ymr184wp,XIII -0.24232 
YMR119W-A Ymr119w-ap,XIII -0.24795 
YKL087C cytochrome c1 heme lyase,XI -0.24927 
YKL179C kinesin-like protein,XI -0.24987 
YLR453C Nuclear protein,XII -0.25151 
YDR525W-A Ydr525w-ap,IV -0.25423 
YLR399C Bdf1p contains two bromodomains, localizes to the nucleus and to chomosomes in spread meiotic 
nuclei,XII 
-0.25581 
YJL097W Yjl097wp,X -0.25814 
YGR236C Spg1p,VII -0.25823 
YMR265C Ymr265cp,XIII -0.26041 
YCL038C Membrane transporter,III -0.26157 
YJL025W member of yeast Pol I core factor (CF) also composed of Rrn11p, Rrn6p and TATA-binding protein,X -0.26202 
YGL036W Mtc2p,VII -0.26646 
YOR164C Yor164cp,XV -0.26678 
YLR059C RNA exonuclease,XII -0.26737 
YLR355C acetohydroxyacid reductoisomerase,XII -0.27025 
YOR012W Yor012wp,XV -0.27088 
YJL063C Mitochondrial ribosomal protein MRPL8 (YmL8) (E. coli L17),X -0.27205 
YLR212C gamma tubulin-like protein, interacts with Spc98p and Spc97p, the Tub4p-Spc98p-Spc97p complex may 
be,XII 
-0.27408 
YEL046C Threonine Aldolase,V -0.27554 
YMR034C Ymr034cp,XIII -0.27847 
YHR072W 2,3-oxidosqualene-lanosterol cyclase,VIII -0.27866 
YOL103W-B TyB Gag-Pol protein.,XV -0.28086 
YGR070W Rho1 GDP/GTP exchange protein,VII -0.2817 
YIL160C peroxisomal 3-oxoacyl CoA thiolase,IX -0.28296 
YGR036C CAX4p contains 3 short stretches of amino acids that are characteristic for a wide variety of phosph,VII -0.28336 
YAL017W Serine/threonine kinase,I -0.28476 
YFR041C Yfr041cp,VI -0.28813 
YOR148C spliceosome-associated protein,XV -0.28831 
YOL005C RNA polymerase II subunit, homologous to S. pombe Rpb11p subunit,XV -0.28951 
YDL116W Protein with homology to mammalian Nup107p,IV -0.29001 
YEL033W Yel033wp,V -0.29044 
YMR273C Zds1p,XIII -0.29401 
YER078C Yer078cp,V -0.29577 
YGR046W Ygr046wp,VII -0.29606 
YJR130C Cystathionine gamma-synthase,X -0.29632 
YPL146C Ypl146cp,XVI -0.29724 
YMR101C cis-prenyltransferase homologue,XIII -0.29742 
YDL034W Ydl034wp,IV -0.29764 
YBL033C GTP cyclohydrolase II,II -0.29883 
YOR072W Yor072wp,XV -0.2989 
YPL025C Ypl025cp,XVI -0.30176 
YHR021W-A (putative) involved in cell wall biogenesis,VIII -0.30228 
YOL049W Glutathione Synthetase,XV -0.30255 
YLR012C Ylr012cp,XII -0.30281 
YKL017C DNA helicase A,XI -0.30299 
YCR049C Ycr049cp,III -0.30389 
YMR055C involved in cell cycle checkpoint,XIII -0.30456 
YJR121W F(1)F(0)-ATPase complex beta subunit, mitochondrial,X -0.30466 
YKL199C Ykt9p,XI -0.30623 
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YDL234C GTPase-activating protein,IV -0.30828 
YAL034C-B empty,I -0.30873 
YPL061W Cytosolic Aldehyde Dehydrogenase,XVI -0.30909 
YDR355C Ydr355cp,IV -0.31108 
YPL064C Ypl064cp,XVI -0.31109 
YGL195W translational activator of GCN4 through activation of GCN2 in response to starvation,VII -0.31111 
YKL056C Ykl056cp,XI -0.3112 
YML127W Yml127wp,XIII -0.31171 
YLR430W component of a nuclear-localized tRNA splicing complex,XII -0.31225 
YER102W Ribosomal protein S8B (S14B) (rp19) (YS9),V -0.31261 
YER103W member of 70 kDa heat shock protein family,V -0.31591 
YHR159W Yhr159wp,VIII -0.31606 
YDL009C Ydl009cp,IV -0.31678 
YLR299W gamma-glutamyltransferase homolog,XII -0.31683 
YJL180C (putative) involved F1F0-ATPase complex assembly,X -0.31698 
YFL063W Yfl063wp,VI -0.31898 
YHR120W mutS homolog involved in mitochondrial DNA repair,VIII -0.32024 
YDR334W DEAH-box protein, putative RNA helicase,IV -0.32042 
YGR100W interacts with Mac1, a transcription factor that regulates genes involved in copper and iron utiliza,VII -0.32067 
YOR150W mitochondrial ribosomal protein of the large subunit,XV -0.32099 
YPL153C protein kinase, Mec1p and Tel1p regulate rad53p phosphorylation,XVI -0.32122 
YHR001W 60kD chaperonin (weak),VIII -0.32207 
YER098W ubiquitin carboxyl-terminal hydrolase,V -0.32325 
YDR274C Ydr274cp,IV -0.32391 
YBL061C Probable Ca++ binding membrane protein (prenylated),II -0.32408 
YDR501W Plm2p,IV -0.32479 
YMR299C Ymr299cp,XIII -0.3254 
YIL115C 159-kDa nucleoporin with coiled-coil domain and repeated motifs typical of nucleoporins,IX -0.32598 
YJL115W involved in silencing,X -0.32608 
YFR031C-A Ribosomal protein L2A (L5A) (rp8) (YL6),VI -0.32659 
YNL041C Ynl041cp,XIV -0.32714 
YPR154W Ypr154wp,XVI -0.3282 
YDL025C Ydl025cp,IV -0.32875 
YGR169C Ygr169cp,VII -0.3292 
YPL034W Ypl034wp,XVI -0.3293 
YJL126W nitrilase superfamily member,X -0.32939 
YJR154W Yjr154wp,X -0.32955 
YPL042C a cyclin(SSN8)-dependent serine/threonine protein kinase,XVI -0.32993 
YPR049C Ypr049cp,XVI -0.33174 
YBL051C Ybl051cp,II -0.33179 
YPL219W cyclin (Pho85p),XVI -0.33379 
YCL030C histidinol dehydrogenase,III -0.33382 
YOR067C glycosyl transferase,XV -0.33426 
YDL213C Ydl213cp,IV -0.33502 
YIR026C protein tyrosine phosphatase,IX -0.33513 
YLR408C Ylr408cp,XII -0.33535 
YOR089C small GTP-binding protein; geranylgeranylated; geranylgeranylation required for membrane 
association,XV 
-0.33558 
YDR272W Cytoplasmic glyoxylase-II,IV -0.33616 
YJL052W Glyceraldehyde-3-phosphate dehydrogenase 1,X -0.33651 
YPR161C CDC28/cdc2 related protein kinase,XVI -0.33672 
YPR132W Ribosomal protein S23B (S28B) (rp37) (YS14),XVI -0.3397 
YGL061C Duo1p,VII -0.33978 
YKL073W novel member of the Hsp70 family of molecular chaperones that localizes to the lumen of the endoplas,XI -0.34089 
YGL172W nuclear pore complex protein with GLFG repetitive sequence motif,VII -0.34205 
YBR092C Acid phosphatase, constitutive,II -0.34271 
YGR032W catalytic component of 1,3-beta-D-glucan synthase,VII -0.34362 
YKL093W MBR1 protein precursor,XI -0.34439 
YGL158W Serine/threonine protein kinase,VII -0.34545 
YBR109C Calmodulin,II -0.34607 
YMR244C-A Ymr244c-ap,XIII -0.34711 
YLR212C gamma tubulin-like protein, interacts with Spc98p and Spc97p, the Tub4p-Spc98p-Spc97p complex may 
be,XII 
-0.34715 
YOL159C-A empty,XV -0.34728 
YPL224C involved in mitochondrial iron accumulation,XVI -0.34746 
YIR022W signal peptidase subunit,IX -0.34778 
YPL221W Bop1p,XVI -0.349 
YBR062C Ybr062cp,II -0.34956 
YLR224W Ylr224wp,XII -0.35069 
YHL008C Potential formate transporter nirC,VIII -0.35172 
YDL184C Ribosomal protein L41A (YL41) (L47A),IV -0.35176 
YNL048W Required for N-linked oligosaccharide assembly,XIV -0.35329 
YDR268W mitochondrial tryptophanyl-tRNA synthetase,IV -0.35343 
YOR213C involved in silencing at telomeres, HML and HMR,XV -0.35348 
YJL109C Yjl109cp,X -0.35356 
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YMR122C Ymr122cp,XIII -0.35392 
YGR172C Golgi integral membrane protein, interacts with Ypt proteins,VII -0.35414 
YLR285W Ylr285wp,XII -0.35561 
YIR016W Yir016wp,IX -0.35584 
YIL069C 40S ribosomal protein S24B,IX -0.35667 
YKL068W Nuclear pore complex protein homologous to Nup116p,XI -0.35705 
YPL202C Ypl202cp,XVI -0.35757 
YLL026W 104 kDa heat shock protein,XII -0.35758 
YDR320C Auxilin-like protein,IV -0.35785 
YLL039C ubiquitin,XII -0.35793 
YDL124W Ydl124wp,IV -0.35814 
YNL272C GDP/GTP exchange factor for Sec4p,XIV -0.36037 
YHL026C Yhl026cp,VIII -0.36071 
YKR055W ras homolog--GTP binding protein,XI -0.36114 
YDL176W Ydl176wp,IV -0.36115 
YGR161C Ygr161cp,VII -0.36199 
YDR510W ubiquitin-like protein,IV -0.36264 
YDR476C Ydr476cp,IV -0.36267 
YGL113W Ygl113wp,VII -0.36314 
YBL005W-B TyB Gag-Pol protein.,II -0.36317 
YOR094W GTP-binding ADP-ribosylation factor,XV -0.36336 
YLR071C component of RNA polymerase II holoenzyme/mediator complex, interacts with Sin4p, Gal11p, and a 50 
k,XII 
-0.36386 
YHR113W Vacuolar aminopeptidase,VIII -0.36436 
YPL281C Similar to enolase,XVI -0.3646 
YBR094W Ybr094wp,II -0.36466 
YML098W TFIID subunit,XIII -0.36519 
YJR051W osmotic growth protein,X -0.36554 
YDR236C Riboflavin kinase,IV -0.36606 
YOR195W possible leucine zipper,XV -0.36677 
YGL133W A subunit of Isw2 chromatin remodeling complex,VII -0.36688 
YBR181C 40S ribosomal gene product S6B (S10B) (rp9) (YS4),II -0.36695 
YNL198C Ynl198cp,XIV -0.36712 
YKL095W Yju2p,XI -0.37013 
YNL053W Dual-specificity protein tyrosine phosphatase,XIV -0.37225 
YPR097W Ypr097wp,XVI -0.3729 
YER006W Yer006wp,V -0.37415 
YPL277C Ypl277cp,XVI -0.37468 
YER148W TATA-binding protein (tfIId),V -0.37468 
YNL025C C-type cyclin associated with the Ssn3p cyclin-dependent kinase,XIV -0.37736 
YEL026W U4/U6.U5 snRNP component,V -0.37928 
YGR038C-A TyA gag protein.,VII -0.37958 
YNL252C mitochondrial ribosomal protein of the large subunit,XIV -0.38099 
YMR186W constitutively expressed heat shock protein,XIII -0.38208 
YKL045W p58 polypeptide of DNA primase,XI -0.3832 
YKL061W Ykl061wp,XI -0.38321 
YLR376C Ylr376cp,XII -0.38668 
YGR065C H+-biotin symporter,VII -0.3889 
YFL013W-A Yfl013w-ap,VI -0.38914 
YIL136W 45-kDa mitochondrial outer membrane protein,IX -0.39217 
YLR065C Ylr065cp,XII -0.39274 
YHL020C negative regulator of phospholipid biosynthesis,VIII -0.39586 
YDL129W Ydl129wp,IV -0.39608 
YHR200W homolog of the mammalian S5a protein, component of 26S proteasome,VIII -0.39795 
YJL107C Yjl107cp,X -0.39821 
YDR004W RecA homolog (similar to DMC1, RAD51, and RAD55), interacts with Rad 55p by two-hybrid analysis,IV -0.40008 
YIL143C DNA helicase homolog; homolog of human XPBC, ERCC3,IX -0.40067 
YDR538W Phenylacrylic acid decarboxylase,IV -0.40089 
YCR006C Ycr006cp,III -0.40276 
YGL019W beta (38kDa) subunit of casein kinase II (CKII),VII -0.4076 
YNL316C prephenate dehydratase,XIV -0.40889 
YFL023W Yfl023wp,VI -0.41569 
YPR075C Opy2p,XVI -0.41662 
YDL101C protein kinase,IV -0.41705 
YKL225W Ykl225wp,XI -0.4173 
YNL120C Ynl120cp,XIV -0.41949 
YBR161W exhibits high homology to Sur1p,II -0.4209 
YDL170W zinc-finger transcription factor of the Zn(2)-Cys(6) binuclear cluster domain type,IV -0.42189 
YOR087W Yor087wp,XV -0.42237 
YPL200W Ypl200wp,XVI -0.42262 
YDR173C dual-specificity inositol 1,4,5-trisphosphate 6-kinase/inositol 1,4,5,6-tetrakisphosphate 3-kinase (,IV -0.4233 
YNL115C Ynl115cp,XIV -0.42545 
YDR170C Guanine nucleotide exchange protein for ARF,IV -0.42763 
YDR279W Ydr279wp,IV -0.43057 
YMR080C putative helicase,XIII -0.43128 
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YGR095C Putative 3'->5' exoribonuclease; component of exosome complex of 3'->5' exonucleases,VII -0.43178 
YGL203C carboxypeptidase B-like processing protease,VII -0.43275 
YPR193C Histone acetyltransferase,XVI -0.43302 
YPL243W component of signal recognition particle,XVI -0.43308 
YLL060C Glutathione transferase,XII -0.43442 
YGR158C nucleolar protein involved in mRNA transport,VII -0.43769 
YJR062C 52-kDa amidase specific for N-terminal asparagine and glutamine,X -0.43833 
YMR091C involved in nuclear protein targeting,XIII -0.43869 
YIL054W Yil054wp,IX -0.44009 
YMR096W encodes highly conserved 35 kDa protein that shows increased expression after entry into stationary,XIII -0.44025 
YEL071W D-lactate dehydrogenase,V -0.4411 
YML108W Yml108wp,XIII -0.44321 
YDR044W Coproporphyrinogen III oxidase,IV -0.4445 
YKR057W Ribosomal protein S21A (S26A) (YS25),XI -0.44457 
YGR234W Yhb1p,VII -0.44612 
YLR262C-A Ylr262c-ap,XII -0.44614 
YDL113C Ydl113cp,IV -0.44991 
YIL155C glycerol-3-phosphate dehydrogenase, mitochondrial,IX -0.45435 
YLR445W Ylr445wp,XII -0.45578 
YJL001W Subunit of 20S proteasome,X -0.45682 
YGR210C Ygr210cp,VII -0.46172 
YJR011C Yjr011cp,X -0.46199 
YOR314W-A empty,XV -0.46392 
YDR234W homoaconitase,IV -0.46424 
YCR051W Ycr051wp,III -0.46494 
YKL060C aldolase,XI -0.46624 
YPL078C F(1)F(0)-ATPase complex delta subunit, mitochondrial,XVI -0.46757 
YMR306C-A Ymr306c-ap,XIII -0.46844 
YGL263W similar to subtelomerically-encoded proteins,VII -0.46931 
YMR122W-A empty,XIII -0.47478 
YKR044W Ykr044wp,XI -0.48095 
YIL165C Yil165cp,IX -0.48192 
YER096W sporulation-specific homolog of csd4,V -0.48273 
YBL066C putative transcription factor,II -0.4871 
YGR191W histidine permease,VII -0.48763 
YJR084W Yjr084wp,X -0.48926 
YLR119W may be involved in RNA export from nucleus,XII -0.49113 
YJL121C D-ribulose-5-Phosphate 3-epimerase,X -0.49366 
YBR129C involved in mating pathway,II -0.49556 
YER093C-A Yer093c-ap,V -0.49583 
YBR083W transcription factor of the TEA/ATTS DNA-binding domain family, regulator of Ty1 expression,II -0.49649 
YNR029C Ynr029cp,XIV -0.49859 
YPL024W involved in cell separation,XVI -0.49925 
YFL013C Yfl013cp,VI -0.50192 
YOR370C Rab geranylgeranyltransferase regulatory subunit,XV -0.50228 
YDR239C Ydr239cp,IV -0.50579 
YER103W member of 70 kDa heat shock protein family,V -0.50922 
YML090W Yml090wp,XIII -0.50947 
YFR057W Yfr057wp,VI -0.513 
YDR069C ubiquitin isopeptidase,IV -0.52027 
YLL053C Yll053cp,XII -0.52689 
YLR351C nitrilase superfamily member,XII -0.54235 
YJR103W CTP synthase,X -0.54397 
YDR347W 37 kDa mitochondrial ribosomal protein,IV -0.54923 
YOR199W Yor199wp,XV -0.55216 
YPL096W peptide N-glycanase,XVI -0.55284 
YHR067W Yhr067wp,VIII -0.55993 
YMR063W involved in sporulation,XIII -0.56209 
YBL081W Ybl081wp,II -0.56902 
YOR119C similar to a C.elegans ZK632.3 protein,XV -0.57859 
YLR156W Ylr156wp,XII -0.57864 
YDR192C 42-kD protein associated with nuclear pore complexes; Nup42p is structurally related to the FG-nucle,IV -0.58636 
YLR078C ER-to-Golgi v-SNARE,XII -0.58708 
YBR012W-B TyB Gag-Pol protein.,II -0.58978 
YGL255W high-affinity zinc transport protein,VII -0.59704 
YPR072W member of the NOT complex, a global negative regulator of transcription,XVI -0.60713 
YKL123W Ykl123wp,XI -0.60923 
YFL039C Actin,VI -0.62403 
YKR084C Hbs1p,XI -0.64041 
YHR153C sporulation protein,VIII -0.64672 
YCR030C Ycr030cp,III -0.64918 
YBR181C 40S ribosomal gene product S6B (S10B) (rp9) (YS4),II -0.66505 
YLR228C involved in cell wall biogenesis (putative),XII -0.66863 
YIL108W Yil108wp,IX -0.67009 
YAR042W ankyrin repeat,I -0.67306 
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YPR196W Ypr196wp,XVI -0.68082 
YJL148W unshared RNA polymerase I subunit,X -0.70742 
YMR153W Component of karyopherin docking complex of the nuclear pore complex,XIII -0.70875 
YGL120C RNA helicase,VII -0.7111 
YOR242C involved in sporulation,XV -0.71122 
YPL171C NAD(P)H dehydrogenase,XVI -0.75453 
YJL051W Yjl051wp,X -0.77497 
YOR225W Yor225wp,XV -0.78218 
YDR324C Ydr324cp,IV -0.7959 
YML123C inorganic phosphate transporter, transmembrane protein,XIII -0.81662 
YOL144W Nucleolar protein required for 60S ribosome biogenesis,XV -0.8869 
YJR162C Yjr162cp,X -0.93801 
 
 
 
Table C.3  Statistically significant ORFs as determined by SAM employing Tusher et al’s method (100 random 
permutations) and the 10 k-nearest neighbors to impute missing or null values.  The resulting n = 207 significant ORFs 
are ordered by mean Fold-Change below. 
ID DESCRIPTION µ FC 
YDR468C tSNARE that affects a Late Golgi compartment,IV 1.006164 
YNL088W topoisomerase II, Top2p localizes to axial cores in meiosis,XIV 0.886799 
YIL120W MFS-MDR transporter,IX 0.701724 
YKL159C calcineurin inhibitor,XI 0.671458 
YPR105C Ypr105cp,XVI 0.547995 
YDR301W Component of pre-mRNA cleavage factor II (CFII); 150-kDa protein associated with polyadenylation fac,IV 0.527273 
YHL032C glyerol kinase (converts glycerol to glycerol-3-phosphate,VIII 0.520155 
YLR367W Ribosomal protein S22B (S24B) (rp50) (YS22),XII 0.508329 
YIL101C transcriptional repressor,IX 0.474573 
YNL281W Hch1p,XIV 0.472367 
YCR024C-A Proteolipid associated with plasma membrane H(+)-ATPase (Pma1p),III 0.465553 
YJR088C Yjr088cp,X 0.463448 
YGL201C component of MCM initiator complex involved in DNA replication,VII 0.46125 
YDR017C Shows homology to basic leucine zipper family of transcription factors,IV 0.457248 
YER183C 5,10-methenyltetrahydrofolate synthetase,V 0.452467 
YOR230W Transcriptional modulator,XV 0.452327 
YOL003C Yol003cp,XV 0.448071 
YLR026C Sed5p is a t-SNARE (soluble NSF attachment protein receptor) required in ER to Golgi transport.,XII 0.447072 
YML129C mitochondrial membrane protein,XIII 0.44464 
YMR066W (putative) involved in respiration,XIII 0.441278 
YCR107W Hypothetical aryl-alcohol dehydrogenase (AAD),III 0.43557 
YNL217W Ynl217wp,XIV 0.426311 
YDL114W Ydl114wp,IV 0.416841 
YKL005C Ykl005cp,XI 0.412961 
YBR135W subunit of the Cdc28 protein kinase,II 0.405655 
YHR045W Yhr045wp,VIII 0.405552 
YLR132C Ylr132cp,XII 0.402998 
YDR210W-C TyA gag protein.,IV 0.400562 
YPR110C RNA polymerase III (C) subunit,XVI 0.398209 
YPL242C Similar to mammalian IQGAP proteins,XVI 0.393369 
YJR058C Clathrin-associated protein, small subunit,X 0.388574 
YDR178W succinate dehydrogenase membrane anchor subunit,IV 0.388283 
YCL031C involved in rRNA processing,III 0.381027 
YMR164C Predicted 758 amino acid polypeptide with poly-glutamine and poly-asparagine domains,XIII 0.375863 
YHR162W Yhr162wp,VIII 0.372466 
YNL023C Transcription factor homolog; similarity to Drosophila melanogaster shuttle craft protein; similarit,XIV 0.369095 
YGL040C delta-aminolevulinate dehydratase (porphobilinogen synthase),VII 0.367289 
YPL016W Zinc-finger transcription factor,XVI 0.366514 
YFR036W cell division control protein,VI 0.36571 
YDR528W Hlr1p,IV 0.36324 
YDR247W Ydr247wp,IV 0.360044 
YNL199C Transcription factor,XIV 0.359259 
YIL147C histidine kinase osmosensor that regulates an osmosensing MAP kinase cascade and is similar to bacte,IX 0.357292 
YMR030W Ymr030wp,XIII 0.356992 
YDL224C Possible RNA binding protein. Homolog of Whi3.,IV 0.355364 
YLL050C Cofilin, actin binding and severing protein,XII 0.350937 
YPL278C Ypl278cp,XVI 0.347366 
YFR002W 96 kDa nucleoporin-interacting component,VI 0.346929 
YOL117W Yol117wp,XV 0.34285 
YER154W involved in cytochrome c oxidase and ATP synthase assembly,V 0.340019 
YLR252W Ylr252wp,XII 0.333469 
YEL019C involved in DNA repair,V 0.330968 
YFR019W type II PI(4)P5-kinase (PIP4,5 kinase) similar to human PIP5K-II,VI 0.327553 
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YNL052W Cytochrome-c oxidase chain Va,XIV 0.32442 
YOL094C Subunit 4 of Replication Factor C; homologous to human RFC 40 kDa subunit,XV 0.323878 
YOL054W Yol054wp,XV 0.321241 
YGL131C Ygl131cp,VII 0.319445 
YER077C Yer077cp,V 0.318935 
YGL093W component of spindle pole,VII 0.317197 
YOR307C homolog of chloroplast phosphate transporter,XV 0.313027 
YMR289W Ymr289wp,XIII 0.31302 
YOR221C malonyl-CoA ACP transferase,XV 0.312324 
YPL085W vesicle coat component,XVI 0.311289 
YLR390W involved in cell wall biogenesis,XII 0.310755 
YOR117W 26S protease regulatory subunit,XV 0.309825 
YGL042C Ygl042cp,VII 0.307969 
YKR047W Ykr047wp,XI 0.305636 
YER103W member of 70 kDa heat shock protein family,V 0.302253 
YKL092C GTPase-activating protein (GAP) for Rsr1p/Bud1p,XI 0.301139 
YJR082C Yjr082cp,X 0.295221 
YDR441C Apt2p,IV 0.294354 
YNR019W Acyl-CoA cholesterol acyltransferase (sterol-ester synthetase),XIV 0.29384 
YLR183C Tos4p,XII 0.293759 
YJR089W Bir1p,X 0.293729 
YHR212C Yhr212cp,VIII 0.29359 
YBR119W U1 snRNP A protein,II 0.288715 
YPR064W Ypr064wp,XVI 0.288344 
YGR162W mRNA cap-binding protein (eIF-4F), 150K subunit , highly homologous to Tif4632p, homologs of mammali,VII 0.288022 
YNL009W peroxisomal NADP-dependent isocitrate dehydrogenase,XIV 0.286016 
YKL006C-A intra-Golgi v-SNARE,XI 0.285371 
YIR041W Yir041wp,IX 0.284957 
YLR184W Ylr184wp,XII 0.284757 
YKL081W Translation elongation factor EF-1gamma,XI 0.284327 
YCR057C regulatory protein,III 0.28098 
YKR063C Las1p,XI 0.280775 
YAR008W 34kDa subunit of the tetrameric tRNA splicing endonuclease,I 0.27816 
YAL019W SNF2 protein family,I 0.278074 
YHR089C small nucleolar RNP proteins,VIII 0.277755 
YJR096W Yjr096wp,X 0.276618 
YGL034C Ygl034cp,VII 0.276553 
YNL263C Similar to NADH dehydrogenases,XIV 0.274743 
YBR181C 40S ribosomal gene product S6B (S10B) (rp9) (YS4),II 0.272932 
YCR097W-A empty,III 0.272787 
YIR025W Yir025wp,IX 0.267832 
YFR055W Yfr055wp,VI 0.267138 
YMR136W Gat2p,XIII 0.265543 
YMR057C Ymr057cp,XIII 0.265532 
YLR212C gamma tubulin-like protein, interacts with Spc98p and Spc97p, the Tub4p-Spc98p-Spc97p complex may be,XII 0.265067 
YJR101W protein of the small subunit of the mitochondrial ribosome,X 0.263682 
YLR326W Ylr326wp,XII 0.263317 
YPL109C Ypl109cp,XVI 0.261967 
YKR081C Ykr081cp,XI 0.261608 
YHR150W Yhr150wp,VIII 0.257766 
YDL204W Ydl204wp,IV 0.257418 
YFL058W a thiamine regulated pyrimidine precursor biosynthesis enzyme,VI 0.253659 
YDL196W Ydl196wp,IV 0.251206 
YOR326W class V myosin,XV 0.250956 
YMR109W myosin I,XIII 0.246068 
YNL179C Ynl179cp,XIV 0.24362 
YLR274W MCM initiator complex protein,XII 0.240965 
YMR216C Serine Protein Kinase,XIII 0.239455 
YJR020W Yjr020wp,X 0.238921 
YKL042W component of the spindle pole body,XI 0.234602 
YGR189C Cell wall protein,VII 0.229675 
YLR240W phosphatidylinositol 3-kinase,XII 0.22073 
YDR215C Ydr215cp,IV 0.217689 
YHR139C sporulation-specific wall maturation protein,VIII 0.213793 
YIL044C ARF GAP with effector function(s),IX 0.212826 
YCR053W threonine synthase,III 0.209782 
YBL085W BEM1-binding protein,II 0.209175 
YNL202W peroxisomal 2,4-dienoyl-CoA reductase,XIV 0.208989 
YOR102W Yor102wp,XV 0.207427 
YCR077C Pat1p,III 0.203858 
YOR332W vacuolar ATPase V1 domain subunit E (27 kDa),XV 0.200155 
YDR448W transcription factor, member of ADA and SAGA, two transcriptional adaptor/HAT (histone acetyltransfe,IV 0.199944 
YCL064C catabolic serine (threonine) dehydratase,III 0.199037 
YLR213C Crr1p,XII 0.193693 
YDR172W translation termination factor eRF3,IV 0.190706 
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YJR003C Yjr003cp,X 0.188469 
YER137C Yer137cp,V 0.178473 
YOL031C Yol031cp,XV 0.178258 
YCR096C Regulatory protein MATa2p (no known function); sequence is the same as the last 119 residues of MATa,III 0.162877 
YCR039C Mating type protein alpha-2,III 0.134541 
YJR001W Yjr001wp,X -0.16086 
YNL142W Ammonia transport protein,XIV -0.18875 
YOR091W Yor091wp,XV -0.19821 
YPR146C Ypr146cp,XVI -0.19838 
YJR008W Yjr008wp,X -0.22581 
YER031C Ypt31p,V -0.22684 
YMR156C Ymr156cp,XIII -0.22756 
YDR158W aspartic beta semi-aldehyde dehydrogenase,IV -0.22915 
YOR186W Yor186wp,XV -0.24169 
YBR080C cytoplasmic protein involved in protein transport between ER and Golgi; ATPase,II -0.24987 
YCR062W NULL,III -0.24991 
YJL048C Yjl048cp,X -0.26585 
YFL009W part of a ubiquitin ligase complex,VI -0.27184 
YNL268W lysine permease,XIV -0.27703 
YJL052W Glyceraldehyde-3-phosphate dehydrogenase 1,X -0.28083 
YMR200W putative membrane protein,XIII -0.28471 
YCL011C Protein with RNA recognition motifs,III -0.29537 
YEL051W vacuolar ATPase V1 domain subunit D,V -0.29722 
YBL033C GTP cyclohydrolase II,II -0.29883 
YHR132W-A Yhr132w-ap,VIII -0.30971 
YHR214W-A Yhr214w-ap,VIII -0.31103 
YDR355C Ydr355cp,IV -0.31108 
YER102W Ribosomal protein S8B (S14B) (rp19) (YS9),V -0.31261 
YMR121C Ribosomal protein L15B (YL10) (L13B) (rp15R),XIII -0.31543 
YER103W member of 70 kDa heat shock protein family,V -0.31591 
YBL061C Probable Ca++ binding membrane protein (prenylated),II -0.32408 
YDR501W Plm2p,IV -0.32479 
YPR154W Ypr154wp,XVI -0.3282 
YIR026C protein tyrosine phosphatase,IX -0.33513 
YGL061C Duo1p,VII -0.33978 
YBR109C Calmodulin,II -0.34607 
YLR224W Ylr224wp,XII -0.35069 
YHL008C Potential formate transporter nirC,VIII -0.35172 
YDL184C Ribosomal protein L41A (YL41) (L47A),IV -0.35176 
YNL048W Required for N-linked oligosaccharide assembly,XIV -0.35329 
YMR122C Ymr122cp,XIII -0.35392 
YLL039C ubiquitin,XII -0.35793 
YGR161C Ygr161cp,VII -0.36199 
YGL113W Ygl113wp,VII -0.36314 
YNL198C Ynl198cp,XIV -0.36712 
YER006W Yer006wp,V -0.37415 
YNL252C mitochondrial ribosomal protein of the large subunit,XIV -0.38099 
YMR186W constitutively expressed heat shock protein,XIII -0.38208 
YKL045W p58 polypeptide of DNA primase,XI -0.3832 
YLR376C Ylr376cp,XII -0.38668 
YBR161W exhibits high homology to Sur1p,II -0.4209 
YPR193C Histone acetyltransferase,XVI -0.43302 
YMR091C involved in nuclear protein targeting,XIII -0.43869 
YIL054W Yil054wp,IX -0.44009 
YDR044W Coproporphyrinogen III oxidase,IV -0.4445 
YGR234W Yhb1p,VII -0.44612 
YLR262C-A Ylr262c-ap,XII -0.44614 
YDR234W homoaconitase,IV -0.46424 
YKR044W Ykr044wp,XI -0.48095 
YER096W sporulation-specific homolog of csd4,V -0.48273 
YBR083W transcription factor of the TEA/ATTS DNA-binding domain family, regulator of Ty1 expression,II -0.49649 
YFL013C Yfl013cp,VI -0.50192 
YOR370C Rab geranylgeranyltransferase regulatory subunit,XV -0.50228 
YDR239C Ydr239cp,IV -0.50579 
YML090W Yml090wp,XIII -0.50947 
YLL053C Yll053cp,XII -0.52689 
YLR351C nitrilase superfamily member,XII -0.54235 
YOR199W Yor199wp,XV -0.55216 
YPL096W peptide N-glycanase,XVI -0.55284 
YBL081W Ybl081wp,II -0.56902 
YBR012W-B TyB Gag-Pol protein.,II -0.58978 
YBR181C 40S ribosomal gene product S6B (S10B) (rp9) (YS4),II -0.66505 
YIL108W Yil108wp,IX -0.67009 
YJL148W unshared RNA polymerase I subunit,X -0.70742 
YOR242C involved in sporulation,XV -0.71122 
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YPL171C NAD(P)H dehydrogenase,XVI -0.75453 
YJL051W Yjl051wp,X -0.77497 
YDR324C Ydr324cp,IV -0.7959 
YJR162C Yjr162cp,X -0.93801 
 
 
 
Figure C.1  SAM Plot representing distribution of significant ORFs (red /green) which fall outside of the cutoff 
region bounded by  y= [2.3039777, -2.4973323] exclusive ( outside of dashed line). This region allows for a median FDR 
of 7.1719%. 
 
Table C.4 Complete GOMiner term mapping to the RP identified significant gene list (Table C.2)   
GOID GO TERM FREQUENC
Y 
GENE(S) 
5737 cytoplasm 315 out of 
549 genes, 
57.4% 
T5,MAP2,RPL32,CST26,PBY1,CMD1,MRPL36,TPS1,VMA2,OPY1,CKS1,CSH1,RPS6B,PCS60,ILV6,ATG
24W,YDL129W,RPL41A,ACK1,WHI4,GYP7,KCS1,HEM13,DOA4,GIS1,PEX7,SEC7,SDH4,UPS3,COQ4,
D1,CFT1,SWA2,HXT6,MRP1,YPS7,YDR352W,RPS17B,TLG1,YDR476C,SMT3,SNA2,HLR1,CAB1,PAD
9,RPS8B,SSA4,OXA1,FAU1,BUD27,CAK1,ACT1,FET5,FAB1,LSB3,RPL2A,ERJ5,YGL010W,YGL036W,H
MCM6,KEX1,GSC2,CAX4,TAM41,VAS1,RRP46,MDR1,CLB1,SPT6,MTR3,RTS3,KRE11,PUS6,YIP1,YGR
C,OPI1,GUT1,OSH7,ARG4,YHR045W,HTD2,ERG7,YHR113W,MSH1,EPT1,TDA11,YAP1801,YHR162
L108W,KGD1,OM45,GUT2,AIM20,POT1,SEC11,YVH1,PRE3,TDH1,MRPL8,PHS1,UTP10,RPE1,AIM2
,NTA1,LIA1,EMC2,URA8,CPA2,ATP2,STR2,SGM1,YJR154W,MRP17,TMA19,FBA1,YKL061W,LHS1,Y
,GPT2,ECM4,MSA2,TRZ1,HBS1,MRPL20,HSP104,UBI4,COF1,GTT2,UBR2,SNF7,SED5,OSW2,SHM2,
TUB4,ECM22,FAR10,TMA7,NNT1,ECM38,NIT3,ILV5,RPS22B,PSY3,YLR408C,YML018C,BET5,ATP18,
SOV1,NAM7,SRT1,YMR122W-A,ADD37,HSC82,TRI1,YMR244C-
OX5A,MSG5,TOP2,OCA1,YNL115C,PGA2,SKO1,VID27,YNL217W,ALG9,ATG2,MRPL17,SEC2,ERG24,
19,YOL099C,YOL159C-
L23,GET4,KIN4,YOR238W,HRK1,YPK9,YOR304C-
3C,ATP4,PNG1,SSE1,MRPL40,CSM4,AFT2,FLC1,MMT2,IQG1,SRP68,PDH1,ATG11,SEC8,NOT5,OPY2
A2 
5634 nucleus 160 out of 
549 genes, 
29.1% 
SWH1,YBL005W-B,SLA1,RIB1,YBR012W-
B,TEC1,MMS4,TFC1,CKS1,SPP381,SWD3,RRP7,POL4,YCR051W,LUG1,MSH3,DUN1,TMA17,NUP
84,YDL124W,YDL129W,MSH5,UGA3,NOP6,RAD57,GIS1,TAF12,ARG82,NUP42,YDR210C-
C,HTB1,RNH202,CFT1,UTP4,SWR1,TFB3,PLM2,SMT3,CAB1,MMS21,SNU13,NUG1,MOT2,ICP55,
SSA4,SPT15,IES1,ACT1,NIC96,CDC26,CKB1,HEM2,DUO1,SRM1,SLD3,PRP43,SNT2,ITC1,NUP49,M
CM6,YGR038C-
175 
 
A,RRP46,CLB1,SPT6,MTR3,RTS3,SOL4,CAB4,CWC22,OPI1,NAM8,SPO16,RHR2,YRB2,XBP1,NUP1
59,SSL2,RRN7,NUP192,SMC3,IME2,UTP10,ASF1,RPA34,NUC1,YJR029W,HIT1,RPA12,LIA1,EAF6,
CSN12,STR2,HIR3,BYE1,HCS1,PRI2,NUP100,YJU2,UIP5,MSA2,TRZ1,HSP104,RGR1,SEN2,YLR132C
,ECM22,TMA7,PSY3,BDF1,SEN1,RIF2,TAF13,YML108W,RSC9,RSF1,NPL6,NUP53,MSS11,RAD14,T
RI1,RNH1,YMR244C-
A,ZDS1,GAS1,SSN8,MSG5,TOP2,PGA2,SKO1,GCR2,HCH1,STB1,DBP6,POP2,RPB11,PSH1,YOL103
W-
B,RRI2,NOP8,EXO1,RIO1,SPP2,SLK19,SAS5,WTM1,RRP12,SWI1,RMI1,SSN3,CWC27,PNG1,NOP5
3,RAD53,CSM4,AFT2,NOT5,RPC40,RRP9,PIN3,SGV1 
5575 cellular 
compone
nt 
unknown 
101 out of 
549 genes, 
18.4% 
YAL034C-
B,YAL064W,SEF1,YBL081W,YBR062C,PPS1,YCR006C,YCR049C,YCR099C,AAD3,YDL009C,YDL025
C,YDL034W,YDL114W,YDL176W,YDL206W,YDR042C,YDR053W,YDR274C,YDR290W,YDR336W,
YDR355C,DIT2,YDR417C,YDR433W,PFA5,JIP4,YDR491C,API2,MTC7,YEL075C,AIM11,YFL012W,Y
FL013W-A,YFL063W,YFL065C,FAR7,ULI1,YFR057W,YGL042C,YGL074C,RCK1,HUR1,YGL258W-
A,COS12,YGR011W,YHL026C,ECM12,FAA3,YIL014C-
A,YIL054W,YIL165C,YIL169C,YIR016W,DAL7,YJL107C,NIT2,YJR011C,YJR012C,ACF4,YJR162C,AIM
26,MBR1,YKL105C,YKL123W,YKL225W,PAU17,YLL053C,YLR012C,YLR065C,YLR156W,YLR252W,
ADE13,YLR445W,YML090W,YMR034C,RIM9,SNZ1,YMR119W-A,YMR122C,YMR265C,YMR306C-
A,YMR316C-A,YMR316C-
B,YNL120C,YNL198C,PFA4,YOR012W,YOR072W,YOR199W,YOR225W,YOR314W-
A,YPL025C,YPL034W,OYE3,YPL185W,YPL278C,ERR2,YPR064W,YPR177C,YPR196W 
5739 mitochon
drion 
92 out of 
549 genes, 
16.8% 
ATP6,MRPL36,OPY1,ILV6,YCL057C-
A,TSC13,ACK1,DOA4,GIS1,SDH4,UPS3,COQ4,LYS4,FMN1,MSW1,CFT1,HXT6,MRP1,PAD1,FMP52
,ICP55,OXA1,FAU1,FAB1,LSB3,SPC105,PRP43,RSM23,GCN1,TAM41,VAS1,SPT6,PUS6,YHB1,SPG
1,HTD2,MSH1,YHR162W,YIL077C,KGD1,OM45,GUT2,TDH1,MRPL8,UTP10,AIM23,ATP12,NUC1,
PET191,CYC1,OSM1,NTA1,ATP2,MRP17,TMA19,FBA1,MDH1,CYT2,GPM1,TRZ1,MRPL20,GTT2,R
EX2,ERG27,SEN2,YLR132C,NIT3,ILV5,ATP18,COX14,RSF1,SOV1,HSC82,HER2,GAS1,IDP3,COX5A,
TOP2,MRPL17,HXT14,AUS1,VPS21,MRPL23,ALD6,ATP4,PNG1,MRPL40,AFT2,MMT2,PDH1,YPR0
97W,SUE1 
16020 membran
e 
91 out of 
549 genes, 
16.6% 
ATP6,FUI1,VMA2,PCS60,ATG22,PMP1,TSC13,NUP84,SDH4,UPS3,NUP42,COQ4,FMN1,SWA2,HX
T6,YDR352W,SNA2,FMP52,SHC1,OXA1,FET5,NIC96,FAB1,NUP49,ZRT1,GSC2,CAX4,TAM41,MUP
1,VHT1,YIP1,HIP1,OPI1,ERG7,SVP26,YRB2,NUP159,QDR1,OM45,SLN1,GUT2,SEC11,NUP192,PH
S1,NUC1,HXT8,PET191,APS2,ATP2,NUP100,ZRT3,COY1,SNF7,OSW2,BOS1,GAA1,NYV1,ERG27,S
EN2,SRN2,NHA1,YLR194C,ECM22,YML018C,ATP18,PHO84,COX14,YET2,FET3,NUP53,ZDS1,GAS1
,ALG11,COX5A,YTP1,ATG2,HXT14,SMF1,AUS1,ALG8,VPS21,OST2,YPK9,MRS6,ATP4,CSM4,MMT
2,YPL264C,PDH1,ATG11,OPY2 
5783 endoplas
mic 
reticulum 
37 out of 
549 genes, 
6.7% 
SWH1,TSC13,SWA2,YPS7,YDR476C,YEA4,FMP52,ERJ5,YGL010W,CAX4,YIP1,OPI1,YHR045W,ERG
7,EPT1,SVP26,TED1,SEC11,PHS1,EMC2,LHS1,GPT2,BOS1,GAA1,ERG27,FAR10,YMR122W-
A,ALG11,PGA2,ALG9,ERG24,ZRG17,ALG8,OST2,SLY41,CSM4,FLC1 
12505 endome
mbrane 
system 
32 out of 
549 genes, 
5.8% 
SWH1,TSC13,NUP84,NUP42,SWA2,MMS21,NIC96,NUP49,CAX4,YIP1,OPI1,SVP26,YRB2,NUP159
,SEC11,NUP192,PHS1,APS2,PRI2,NUP100,COY1,UIP5,BOS1,GAA1,ERG27,NUP53,ZDS1,PGA2,GC
R2,ALG8,OST2,CSM4 
5840 ribosome 29 out of 
549 genes, 
5.3% 
RPL32,MRPL36,RPS6B,TMA17,RPL41A,YDR239C,MRP1,RPS17B,RPS8B,RPL2A,RSM23,GCN1,YHR
113W,NMD3,RPS24B,MRPL8,MRP17,TMA19,RPS21A,MRPL20,RPS22B,YET2,MRPL17,YOL099C,
MRPL23,RRP12,YPL073C,MRPL40,RPS23B 
5694 chromoso
me 
26 out of 
549 genes, 
4.7% 
HTB1,SWR1,PLM2,SMT3,MMS21,IES1,ACT1,DUO1,SRM1,SLD3,SNT2,MCM6,SPO16,SMC3,UTP1
0,HCS1,PRI2,BDF1,RIF2,TOP2,STB1,RFC4,SLK19,SAS5,RMI1,CSM4 
5740 mitochon
drial 
envelope 
24 out of 
549 genes, 
4.4% 
ATP6,SDH4,UPS3,COQ4,FMN1,FMP52,OXA1,TAM41,OM45,GUT2,NUC1,PET191,CYC1,ATP2,CYT
2,ERG27,SEN2,ATP18,COX14,COX5A,VPS21,ATP4,PDH1,SUE1 
5886 plasma 
membran
e 
21 out of 
549 genes, 
3.8% 
FUI1,PMP1,HXT6,ZRT1,GSC2,MUP1,VHT1,HIP1,ERG7,QDR1,SLN1,HXT8,APS2,NHA1,YLR194C,PH
O84,FET3,GAS1,HXT14,SMF1,OPY2 
5773 vacuole 20 out of 
549 genes, 
3.6% 
VMA2,CSH1,ATG22,YDR352W,FET5,FAB1,HSV2,YHL008C,AIM20,PHS1,ZRT3,NYV1,ECM38,YML0
18C,YNL115C,YNL217W,YVC1,YPK9,FLC1,OPY2 
5730 nucleolus 19 out of 
549 genes, 
3.5% 
RRP7,LUG1,NOP6,UTP4,SNU13,NUG1,SPT15,CKB1,MTR3,RRN7,UTP10,RPA34,RPA12,TRI1,DBP6
,NOP8,NOP53,RPC40,RRP9 
30427 site of 
polarized 
growth 
18 out of 
549 genes, 
3.3% 
SLA1,SKT5,CMD1,SYP1,ACT1,LSB3,SHM2,ZDS1,SEC2,POP2,ARF3,KIN4,YOR304C-
A,SVL3,FLC1,IQG1,SEC8,MLC2 
5856 cytoskelet
on 
17 out of 
549 genes, 
3.1% 
SKT5,CMD1,SMT3,ACT1,DUO1,SPC105,GSC2,YAP1801,ARC19,COF1,TUB4,BUB2,DYN3,SLK19,KI
N4,IQG1,MLC2 
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5624 membran
e fraction 
16 out of 
549 genes, 
2.9% 
ATG20,YDL124W,DOA4,IPT1,FMN1,HXT6,GSC2,HSV2,TDH1,GPT2,COF1,SHM2,HSC82,GAS1,ATG
19,YPL277C 
5794 Golgi 
apparatus 
15 out of 
549 genes, 
2.7% 
SWH1,SEC7,TLG1,KEX1,KRE11,YIP1,SVP26,SGM1,COY1,SED5,BET5,GAS1,COG6,COG5,COG4 
5933 cellular 
bud 
15 out of 
549 genes, 
2.7% 
SKT5,CMD1,SYP1,ACT1,LSB3,IRC8,ZDS1,ARF3,KIN4,YOR304C-A,SVL3,FLC1,IQG1,SEC8,MLC2 
5938 cell cortex 11 out of 
549 genes, 
2.0% 
SLA1,SKT5,SMT3,ACT1,GSC2,YAP1801,COF1,KIN4,IQG1,SEC8,MLC2 
16023 cytoplasm
ic 
membran
e-
bounded 
vesicle 
8 out of 549 
genes, 1.5% 
SEC7,SCY1,YIP1,SVP26,APS2,SGM1,GAS1,SEC2 
5815 microtub
ule 
organizin
g center 
6 out of 549 
genes, 1.1% 
CMD1,DUO1,SPC105,TUB4,BUB2,KIN4 
5618 cell wall 5 out of 549 
genes, 0.9% 
MKC7,TDH1,YLR194C,GAS1,SSP2 
5777 peroxiso
me 
4 out of 549 
genes, 0.7% 
PCS60,PEX7,POT1,IDP3 
5576 extracellu
lar region 
0 out of 549 
genes, 0% 
none 
OTHE
R 
other 11 out of 
549 genes, 
2.0% 
PHO3,HIS4,SRO9,ROM1,RPN10,BUD2,RHO4,YLR224W,GSH2,MKK2,PCL8 
NOT_
YET_A
NNOT
ATED 
not_yet_a
nnotated 
1 out of 549 
genes, 0.2% 
YKL199C 
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